data_1cix_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1cix _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HB3' ' N ' ' A' ' 24' ' ' CYS . 55.5 m -118.99 172.87 7.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.18 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -63.69 -168.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.146 -0.971 . . . . 0.0 109.317 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.96 179.85 3.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.66 150.38 23.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.52 34.62 89.63 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.87 -166.88 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -1.133 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -103.26 171.95 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.221 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 168.54 21.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.518 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 t -121.76 112.84 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.9 m -87.76 9.3 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.445 ' HB2' HG21 ' A' ' 37' ' ' THR . 9.7 ttt180 -120.01 -5.97 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -58.07 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 24.7 m-85 -72.64 141.2 48.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 109.321 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.53 87.0 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.546 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 12.8 mt 43.86 59.7 12.23 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.394 -1.062 . . . . 0.0 109.978 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.69 -40.65 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.467 2.112 . . . . 0.0 110.173 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.5 m -78.27 144.2 36.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.62 122.58 83.98 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.76 149.76 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.433 2.089 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.58 161.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.454 ' N ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -73.11 168.2 19.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.696 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -52.93 142.08 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.78 -20.25 41.97 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 1.1 mt -110.63 139.28 46.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -1.171 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.3 162.93 14.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.02 113.3 16.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 158.84 25.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 155.26 17.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 99.1 m-85 -62.44 -19.9 63.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.61 167.69 0.15 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.213 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 34.6 Cg_endo -77.27 120.56 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.541 2.161 . . . . 0.0 110.311 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.36 11.37 8.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 p -123.96 -167.38 1.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 14' ' ' ARG . 3.4 m -142.03 25.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.667 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 176.44 9.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -173.32 -163.48 27.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 173.06 11.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.5 t -136.63 126.59 25.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 1.2 mt-30 -129.36 175.86 8.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 27.5 ttm-85 -86.03 43.74 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' OXT' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 p -138.8 151.1 46.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -61.78 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.892 . . . . 0.0 109.232 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.99 160.5 14.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.351 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' C ' ' OE1' ' A' ' 7' ' ' GLN . 3.1 tm0? -67.34 157.67 33.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.156 -0.965 . . . . 0.0 109.556 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.98 57.02 9.18 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.6 -164.27 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -1.111 . . . . 0.0 109.459 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.35 161.0 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 t -154.48 150.76 28.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 12' ' ' VAL . 12.2 p -103.09 119.37 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 109.643 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 m -81.52 -22.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' SER . 8.6 mmt180 -90.47 -84.27 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 62.65 106.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -101.51 93.51 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 104.05 8.59 38.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.521 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.9 mm? 61.65 60.9 2.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.181 -1.188 . . . . 0.0 109.532 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.7 Cg_endo -77.71 -66.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.426 2.084 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 m -72.87 164.06 27.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 109.289 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 5.0 mm -84.23 137.94 39.55 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.8 Cg_endo -78.64 -167.48 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.679 2.253 . . . . 0.0 110.48 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.5 m -98.64 156.68 16.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.38 161.62 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 139.09 55.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' OXT' ' A' ' 44' ' ' TYR . . . 108.84 -26.79 14.59 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.53 166.83 12.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -140.36 160.71 39.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.3 t -101.88 129.54 48.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.4 ttt180 -133.44 131.42 39.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -98.9 152.22 20.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m-85 -53.81 -69.87 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 109.32 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.567 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 172.06 -55.81 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 109.707 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.1 Cg_endo -78.29 127.0 8.01 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 110.322 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.18 48.41 79.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.42 ' O ' ' OG1' ' A' ' 37' ' ' THR . 97.6 p -45.75 113.18 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -1.075 . . . . 0.0 109.668 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 36' ' ' SER . 28.2 m -166.08 -41.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -137.35 119.39 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.344 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -127.79 -143.58 5.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -124.25 162.9 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.32 131.65 55.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.08 -172.1 2.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.37 -0.831 . . . . 0.0 109.404 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -100.11 61.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.462 ' OXT' ' O ' ' A' ' 26' ' ' GLY . 3.6 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.343 0.592 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -131.7 166.9 20.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.514 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -95.72 -170.79 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 1.9 mp -106.23 156.75 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -74.7 141.02 44.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 62.5 4.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 1.6 m-85 -141.52 -163.96 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.212 . . . . 0.0 109.433 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -79.53 130.5 35.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -124.64 176.49 6.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 109.626 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.51 167.59 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.198 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' A' ' 31' ' ' SER . 35.6 m -138.32 6.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.736 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.72 33.95 5.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.62 58.79 2.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -102.38 72.67 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.18 -49.39 0.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 159.28 49.35 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.189 -1.183 . . . . 0.0 109.417 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.92 111.26 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.62 2.214 . . . . 0.0 110.472 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -156.66 128.49 7.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.5 mm -85.15 117.66 69.23 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 -179.22 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.264 1.976 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' CYS . 12.5 m -71.2 155.83 40.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 7.7 m -43.65 161.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -62.74 144.84 56.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.409 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 96.29 -15.66 62.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 43' ' ' ARG . 64.6 mt -105.65 173.24 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.98 -174.72 4.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 40.7 m -146.49 165.93 27.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.16 50.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB3' HG12 ' A' ' 13' ' ' VAL . 13.4 p -88.64 138.97 30.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.203 -0.936 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 34.2 m-85 -46.76 -68.91 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.081 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 165.0 -54.35 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.295 -0.878 . . . . 0.0 109.395 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.4 Cg_endo -79.85 116.62 3.48 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.465 2.11 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.62 59.49 7.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -48.0 102.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -1.016 . . . . 0.0 109.759 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -148.41 -52.27 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.328 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.85 142.06 51.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.71 -140.63 3.75 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.55 144.47 51.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.299 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -101.38 139.42 37.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.788 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -162.01 0.94 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 108.982 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HA ' HD22 ' A' ' 27' ' ' LEU . 2.3 ttm180 -102.11 59.59 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.0 109.347 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.541 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 2.8 t -90.89 128.57 36.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.39 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.4 163.5 17.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -62.75 124.65 21.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.05 58.56 1.77 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.95 -166.55 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -1.072 . . . . 0.0 109.556 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.39 133.82 34.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.2 t -131.95 149.17 52.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 20' ' ' THR . 4.3 p -85.08 140.12 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.21 -20.99 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.932 . . . . 0.0 109.638 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 58.31 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.64 99.04 8.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 35.8 p90 -123.75 55.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.34 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.28 -35.91 3.47 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 153.82 3.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.171 -1.193 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.8 86.77 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.54 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.407 HG22 HG12 ' A' ' 12' ' ' VAL . 2.0 t -148.03 97.51 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 3.3 tt -62.08 113.8 9.65 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.88 . . . . 0.0 109.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.72 -161.51 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.343 2.029 . . . . 0.0 110.147 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.95 -168.23 0.26 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.6 m -91.02 -179.1 5.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.55 127.72 33.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.382 -0.824 . . . . 0.0 109.703 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 27' ' ' LEU . . . 109.28 -7.21 32.41 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' CD2' ' HG2' ' A' ' 43' ' ' ARG . 22.1 mt -118.14 109.94 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -1.198 . . . . 0.0 109.556 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 p -83.59 174.39 10.59 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.186 -0.946 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.3 m -125.1 140.32 52.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.153 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 134.22 34.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 t -83.62 100.68 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 109.391 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.558 ' CE2' ' HA2' ' A' ' 39' ' ' GLY . 3.4 p90 -45.92 -27.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -0.976 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -127.79 145.86 56.61 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.416 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.42 93.15 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.644 2.229 . . . . 0.0 110.508 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.68 -30.9 1.93 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 p -79.11 104.13 9.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -1.223 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -52.56 -22.81 5.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.53 131.37 49.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -129.37 -136.93 4.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -125.8 175.45 7.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.189 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -129.58 134.99 48.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 18.8 mt-30 -149.66 -177.2 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.945 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.496 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -88.22 38.67 0.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.566 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 35.4 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.446 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 m -141.13 142.84 34.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.555 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 10' ' ' ASN . 2.7 mt-30 -66.38 -167.66 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.17 171.63 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -67.4 146.7 53.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.25 68.62 1.6 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 1.7 m-85 -146.41 -165.73 2.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -1.117 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.464 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 6.1 m-20 -89.57 141.31 28.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 19.5 t -143.42 158.08 43.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 10.0 p -99.23 145.24 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.434 ' N ' HG21 ' A' ' 12' ' ' VAL . 29.3 m -120.36 -21.6 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -130.69 52.48 2.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' ARG . 12.4 t -45.03 131.8 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.538 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -113.31 85.78 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.92 44.15 49.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.85 148.45 56.74 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.656 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.6 91.86 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.588 2.192 . . . . 0.0 110.012 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 t -134.12 161.44 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.86 . . . . 0.0 109.735 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.453 HG21 ' HD2' ' A' ' 22' ' ' PRO . 23.7 mm -127.47 128.15 24.04 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 109.088 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 21' ' ' ILE . 35.5 Cg_endo -77.57 167.01 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.388 2.058 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 89.4 m -60.62 146.88 43.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.73 165.09 4.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -46.01 151.29 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.68 -6.23 79.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -125.36 124.81 42.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.246 . . . . 0.0 109.506 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.4 147.58 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.38 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.2 m -103.51 133.35 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -121.68 159.16 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.98 153.91 28.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 34.3 m-85 -58.3 -72.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 168.74 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -77.74 110.8 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.448 2.099 . . . . 0.0 110.345 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 65.96 62.99 4.29 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 35' ' ' GLY . 6.0 p -43.36 120.18 1.82 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -1.124 . . . . 0.0 109.568 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -160.29 -81.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.61 122.24 45.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.4 -145.67 5.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -114.51 -173.27 2.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -1.204 . . . . 0.0 109.502 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.2 t -138.2 127.04 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -111.3 -178.3 3.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -103.87 47.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.972 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.568 ' CD1' ' OXT' ' A' ' 44' ' ' TYR . 30.3 t80 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.2 mmm180 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' GLN . 40.0 t -143.3 99.34 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' CYS . 5.1 mt-30 -54.56 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -177.9 3.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.579 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' CD ' ' N ' ' A' ' 8' ' ' GLY . 18.2 tm0? -77.68 169.67 17.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 7' ' ' GLN . . . 44.61 48.67 8.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -164.19 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.372 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.39 122.94 45.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.561 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 43.0 t -132.2 157.36 44.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.4 p -89.62 136.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.417 HG21 ' N ' ' A' ' 14' ' ' ARG . 6.6 m -97.44 -22.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.417 ' N ' HG21 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -91.09 67.15 5.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.314 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -94.15 27.35 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -87.68 109.62 19.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -5.68 84.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.31 112.56 26.02 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.245 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.47 75.82 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.424 2.083 . . . . 0.0 110.361 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -166.82 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 4.0 mp -116.3 94.04 41.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.65 -179.12 5.14 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.622 2.215 . . . . 0.0 110.464 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.59 154.04 41.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.21 161.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -50.48 156.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 -49.2 1.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 10.1 mt -91.16 135.33 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -1.099 . . . . 0.0 109.506 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 146.6 39.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.98 116.38 24.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 109.36 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 159.25 22.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.0 p -108.95 154.11 22.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.35 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.81 1.07 22.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -127.2 158.25 69.81 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.052 -1.03 . . . . 0.0 109.629 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD2' ' CD2' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -78.07 134.58 13.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.547 2.165 . . . . 0.0 110.525 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.53 47.11 64.27 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -162.29 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -1.19 . . . . 0.0 109.438 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.4 m -135.68 -58.58 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.477 ' CE1' ' HB ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.42 142.99 34.22 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.595 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -159.73 8.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -94.7 167.99 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -1.15 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.0 t -117.69 138.36 52.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.76 -175.48 4.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -85.98 50.2 1.93 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.97 -1.015 . . . . 0.0 109.477 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.407 0.622 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.74 170.2 21.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -91.21 156.51 17.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.98 154.97 21.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.544 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.15 115.18 9.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.41 41.4 1.15 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -120.59 -149.17 0.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.233 -1.157 . . . . 0.0 109.688 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -118.6 109.44 16.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.31 153.16 20.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 109.482 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.83 170.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.868 . . . . 0.0 109.345 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.54 -15.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.24 42.53 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.674 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.1 100.95 13.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 6.2 p90 -150.83 122.29 7.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.57 -25.97 25.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.513 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.06 175.8 2.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 18' ' ' LEU . 34.6 Cg_endo -77.61 118.42 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.555 2.17 . . . . 0.0 110.397 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 m -158.7 155.43 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -114.38 106.4 52.7 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 150.59 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.335 2.024 . . . . 0.0 110.422 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 90.1 m -51.32 163.53 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -178.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 4.5 tpm_? -69.39 146.59 51.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.743 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 91.24 -28.18 8.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -83.28 140.97 32.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.114 -1.227 . . . . 0.0 109.686 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.02 151.21 40.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.65 121.58 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' SER . 3.1 ttt180 -110.81 100.51 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.417 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -44.04 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 8.3 m-85 -59.51 -65.31 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.63 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.2 -53.78 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.02 . . . . 0.0 109.847 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.5 Cg_endo -78.86 66.99 8.64 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.584 2.189 . . . . 0.0 110.798 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.95 31.91 0.5 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.476 ' CB ' ' HB2' ' A' ' 32' ' ' TYR . 19.3 p -61.06 145.59 50.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 m -83.37 -27.75 29.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.57 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -122.77 117.33 25.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -106.35 -157.62 21.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -110.54 175.3 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -1.109 . . . . 0.0 109.522 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.0 t -128.69 137.83 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.99 173.62 11.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' HG ' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -90.85 58.13 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.8 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.449 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.35 0.595 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' GLN . 26.4 p -152.39 156.66 39.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.483 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' CYS . 4.3 mt-30 -46.45 172.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.12 167.95 9.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.25 -0.907 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.496 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 3.0 tt0 -73.84 149.77 41.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.06 65.75 3.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -149.69 -161.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -1.186 . . . . 0.0 109.409 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.75 161.92 21.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 109.539 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 41' ' ' CYS . 48.7 t -153.85 159.44 41.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.895 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.46 HG13 ' CA ' ' A' ' 15' ' ' SER . 35.4 t -118.38 96.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.49 -26.74 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' SER . 0.2 OUTLIER -92.0 -84.56 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 63.89 84.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.378 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -78.14 107.6 10.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.695 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.4 17.19 67.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 55.22 66.52 3.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -1.125 . . . . 0.0 109.521 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HD2' ' OG ' ' A' ' 15' ' ' SER . 35.4 Cg_endo -78.04 -16.19 14.3 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.624 2.216 . . . . 0.0 110.551 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.8 m -136.08 157.52 46.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.5 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 60.7 mt -63.84 139.44 97.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 36.2 Cg_endo -78.26 -174.09 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.65 145.55 26.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.385 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -44.15 168.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -64.75 145.59 56.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.43 -15.13 55.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.503 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -89.93 147.27 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -1.178 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.92 156.45 33.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.8 t -97.33 115.19 27.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 113.52 20.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 109.163 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.463 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.0 OUTLIER -92.9 179.13 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' CE1' ' HA2' ' A' ' 39' ' ' GLY . 4.9 p90 -129.45 12.32 5.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.936 . . . . 0.0 109.658 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.402 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.2 OUTLIER -127.55 162.52 48.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.31 73.27 5.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.512 2.141 . . . . 0.0 110.444 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.55 51.04 4.76 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' THR . 2.5 t -85.29 -8.86 58.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.561 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 36' ' ' SER . 1.3 m 72.5 3.05 4.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.501 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE1' HG21 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -153.83 157.1 38.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.188 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.516 ' HA2' ' CE1' ' A' ' 32' ' ' TYR . . . -173.61 -147.59 6.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.04 168.23 11.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.589 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.3 t -120.69 161.16 21.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 10.3 pt20 -151.4 -178.2 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' TYR . 12.9 ttt85 -105.77 46.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' CG ' ' OXT' ' A' ' 44' ' ' TYR . 79.6 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.485 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 40.64 3.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.0 109.559 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 7.0 tp60 51.35 -160.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -178.55 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 43' ' ' ARG . 46.7 tt0 -82.0 153.25 26.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 43.53 74.7 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 -163.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -1.125 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -84.72 117.58 23.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.392 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.6 t -105.25 154.55 20.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 15' ' ' SER . 10.6 p -102.04 149.18 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.01 -30.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.868 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.01 63.86 0.71 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 109.681 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.461 ' HB3' HG22 ' A' ' 12' ' ' VAL . 35.7 t -109.59 66.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.687 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -78.32 149.48 33.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.83 -25.88 9.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.12 155.17 44.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.131 -1.217 . . . . 0.0 109.598 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.01 109.68 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.519 2.146 . . . . 0.0 110.063 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 20' ' ' THR . 9.1 t -135.97 129.88 32.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 6.4 mt -106.71 124.44 35.53 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.212 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 172.22 16.04 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.316 2.01 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 27' ' ' LEU . 47.6 m -65.5 -171.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -178.27 4.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.95 133.87 51.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.82 -20.04 27.35 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.57 126.97 47.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -1.155 . . . . 0.0 109.531 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.98 160.1 17.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.6 127.6 55.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.377 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 111.15 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -0.971 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.8 t -63.33 145.06 56.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.574 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 34.7 m-85 -56.04 -72.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.475 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -116.29 172.45 3.8 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.2 Cg_endo -77.52 123.24 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.532 2.154 . . . . 0.0 110.254 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.22 18.59 21.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -106.58 178.88 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -1.072 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 m -121.09 -10.17 9.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.526 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 170.47 14.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -164.75 -138.89 2.51 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.99 166.22 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.344 -1.092 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.28 129.17 53.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.415 ' C ' HD22 ' A' ' 27' ' ' LEU . 16.1 pt20 -124.38 146.38 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.388 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.454 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -88.45 42.93 1.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.279 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.27 0.557 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 24' ' ' CYS . 1.4 p -127.45 173.71 9.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -150.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 0.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.21 162.15 26.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -73.48 137.67 44.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.76 54.28 6.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.51 -165.25 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -1.125 . . . . 0.0 109.484 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -87.16 160.71 18.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.505 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -146.21 178.34 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 109.401 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 38' ' ' TYR . 2.4 p -121.71 95.65 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.27 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.493 HG21 ' N ' ' A' ' 14' ' ' ARG . 3.2 m -67.95 -21.13 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.493 ' N ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -85.25 102.46 13.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.9 135.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.098 -1.001 . . . . 0.0 109.658 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 18.4 p90 -149.92 90.15 1.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -6.12 83.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.34 152.95 83.98 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.215 -1.168 . . . . 0.0 109.48 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.88 54.05 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.895 2.397 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 t -86.59 -179.73 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.052 -1.03 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -118.52 86.95 29.96 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.88 -171.83 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 110.45 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -63.47 171.09 2.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -58.72 168.43 1.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 132.23 45.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.357 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.28 -20.2 33.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 43' ' ' ARG . 62.0 mt -95.27 167.42 11.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.116 . . . . 0.0 109.356 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.43 149.76 51.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 m -121.87 138.89 54.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -124.29 165.86 16.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -91.89 176.52 6.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 6.7 m-85 -75.29 -67.39 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.553 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 163.3 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.909 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.7 Cg_endo -78.23 70.34 7.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.171 1.914 . . . . 0.0 110.908 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 41.28 43.29 3.54 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.61 125.93 35.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.42 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 13' ' ' VAL . 14.5 t -69.26 -23.66 63.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 2.1 m-85 -113.58 160.85 18.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.58 -145.38 4.12 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -117.31 169.76 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.141 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 47.8 t -126.4 141.62 51.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.65 -177.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.686 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HA ' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -90.14 41.44 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.509 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.486 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' GLN . 51.3 t -157.95 129.58 6.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.202 -0.936 . . . . 0.0 109.507 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -53.61 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.53 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 164.88 12.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.685 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.36 139.09 38.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.91 56.41 3.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 16.7 m-85 -143.02 -175.95 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 109.168 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 16.3 p-10 -81.9 152.57 26.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.96 156.57 36.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.7 136.58 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.549 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 31' ' ' SER . 11.3 m -97.04 -25.55 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.271 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' NH1' ' OG1' ' A' ' 37' ' ' THR . 1.5 ttm180 -96.99 -65.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.368 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 64.05 170.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.729 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 3.8 p90 -149.85 68.21 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.61 25.74 6.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.545 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.7 mt 51.66 59.06 15.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.446 -1.032 . . . . 0.0 109.886 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.7 Cg_endo -79.01 -68.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.583 2.188 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.5 m -64.7 151.23 45.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.46 113.7 12.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.1 Cg_endo -77.83 169.37 20.79 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.344 2.03 . . . . 0.0 110.234 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.76 164.47 25.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.0 166.53 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -56.55 147.42 22.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.847 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.42 -26.41 17.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 136.04 38.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -1.129 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 153.07 31.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.7 114.69 27.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.68 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 4.7 tpt180 -101.96 152.62 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.314 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.472 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.92 168.64 10.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 109.468 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 13.2 m-85 -62.65 -65.01 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 166.8 -52.29 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -79.46 60.64 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.166 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.14 42.73 2.44 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.8 p -75.88 -5.57 46.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -1.109 . . . . 0.0 109.626 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.575 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 98.3 m 48.36 23.57 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.118 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 37' ' ' THR . 6.3 m-85 -160.26 138.32 9.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 108.983 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -155.62 -139.76 2.84 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 17.1 mtp180 -121.51 -169.74 1.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' PHE . 2.6 t -134.79 125.75 27.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.395 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -120.82 176.37 5.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -100.44 62.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 t -155.53 138.98 15.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.12 152.87 38.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 18.1 mt -104.09 -178.38 3.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 14.9 tt0 -67.96 155.4 39.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 67.28 29.65 74.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.67 -164.53 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -1.092 . . . . 0.0 109.351 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.09 159.17 15.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.387 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.33 175.87 9.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.324 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -139.43 114.49 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.47 -11.17 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.474 ' HD3' ' CG2' ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.68 23.45 14.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.447 ' OG ' ' HB ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -88.81 109.89 20.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 23.7 p90 -156.02 101.49 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 109.334 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.47 41.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 158.29 34.17 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 4.64 6.01 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.648 2.232 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.7 m -52.34 108.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' A' ' 21' ' ' ILE . 26.9 mm -63.22 117.18 31.0 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.29 179.27 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.424 2.083 . . . . 0.0 110.16 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 11.1 m -65.06 169.36 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.434 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ARG . 14.1 m -69.19 151.79 45.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 26' ' ' GLY . 4.6 ttm180 -43.08 138.75 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.45 ' N ' ' HG2' ' A' ' 25' ' ' ARG . . . 96.25 5.86 59.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.403 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mt -125.5 128.05 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.7 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.92 -168.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 88.2 m -142.06 158.77 43.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.05 124.44 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -49.98 150.87 2.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 26.9 m-85 -50.17 -30.96 12.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 171.43 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.005 . . . . 0.0 109.713 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 34.9 Cg_endo -77.24 -167.94 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.43 2.086 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.6 32.68 4.41 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -56.84 164.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -1.107 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -93.11 -6.88 47.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 131.53 53.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.08 -166.16 11.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.29 53.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -1.191 . . . . 0.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.86 130.34 34.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.366 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.76 -178.96 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.77 50.59 1.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.843 . . . . 0.0 109.453 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 12.1 mmm-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.26 0.553 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 3' ' ' ARG . 31.3 m -151.19 156.18 40.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 109.514 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.08 -157.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -107.2 159.44 16.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.535 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -66.86 138.38 57.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 41' ' ' CYS . . . 78.36 40.14 20.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -125.06 -160.57 0.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.39 142.51 27.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -135.44 151.09 50.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 13' ' ' VAL . 10.9 p -97.01 151.39 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.156 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 14' ' ' ARG . 3.6 m -122.5 -41.2 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -118.01 86.31 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.604 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -78.71 167.75 20.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.344 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -156.54 64.85 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.435 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.27 42.57 6.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.529 ' CD2' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -136.53 149.32 67.05 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.262 -1.14 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 18' ' ' LEU . 35.9 Cg_endo -78.09 4.85 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.669 2.246 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -42.39 111.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.418 HG21 ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt -90.04 131.47 39.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' HG21 ' A' ' 21' ' ' ILE . 36.2 Cg_endo -79.05 178.59 7.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.385 2.057 . . . . 0.0 110.453 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.18 156.67 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 166.45 5.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.053 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -56.22 150.32 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.14 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.427 HD21 ' C ' ' A' ' 42' ' ' GLN . 1.5 mt -115.03 147.67 39.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 157.61 24.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -116.18 124.93 51.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 110.3 20.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.838 . . . . 0.0 109.631 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.06 150.46 46.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 23.2 m-85 -61.94 -72.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 109.656 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER 169.73 -55.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.6 Cg_endo -77.42 114.41 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.386 2.058 . . . . 0.0 110.248 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 57.03 15.46 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -45.75 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -1.139 . . . . 0.0 109.749 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.541 HG21 ' CE1' ' A' ' 38' ' ' TYR . 2.4 m -137.53 -47.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 0.0 109.251 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.541 ' CE1' HG21 ' A' ' 37' ' ' THR . 81.6 m-85 -143.87 133.52 23.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 -156.79 8.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -95.56 165.98 12.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -1.157 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.466 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 17.0 t -125.07 132.44 53.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.427 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.9 tt0 -133.88 159.92 39.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -89.6 50.23 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 35.8 t -143.06 28.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER 55.16 169.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.392 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.65 144.47 42.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -47.99 114.93 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.303 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.6 51.34 1.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.509 ' CB ' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -123.62 -163.44 1.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -1.095 . . . . 0.0 109.401 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -99.26 124.86 44.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -108.22 156.28 19.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 15' ' ' SER . 43.0 t -97.09 121.56 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.55 -12.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -119.49 18.19 12.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.47 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.522 ' CA ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -45.12 127.62 6.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.68 101.55 6.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 109.504 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 18' ' ' LEU . . . 71.6 7.24 64.42 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.516 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 70.01 62.6 0.51 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.105 -1.233 . . . . 0.0 109.554 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.55 -24.83 7.19 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.659 2.239 . . . . 0.0 110.342 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -97.53 -179.83 4.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.915 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 21' ' ' ILE . 31.0 mm -86.81 140.16 33.15 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.6 Cg_endo -78.16 162.68 28.5 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.545 2.163 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -67.33 169.73 8.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.462 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 38.5 m -71.42 172.9 8.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.256 -0.902 . . . . 0.0 109.101 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -66.6 146.98 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.237 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.87 -12.33 59.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 4.4 mm? -86.0 163.56 17.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -1.101 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 139.37 30.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.583 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.6 m -100.22 108.05 20.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -107.94 122.78 47.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 32' ' ' TYR . 3.5 p -77.16 132.58 38.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 22.9 m-85 -44.13 -65.96 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.399 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.54 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.79 -53.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.667 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.2 Cg_endo -78.04 114.65 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.362 2.041 . . . . 0.0 110.396 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 61.86 60.6 7.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -44.95 110.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.525 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -163.16 -37.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.977 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.36 105.13 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.835 . . . . 0.0 109.552 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.6 -160.89 12.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -113.06 172.97 6.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -1.18 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.45 120.37 34.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 3.3 mm-40 -114.11 168.98 9.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.555 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.89 54.97 2.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.524 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.227 0.537 . . . . 0.0 109.796 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -86.0 147.39 26.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.35 153.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 mt -81.62 -173.81 4.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -81.88 141.16 33.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.494 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.11 75.43 0.46 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -154.24 -171.86 4.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -1.199 . . . . 0.0 109.561 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.45 102.55 13.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.604 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.5 t -89.07 153.9 20.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.39 142.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.37 7.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 109.546 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 36.96 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.7 t -93.66 97.0 10.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 77.54 1.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.54 55.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.3 153.11 48.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 111.85 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.525 2.15 . . . . 0.0 110.349 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -148.36 162.31 39.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 mm -110.32 96.57 27.21 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.374 -0.829 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 20' ' ' THR . 34.4 Cg_endo -76.98 -163.05 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.51 2.14 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -73.61 176.3 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 176.07 8.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -68.94 134.14 49.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.91 -7.82 49.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 16.9 mt -103.21 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.538 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 132.07 32.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.5 t -98.99 141.62 31.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.257 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -147.0 144.71 29.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.086 -1.009 . . . . 0.0 109.773 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 p -97.11 154.72 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.333 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 23.4 m-85 -62.05 -70.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.0 109.364 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.5 -53.48 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -79.0 87.18 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.457 2.105 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 120.77 -36.58 3.3 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 11.5 p 47.36 49.37 15.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 109.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.5 m -120.99 -41.66 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -143.74 116.23 8.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -114.13 -138.24 6.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 11.1 mtt180 -125.82 163.76 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -1.097 . . . . 0.0 109.518 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.27 154.15 35.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.337 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -154.27 -174.82 5.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' CG ' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.05 75.85 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.365 -0.835 . . . . 0.0 109.39 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.742 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.307 0.575 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 -151.74 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.239 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.13 158.82 43.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.46 134.78 34.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.85 152.09 7.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 109.255 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.83 21.28 66.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 3.0 m-85 -106.25 -167.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -97.99 160.68 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.263 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -126.36 172.37 10.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 5.1 t -111.48 85.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 m -52.25 -21.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -100.96 -80.63 0.49 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 13.0 t 52.09 22.45 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -97.86 110.39 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.19 -16.37 35.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.5 mt -134.0 143.95 49.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.419 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.34 145.76 21.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.554 2.169 . . . . 0.0 110.385 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -172.92 4.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.63 106.98 51.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.43 152.47 30.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.346 2.03 . . . . 0.0 110.461 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 79.8 m -59.31 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.94 168.07 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.788 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.77 124.96 15.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' ARG . . . 103.22 12.18 32.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.475 ' N ' HD21 ' A' ' 27' ' ' LEU . 4.1 mm? -116.73 100.64 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -1.017 . . . . 0.0 109.386 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 147.0 28.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.3 m -110.07 146.83 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.574 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.41 134.45 19.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 159.51 8.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.534 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.58 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 23.7 t80 160.38 -47.28 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.586 . . . . 0.0 109.69 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -77.89 -169.2 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.959 1.772 . . . . 0.0 110.39 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.42 17.13 58.25 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -51.43 155.62 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -1.197 . . . . 0.0 109.493 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.0 t -89.22 23.26 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.77 153.91 40.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.23 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 10' ' ' ASN . . . -155.02 -140.64 3.05 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 10' ' ' ASN . 2.7 ttt85 -118.32 176.0 5.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 109.508 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 25.0 t -142.84 124.22 14.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -145.53 174.49 11.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -97.35 -8.76 28.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 0.0 109.473 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 41.7 t80 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLN . 57.6 m -147.6 153.92 40.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 0.0 109.718 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 4' ' ' CYS . 46.0 mt-30 -50.38 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 168.97 23.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 109.582 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.382 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 9' ' ' PHE . . . 105.24 48.54 1.05 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 8' ' ' GLY . 38.6 m-85 -141.59 -165.31 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 17.5 p30 -79.62 138.14 37.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.489 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 42.5 t -121.57 154.0 37.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 12' ' ' VAL . 14.1 p -103.61 113.48 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 m -78.68 -20.12 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.445 ' HB2' HG21 ' A' ' 37' ' ' THR . 6.6 tpp180 -99.28 57.7 1.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 20' ' ' THR . 0.2 OUTLIER -103.78 5.27 35.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -95.52 107.03 19.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.23 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.25 26.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 151.14 38.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -1.199 . . . . 0.0 109.391 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.22 123.57 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.572 2.181 . . . . 0.0 110.539 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 15' ' ' SER . 11.4 t -162.85 178.87 8.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.317 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -115.56 90.16 24.97 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.137 -0.977 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.06 -159.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.575 2.184 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 89.4 m -86.69 164.83 16.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -179.48 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -73.42 136.03 44.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 -24.19 31.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 19.8 mt -85.64 142.79 28.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -1.134 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.43 153.54 23.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.757 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.1 m -124.34 150.84 45.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -0.813 . . . . 0.0 109.131 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -148.62 108.38 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' TYR . 2.9 p -50.02 133.23 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.294 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' SER . 27.9 m-85 -43.96 -53.12 6.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.569 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -106.33 172.27 4.06 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.28 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 35.1 Cg_endo -78.79 74.2 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.534 2.156 . . . . 0.0 110.275 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' SER . . . 146.5 -24.06 1.68 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.6 m -50.49 -179.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -1.133 . . . . 0.0 109.457 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 14' ' ' ARG . 51.0 m -123.2 -12.29 7.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 118.86 23.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 -150.02 7.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.9 174.03 6.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -1.098 . . . . 0.0 109.131 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.62 119.07 19.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 109.777 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -111.4 -173.18 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.257 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.7 68.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.448 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.268 0.556 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 5' ' ' GLN . 28.6 t -117.23 156.83 27.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.394 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -85.36 172.32 11.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.333 -0.854 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -115.71 -174.87 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.372 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.32 136.73 46.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.513 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.55 65.83 2.65 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 2.8 m-85 -140.35 -167.11 2.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 109.373 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . 0.419 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 4.7 m-20 -90.92 116.13 28.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.45 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -109.01 152.61 24.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 0.0 109.406 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 15' ' ' SER . 8.3 p -106.39 131.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.1 m -102.1 -18.94 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -86.51 48.2 1.59 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.636 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB2' HG12 ' A' ' 12' ' ' VAL . 36.4 t -113.55 101.02 8.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.039 -1.038 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 5.3 p90 -144.54 70.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.304 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.42 -27.58 5.75 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -96.96 143.45 26.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.305 -1.115 . . . . 0.0 109.388 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.2 Cg_endo -78.53 127.12 7.9 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.576 2.184 . . . . 0.0 110.43 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.62 -148.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.0 mm -124.99 84.15 59.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.143 -0.973 . . . . 0.0 109.385 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 156.14 30.61 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.651 2.234 . . . . 0.0 110.46 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.9 m -63.16 164.87 7.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 m -61.66 169.93 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.704 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -66.63 124.87 24.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.828 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.19 -2.11 31.29 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.76 152.26 21.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -1.142 . . . . 0.0 109.467 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.22 137.65 41.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.392 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 41' ' ' CYS . 1.6 p -128.6 140.07 51.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.057 -1.027 . . . . 0.0 109.866 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 31' ' ' SER . 1.1 ttp180 -127.72 142.26 51.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.317 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -44.08 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.709 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 18.1 m-85 -61.79 -39.16 90.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 172.76 -54.16 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.827 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 37.5 Cg_endo -82.0 52.19 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.561 2.174 . . . . 0.0 110.577 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.37 32.08 1.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 31' ' ' SER . 6.5 t -52.0 146.4 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -1.086 . . . . 0.0 109.793 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -66.69 -33.18 75.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.189 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.71 124.38 52.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.053 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.05 -153.12 11.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -120.8 139.61 52.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.277 -1.131 . . . . 0.0 109.438 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -94.83 155.64 16.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 31.9 mt-30 -148.69 172.2 14.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.85 35.64 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.302 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.415 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 11.3 p -126.43 -174.03 3.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 4' ' ' CYS . 7.5 mm-40 -53.41 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 121.57 31.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -60.57 149.0 36.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.42 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.99 62.95 5.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 -151.81 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -1.152 . . . . 0.0 109.343 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.66 138.31 35.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.354 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 159.15 19.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.622 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.42 127.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.12 -2.7 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.461 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -89.66 54.41 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 109.459 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 t -114.02 123.81 50.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.451 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 2.2 p90 -129.56 93.82 3.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.44 17.11 78.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.8 164.16 15.59 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.97 -83.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.625 2.217 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m 48.18 69.98 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 mm -45.41 109.35 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.8 Cg_endo -77.63 -177.25 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.488 2.126 . . . . 0.0 110.571 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' PRO . 77.7 m -48.05 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 54.9 m -74.21 174.69 8.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -67.92 137.29 55.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.96 -16.74 30.33 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.88 167.82 11.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.88 167.81 20.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.6 t -123.67 128.95 50.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.24 110.86 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.509 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 m -68.01 162.29 24.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.446 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 27.9 m-85 -75.86 -71.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.541 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 164.72 -52.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.0 109.474 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.76 100.3 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.469 2.113 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 95.93 -33.58 5.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 2.6 p 48.53 71.12 0.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -1.091 . . . . 0.0 109.532 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 m -128.25 -74.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 3.2 m-85 -109.49 117.87 35.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.88 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -112.76 -128.3 4.93 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.25 144.37 49.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.378 -1.072 . . . . 0.0 109.479 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.5 t -106.64 120.86 43.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.218 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.94 175.21 5.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.187 -0.946 . . . . 0.0 109.748 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -117.91 67.87 0.76 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.46 -177.24 6.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -104.25 179.69 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.321 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.44 173.11 12.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.967 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.65 138.4 35.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.77 74.26 1.19 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.15 -159.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.314 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -104.64 134.78 47.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -131.88 151.32 51.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -95.1 145.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.471 HG12 ' CB ' ' A' ' 31' ' ' SER . 31.3 m -101.68 16.09 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -140.74 17.55 2.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.367 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -44.81 -29.68 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.561 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -48.35 98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.244 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 15' ' ' SER . . . 140.35 -51.83 0.71 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.12 150.82 37.83 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.343 -1.092 . . . . 0.0 109.094 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.2 113.82 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.399 2.066 . . . . 0.0 110.357 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -140.06 160.82 39.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.773 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.17 109.82 53.56 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.1 Cg_endo -77.48 160.15 32.09 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.348 2.032 . . . . 0.0 110.434 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' PRO . 35.4 m -51.88 -175.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.24 168.75 15.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -59.69 135.28 57.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.84 -3.67 41.91 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' SG ' ' A' ' 41' ' ' CYS . 2.2 mp -114.53 170.56 8.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -1.149 . . . . 0.0 109.313 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.48 163.67 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 109.897 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.1 m -106.92 135.62 48.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 111.11 14.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.471 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -66.19 140.41 58.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -57.58 -64.35 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.466 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 97.8 m-85 -108.08 159.59 30.02 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.762 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.5 Cg_endo -78.4 78.93 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.708 2.272 . . . . 0.0 110.457 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.44 -25.44 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -178.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.166 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 37' ' ' THR . 15.3 m -124.71 38.2 4.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.74 20.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.464 ' CA ' ' HA ' ' A' ' 31' ' ' SER . . . -146.63 -154.11 6.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 41' ' ' CYS . 5.8 ttm180 -139.88 142.77 36.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 109.389 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.479 ' N ' ' HG2' ' A' ' 40' ' ' ARG . 47.7 t -83.47 141.14 31.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.68 -174.26 4.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.445 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 3.5 ttp85 -93.12 49.3 1.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 11.6 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.66 159.59 35.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.77 -173.61 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.329 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 1.6 mt -96.25 170.77 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.22 133.43 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.365 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.79 68.59 1.53 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.79 -165.41 2.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -1.127 . . . . 0.0 109.529 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -87.76 136.18 33.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.5 t -134.84 147.17 49.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 2.2 p -89.37 150.2 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.325 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.71 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.663 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.443 ' HB3' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -113.36 -67.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 70.53 85.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.131 -179.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -127.2 71.24 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 -179.702 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.49 -56.79 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.71 149.09 72.03 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.305 -1.115 . . . . 0.0 109.494 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 96.89 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.702 2.268 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ILE . 61.3 m -76.55 129.5 36.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' THR . 52.8 mt -43.92 110.17 0.93 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.217 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.96 167.62 24.84 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.355 2.037 . . . . 0.0 110.571 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.3 -176.46 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.47 -161.67 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.59 140.79 46.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 -9.5 76.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.7 mm? -99.73 96.61 7.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -1.104 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.72 139.54 36.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.216 -0.928 . . . . 0.0 109.56 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 12' ' ' VAL . 8.6 t -88.85 148.94 23.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.305 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -154.67 140.66 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.14 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.679 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 25.4 m-85 -62.06 -47.13 86.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 169.32 -53.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.7 Cg_endo -80.82 58.08 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.529 2.152 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 43.51 28.06 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.34 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.385 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.5 m -92.4 -16.9 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -135.38 141.84 45.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.644 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -142.17 -128.86 2.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -143.77 176.26 9.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -1.169 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 120.42 32.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -0.88 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -111.16 176.05 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.492 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 18.33 14.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 179.862 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.285 0.564 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 2.6 m -128.76 180.0 5.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.64 164.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.305 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 137.65 32.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.663 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -52.86 103.03 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.23 44.18 0.8 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -163.48 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -1.101 . . . . 0.0 109.377 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -84.46 175.57 9.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.089 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 26.5 t -155.2 156.73 36.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.04 . . . . 0.0 109.768 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -112.99 105.69 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -88.74 15.04 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -0.996 . . . . 0.0 109.542 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 -5.04 7.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 2.6 p -48.15 148.1 1.93 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 9.3 p90 -127.36 106.25 9.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' LEU . . . 97.22 30.42 7.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.544 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 42.21 59.17 10.22 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.975 . . . . 0.0 109.724 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.4 Cg_endo -78.58 -60.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.154 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 21' ' ' ILE . 5.5 t -63.26 -164.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.425 ' N ' HG22 ' A' ' 20' ' ' THR . 3.2 mt -123.62 98.18 40.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 109.388 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 35.7 Cg_endo -77.19 158.11 33.66 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.492 2.128 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 94.8 m -43.85 154.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.2 m -55.62 166.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.54 145.53 22.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.82 -34.9 5.27 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.483 ' CD1' ' HB3' ' A' ' 23' ' ' CYS . 1.8 mt -86.35 167.75 14.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -1.06 . . . . 0.0 109.294 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 135.88 41.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.841 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.7 t -90.53 146.43 24.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 109.076 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 ttt-85 -145.4 134.93 23.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.74 144.76 25.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' OH ' ' HG3' ' A' ' 40' ' ' ARG . 6.0 m-85 -47.16 -61.89 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.4 166.64 10.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.02 93.19 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.751 2.301 . . . . 0.0 110.443 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.58 -33.49 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.46 163.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -1.07 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -103.93 -21.03 13.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.33 172.85 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.522 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -141.24 3.68 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.455 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 13.8 mtt180 -141.31 155.25 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -1.107 . . . . 0.0 109.371 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.57 128.39 50.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -149.82 179.36 8.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.76 47.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.43 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' ' OXT' ' A' ' 44' ' ' TYR . 82.3 t80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.506 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 t -143.7 41.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 55.12 -178.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 109.634 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -112.0 128.21 56.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 147.56 40.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.65 53.28 39.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -142.57 -161.21 1.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -1.197 . . . . 0.0 109.486 179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.8 149.52 31.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 t -144.65 147.96 33.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.16 149.47 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.179 -0.951 . . . . 0.0 109.171 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.73 -20.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -133.06 -49.77 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.616 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 t 62.27 127.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 109.436 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 7.1 p90 -138.91 84.65 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.427 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.409 ' C ' ' HG ' ' A' ' 18' ' ' LEU . . . 159.83 -53.62 0.36 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.9 mt -137.29 157.99 73.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 18' ' ' LEU . 34.8 Cg_endo -77.02 95.21 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.358 2.039 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -69.07 153.49 43.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.26 126.35 65.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 109.419 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 169.5 19.58 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.436 2.09 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.2 m -68.72 163.8 23.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.36 167.85 4.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -65.34 129.52 40.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.42 -1.97 32.71 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -100.12 -167.82 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.35 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -153.8 136.87 15.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 109.626 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.4 t -124.97 128.67 48.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 109.235 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.463 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.0 ttp85 -144.88 153.85 42.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 109.819 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.9 p -95.41 149.82 20.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.309 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -65.15 -65.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.109 -0.994 . . . . 0.0 109.497 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.07 157.08 37.11 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 109.674 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.89 81.86 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.558 2.172 . . . . 0.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.99 -35.97 0.61 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 m -61.17 146.0 49.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -1.041 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.21 27.79 3.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.98 159.01 43.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -164.57 -135.31 1.8 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -148.87 155.12 40.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 28' ' ' THR . 7.8 t -117.39 144.04 45.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.895 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.437 ' O ' HD21 ' A' ' 27' ' ' LEU . 90.1 mt-30 -142.6 178.33 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 109.665 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.52 39.68 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.917 . . . . 0.0 109.505 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HB2' ' N ' ' A' ' 24' ' ' CYS . 11.4 p -105.91 62.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.586 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 60.88 -175.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.847 . . . . 0.0 109.733 179.818 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.6 171.56 11.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.66 144.71 43.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.37 77.62 0.15 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.37 -163.41 1.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.497 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -95.2 141.49 28.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -143.17 148.1 35.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 109.299 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.448 HG23 ' N ' ' A' ' 15' ' ' SER . 6.2 p -91.8 154.52 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.34 -27.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -36.36 3.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 109.591 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 59.29 159.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.637 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 5.9 p90 -153.0 79.44 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.842 . . . . 0.0 109.509 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.03 56.02 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.57 143.88 16.84 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.124 . . . . 0.0 109.413 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.81 101.15 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.609 2.206 . . . . 0.0 110.429 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -135.18 116.8 14.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.0 mt -84.51 125.45 71.58 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.351 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 173.28 14.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.381 2.054 . . . . 0.0 110.342 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HB3' HD11 ' A' ' 27' ' ' LEU . 7.3 m -67.53 153.27 44.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.893 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.519 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 7.9 p -87.35 -179.28 6.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.71 143.71 9.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.8 -33.63 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 36.0 mt -105.24 -168.79 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 119.41 2.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -82.72 105.53 13.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 139.78 46.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 p -73.96 166.01 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 109.575 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 54.3 m-85 -58.54 -56.22 24.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.958 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.97 -51.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.012 . . . . 0.0 110.024 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 37.0 Cg_endo -80.25 57.32 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.775 2.316 . . . . 0.0 111.177 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.41 47.73 5.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.5 144.73 39.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -1.101 . . . . 0.0 109.571 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -71.12 -10.31 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -129.5 -175.47 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.47 -151.79 8.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -134.51 161.32 35.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -1.121 . . . . 0.0 109.391 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 11.9 t -109.93 128.48 55.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.489 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.7 175.36 6.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.41 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -92.82 40.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t 46.88 68.56 0.61 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.418 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 173.15 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HB3' ' N ' ' A' ' 24' ' ' CYS . 55.5 m -118.99 172.87 7.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.18 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -63.69 -168.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.146 -0.971 . . . . 0.0 109.317 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.96 179.85 3.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.66 150.38 23.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.52 34.62 89.63 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.87 -166.88 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -1.133 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -103.26 171.95 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.221 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 168.54 21.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.518 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 3.7 t -121.76 112.84 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.9 m -87.76 9.3 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.517 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.445 ' HB2' HG21 ' A' ' 37' ' ' THR . 9.7 ttt180 -120.01 -5.97 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.466 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -58.07 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 24.7 m-85 -72.64 141.2 48.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 109.321 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.53 87.0 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.546 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 12.8 mt 43.86 59.7 12.23 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.394 -1.062 . . . . 0.0 109.978 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.69 -40.65 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.467 2.112 . . . . 0.0 110.173 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.5 m -78.27 144.2 36.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.62 122.58 83.98 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.76 149.76 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.433 2.089 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.58 161.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.454 ' N ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -73.11 168.2 19.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.696 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -52.93 142.08 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.78 -20.25 41.97 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HA ' ' O ' ' A' ' 42' ' ' GLN . 1.1 mt -110.63 139.28 46.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -1.171 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.3 162.93 14.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.02 113.3 16.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 158.84 25.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 155.26 17.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.506 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 99.1 m-85 -62.44 -19.9 63.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.551 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.61 167.69 0.15 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.213 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 34.6 Cg_endo -77.27 120.56 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.541 2.161 . . . . 0.0 110.311 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.36 11.37 8.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 p -123.96 -167.38 1.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 14' ' ' ARG . 3.4 m -142.03 25.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.667 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 176.44 9.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.506 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -173.32 -163.48 27.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 173.06 11.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.5 t -136.63 126.59 25.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 1.2 mt-30 -129.36 175.86 8.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 27.5 ttm-85 -86.03 43.74 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' OXT' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 42.07 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -110.12 126.2 53.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 p -138.8 151.1 46.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -61.78 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.892 . . . . 0.0 109.232 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.99 160.5 14.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.351 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' C ' ' OE1' ' A' ' 7' ' ' GLN . 3.1 tm0? -67.34 157.67 33.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.156 -0.965 . . . . 0.0 109.556 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.98 57.02 9.18 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.6 -164.27 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -1.111 . . . . 0.0 109.459 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.35 161.0 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 t -154.48 150.76 28.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 12' ' ' VAL . 12.2 p -103.09 119.37 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 109.643 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.8 m -81.52 -22.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.42 ' O ' ' HB3' ' A' ' 15' ' ' SER . 8.6 mmt180 -90.47 -84.27 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 62.65 106.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -101.51 93.51 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 104.05 8.59 38.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.521 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.9 mm? 61.65 60.9 2.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.181 -1.188 . . . . 0.0 109.532 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.521 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.7 Cg_endo -77.71 -66.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.426 2.084 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 m -72.87 164.06 27.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 109.289 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.427 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 5.0 mm -84.23 137.94 39.55 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.427 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.8 Cg_endo -78.64 -167.48 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.679 2.253 . . . . 0.0 110.48 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.5 m -98.64 156.68 16.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.38 161.62 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 139.09 55.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' OXT' ' A' ' 44' ' ' TYR . . . 108.84 -26.79 14.59 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.53 166.83 12.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.352 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -140.36 160.71 39.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.3 t -101.88 129.54 48.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.4 ttt180 -133.44 131.42 39.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -98.9 152.22 20.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m-85 -53.81 -69.87 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 109.32 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.567 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 172.06 -55.81 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 109.707 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.1 Cg_endo -78.29 127.0 8.01 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 110.322 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.18 48.41 79.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.42 ' O ' ' OG1' ' A' ' 37' ' ' THR . 97.6 p -45.75 113.18 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -1.075 . . . . 0.0 109.668 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 36' ' ' SER . 28.2 m -166.08 -41.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -137.35 119.39 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.344 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -127.79 -143.58 5.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -124.25 162.9 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.32 131.65 55.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -129.08 -172.1 2.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.37 -0.831 . . . . 0.0 109.404 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -100.11 61.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.462 ' OXT' ' O ' ' A' ' 26' ' ' GLY . 3.6 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.2 75.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -102.92 71.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.512 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -131.7 166.9 20.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.514 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -95.72 -170.79 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 1.9 mp -106.23 156.75 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -74.7 141.02 44.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 62.5 4.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.435 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 1.6 m-85 -141.52 -163.96 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.212 . . . . 0.0 109.433 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -79.53 130.5 35.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -124.64 176.49 6.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 109.626 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.64 ' CG1' ' CE1' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.51 167.59 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.198 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.453 HG12 ' HB3' ' A' ' 31' ' ' SER . 35.6 m -138.32 6.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.736 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.72 33.95 5.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.62 58.79 2.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -102.38 72.67 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.18 -49.39 0.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 159.28 49.35 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.189 -1.183 . . . . 0.0 109.417 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.92 111.26 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.62 2.214 . . . . 0.0 110.472 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -156.66 128.49 7.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 46.5 mm -85.15 117.66 69.23 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 -179.22 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.264 1.976 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' CYS . 12.5 m -71.2 155.83 40.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 7.7 m -43.65 161.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -62.74 144.84 56.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.409 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 96.29 -15.66 62.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 43' ' ' ARG . 64.6 mt -105.65 173.24 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.98 -174.72 4.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 40.7 m -146.49 165.93 27.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.16 50.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB3' HG12 ' A' ' 13' ' ' VAL . 13.4 p -88.64 138.97 30.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.203 -0.936 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 34.2 m-85 -46.76 -68.91 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.081 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 165.0 -54.35 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.295 -0.878 . . . . 0.0 109.395 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.4 Cg_endo -79.85 116.62 3.48 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.465 2.11 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.62 59.49 7.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -48.0 102.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -1.016 . . . . 0.0 109.759 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -148.41 -52.27 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.328 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.64 ' CE1' ' CG1' ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.85 142.06 51.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.71 -140.63 3.75 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.55 144.47 51.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.299 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -101.38 139.42 37.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.788 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -162.01 0.94 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 108.982 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.428 ' HA ' HD22 ' A' ' 27' ' ' LEU . 2.3 ttm180 -102.11 59.59 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.0 109.347 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.541 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.17 106.07 4.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.09 -178.53 5.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 2.8 t -90.89 128.57 36.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.39 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.4 163.5 17.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -62.75 124.65 21.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.05 58.56 1.77 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.95 -166.55 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -1.072 . . . . 0.0 109.556 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.39 133.82 34.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.2 t -131.95 149.17 52.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG12 HG22 ' A' ' 20' ' ' THR . 4.3 p -85.08 140.12 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.6 m -106.21 -20.99 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.932 . . . . 0.0 109.638 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 58.31 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -110.64 99.04 8.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 35.8 p90 -123.75 55.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.34 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.28 -35.91 3.47 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 153.82 3.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.171 -1.193 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.8 86.77 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.54 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.407 HG22 HG12 ' A' ' 12' ' ' VAL . 2.0 t -148.03 97.51 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.432 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 3.3 tt -62.08 113.8 9.65 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.88 . . . . 0.0 109.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.72 -161.51 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.343 2.029 . . . . 0.0 110.147 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.95 -168.23 0.26 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.6 m -91.02 -179.1 5.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.55 127.72 33.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.382 -0.824 . . . . 0.0 109.703 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 27' ' ' LEU . . . 109.28 -7.21 32.41 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' CD2' ' HG2' ' A' ' 43' ' ' ARG . 22.1 mt -118.14 109.94 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -1.198 . . . . 0.0 109.556 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 p -83.59 174.39 10.59 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.186 -0.946 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.3 m -125.1 140.32 52.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.153 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 134.22 34.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 t -83.62 100.68 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 109.391 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.558 ' CE2' ' HA2' ' A' ' 39' ' ' GLY . 3.4 p90 -45.92 -27.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -0.976 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -127.79 145.86 56.61 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.416 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.42 93.15 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.644 2.229 . . . . 0.0 110.508 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.68 -30.9 1.93 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 p -79.11 104.13 9.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -1.223 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 15.2 t -52.56 -22.81 5.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.632 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.53 131.37 49.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.558 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -129.37 -136.93 4.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -125.8 175.45 7.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.189 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -129.58 134.99 48.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 18.8 mt-30 -149.66 -177.2 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.945 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -88.22 38.67 0.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.566 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 35.4 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -153.75 100.81 2.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.446 ' O ' ' CG2' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -123.93 100.24 6.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.474 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 m -141.13 142.84 34.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.555 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 10' ' ' ASN . 2.7 mt-30 -66.38 -167.66 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.17 171.63 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -67.4 146.7 53.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.25 68.62 1.6 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 1.7 m-85 -146.41 -165.73 2.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -1.117 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 6.1 m-20 -89.57 141.31 28.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 19.5 t -143.42 158.08 43.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 10.0 p -99.23 145.24 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.434 ' N ' HG21 ' A' ' 12' ' ' VAL . 29.3 m -120.36 -21.6 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -130.69 52.48 2.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' ARG . 12.4 t -45.03 131.8 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.538 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -113.31 85.78 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.92 44.15 49.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.85 148.45 56.74 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.656 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.6 91.86 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.588 2.192 . . . . 0.0 110.012 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 t -134.12 161.44 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.86 . . . . 0.0 109.735 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.453 HG21 ' HD2' ' A' ' 22' ' ' PRO . 23.7 mm -127.47 128.15 24.04 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 109.088 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 21' ' ' ILE . 35.5 Cg_endo -77.57 167.01 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.388 2.058 . . . . 0.0 110.626 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 89.4 m -60.62 146.88 43.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.73 165.09 4.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -46.01 151.29 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.68 -6.23 79.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.466 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -125.36 124.81 42.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.246 . . . . 0.0 109.506 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.4 147.58 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.38 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.2 m -103.51 133.35 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -121.68 159.16 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.98 153.91 28.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 34.3 m-85 -58.3 -72.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.548 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 168.74 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -77.74 110.8 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.448 2.099 . . . . 0.0 110.345 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 65.96 62.99 4.29 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 35' ' ' GLY . 6.0 p -43.36 120.18 1.82 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -1.124 . . . . 0.0 109.568 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 87.1 m -160.29 -81.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.61 122.24 45.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.4 -145.67 5.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -114.51 -173.27 2.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -1.204 . . . . 0.0 109.502 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.2 t -138.2 127.04 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -111.3 -178.3 3.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 -103.87 47.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.972 . . . . 0.0 109.605 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.568 ' CD1' ' OXT' ' A' ' 44' ' ' TYR . 30.3 t80 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.28 0.562 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t 54.2 76.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.441 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.2 mmm180 -85.98 84.56 7.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.39 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' GLN . 40.0 t -143.3 99.34 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' CYS . 5.1 mt-30 -54.56 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -177.9 3.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.579 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' CD ' ' N ' ' A' ' 8' ' ' GLY . 18.2 tm0? -77.68 169.67 17.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 7' ' ' GLN . . . 44.61 48.67 8.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -164.19 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.372 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.39 122.94 45.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.561 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 43.0 t -132.2 157.36 44.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.477 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.4 p -89.62 136.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.417 HG21 ' N ' ' A' ' 14' ' ' ARG . 6.6 m -97.44 -22.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.417 ' N ' HG21 ' A' ' 13' ' ' VAL . 0.5 OUTLIER -91.09 67.15 5.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.314 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -94.15 27.35 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -87.68 109.62 19.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -5.68 84.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.31 112.56 26.02 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.245 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.47 75.82 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.424 2.083 . . . . 0.0 110.361 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -166.82 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.501 ' N ' ' CD1' ' A' ' 21' ' ' ILE . 4.0 mp -116.3 94.04 41.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.65 -179.12 5.14 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.622 2.215 . . . . 0.0 110.464 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.59 154.04 41.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.21 161.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -50.48 156.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 -49.2 1.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.404 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 10.1 mt -91.16 135.33 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -1.099 . . . . 0.0 109.506 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 146.6 39.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.98 116.38 24.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 109.36 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 159.25 22.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.0 p -108.95 154.11 22.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.35 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.81 1.07 22.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -127.2 158.25 69.81 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.052 -1.03 . . . . 0.0 109.629 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD2' ' CD2' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -78.07 134.58 13.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.547 2.165 . . . . 0.0 110.525 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.53 47.11 64.27 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -162.29 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -1.19 . . . . 0.0 109.438 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 55.4 m -135.68 -58.58 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.591 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.477 ' CE1' ' HB ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.42 142.99 34.22 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.595 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -159.73 8.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -94.7 167.99 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -1.15 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.0 t -117.69 138.36 52.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.76 -175.48 4.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -85.98 50.2 1.93 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.97 -1.015 . . . . 0.0 109.477 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -167.63 101.01 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.6 64.64 1.59 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.74 170.2 21.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -91.21 156.51 17.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.98 154.97 21.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.544 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.15 115.18 9.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.41 41.4 1.15 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -120.59 -149.17 0.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.233 -1.157 . . . . 0.0 109.688 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -118.6 109.44 16.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.31 153.16 20.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 109.482 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.83 170.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.868 . . . . 0.0 109.345 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.54 -15.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.628 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.24 42.53 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.674 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.1 100.95 13.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 6.2 p90 -150.83 122.29 7.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.57 -25.97 25.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.513 ' CB ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.06 175.8 2.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.513 ' HD2' ' CB ' ' A' ' 18' ' ' LEU . 34.6 Cg_endo -77.61 118.42 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.555 2.17 . . . . 0.0 110.397 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.6 m -158.7 155.43 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -114.38 106.4 52.7 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 150.59 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.335 2.024 . . . . 0.0 110.422 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 90.1 m -51.32 163.53 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -178.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 4.5 tpm_? -69.39 146.59 51.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.743 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 91.24 -28.18 8.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' HG ' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -83.28 140.97 32.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.114 -1.227 . . . . 0.0 109.686 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.02 151.21 40.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.65 121.58 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' SER . 3.1 ttt180 -110.81 100.51 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.417 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -44.04 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 8.3 m-85 -59.51 -65.31 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.63 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.545 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.2 -53.78 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.02 . . . . 0.0 109.847 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.5 Cg_endo -78.86 66.99 8.64 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.584 2.189 . . . . 0.0 110.798 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.95 31.91 0.5 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.476 ' CB ' ' HB2' ' A' ' 32' ' ' TYR . 19.3 p -61.06 145.59 50.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 m -83.37 -27.75 29.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.57 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -122.77 117.33 25.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -106.35 -157.62 21.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -110.54 175.3 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -1.109 . . . . 0.0 109.522 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.0 t -128.69 137.83 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.99 173.62 11.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.41 ' HG3' ' HG ' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -90.85 58.13 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.8 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.449 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.52 56.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.601 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -145.33 93.49 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.568 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' GLN . 26.4 p -152.39 156.66 39.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.483 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' CYS . 4.3 mt-30 -46.45 172.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.12 167.95 9.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.25 -0.907 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.496 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 3.0 tt0 -73.84 149.77 41.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.06 65.75 3.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -149.69 -161.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -1.186 . . . . 0.0 109.409 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.75 161.92 21.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 109.539 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 41' ' ' CYS . 48.7 t -153.85 159.44 41.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.895 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.46 HG13 ' CA ' ' A' ' 15' ' ' SER . 35.4 t -118.38 96.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m -61.49 -26.74 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' O ' ' HB3' ' A' ' 15' ' ' SER . 0.2 OUTLIER -92.0 -84.56 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 63.89 84.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.378 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -78.14 107.6 10.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.695 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.4 17.19 67.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.436 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 55.22 66.52 3.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -1.125 . . . . 0.0 109.521 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.455 ' HD2' ' OG ' ' A' ' 15' ' ' SER . 35.4 Cg_endo -78.04 -16.19 14.3 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.624 2.216 . . . . 0.0 110.551 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 73.8 m -136.08 157.52 46.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 109.44 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.5 ' CG2' ' HD2' ' A' ' 22' ' ' PRO . 60.7 mt -63.84 139.44 97.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.5 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 36.2 Cg_endo -78.26 -174.09 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.503 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.65 145.55 26.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.385 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -44.15 168.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -64.75 145.59 56.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.43 -15.13 55.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.503 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 0.4 OUTLIER -89.93 147.27 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -1.178 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.92 156.45 33.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.8 t -97.33 115.19 27.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 113.52 20.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 109.163 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.463 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.0 OUTLIER -92.9 179.13 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' CE1' ' HA2' ' A' ' 39' ' ' GLY . 4.9 p90 -129.45 12.32 5.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.936 . . . . 0.0 109.658 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.402 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.2 OUTLIER -127.55 162.52 48.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.31 73.27 5.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.512 2.141 . . . . 0.0 110.444 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.55 51.04 4.76 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' THR . 2.5 t -85.29 -8.86 58.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.561 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 36' ' ' SER . 1.3 m 72.5 3.05 4.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.501 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' CE1' HG21 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -153.83 157.1 38.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.188 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.516 ' HA2' ' CE1' ' A' ' 32' ' ' TYR . . . -173.61 -147.59 6.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.04 168.23 11.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.589 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.464 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.3 t -120.69 161.16 21.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.445 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 10.3 pt20 -151.4 -178.2 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' TYR . 12.9 ttt85 -105.77 46.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' CG ' ' OXT' ' A' ' 44' ' ' TYR . 79.6 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.485 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.412 ' C ' ' OG ' ' A' ' 2' ' ' SER . 2.2 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.294 0.568 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 1' ' ' TYR . 0.0 OUTLIER -176.2 43.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.405 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.43 38.14 4.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 40.64 3.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.0 109.559 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 7.0 tp60 51.35 -160.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -178.55 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HG3' ' HB2' ' A' ' 43' ' ' ARG . 46.7 tt0 -82.0 153.25 26.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 43.53 74.7 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 -163.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -1.125 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -84.72 117.58 23.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.392 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.6 t -105.25 154.55 20.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG22 ' HB3' ' A' ' 15' ' ' SER . 10.6 p -102.04 149.18 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.01 -30.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.868 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -154.01 63.86 0.71 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 109.681 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.461 ' HB3' HG22 ' A' ' 12' ' ' VAL . 35.7 t -109.59 66.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.687 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -78.32 149.48 33.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.83 -25.88 9.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.12 155.17 44.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.131 -1.217 . . . . 0.0 109.598 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.01 109.68 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.519 2.146 . . . . 0.0 110.063 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.449 ' O ' HG21 ' A' ' 20' ' ' THR . 9.1 t -135.97 129.88 32.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 6.4 mt -106.71 124.44 35.53 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.212 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 172.22 16.04 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.316 2.01 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.46 ' HB3' HD11 ' A' ' 27' ' ' LEU . 47.6 m -65.5 -171.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.574 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -178.27 4.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.95 133.87 51.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.82 -20.04 27.35 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD11 ' HB3' ' A' ' 23' ' ' CYS . 0.5 OUTLIER -100.57 126.97 47.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -1.155 . . . . 0.0 109.531 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.98 160.1 17.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.6 127.6 55.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.377 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 111.15 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -0.971 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.8 t -63.33 145.06 56.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.574 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 34.7 m-85 -56.04 -72.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.475 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -116.29 172.45 3.8 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.2 Cg_endo -77.52 123.24 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.532 2.154 . . . . 0.0 110.254 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.22 18.59 21.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -106.58 178.88 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -1.072 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 m -121.09 -10.17 9.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.526 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 170.47 14.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.574 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -164.75 -138.89 2.51 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.99 166.22 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.344 -1.092 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.28 129.17 53.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' C ' HD22 ' A' ' 27' ' ' LEU . 16.1 pt20 -124.38 146.38 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.388 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.454 ' N ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -88.45 42.93 1.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.279 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.25 0.548 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.45 141.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.416 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 77.19 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.535 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' CB ' ' HA ' ' A' ' 24' ' ' CYS . 1.4 p -127.45 173.71 9.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -150.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 0.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.21 162.15 26.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -73.48 137.67 44.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.76 54.28 6.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.51 -165.25 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -1.125 . . . . 0.0 109.484 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -87.16 160.71 18.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.505 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -146.21 178.34 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 109.401 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' CZ ' ' A' ' 38' ' ' TYR . 2.4 p -121.71 95.65 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.27 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.493 HG21 ' N ' ' A' ' 14' ' ' ARG . 3.2 m -67.95 -21.13 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.493 ' N ' HG21 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -85.25 102.46 13.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.843 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.9 135.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.098 -1.001 . . . . 0.0 109.658 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 18.4 p90 -149.92 90.15 1.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -6.12 83.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.4 mt -76.34 152.95 83.98 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.215 -1.168 . . . . 0.0 109.48 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -80.88 54.05 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.895 2.397 . . . . 0.0 110.644 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 t -86.59 -179.73 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.052 -1.03 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -118.52 86.95 29.96 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.88 -171.83 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 110.45 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.433 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -63.47 171.09 2.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.494 ' HA ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -58.72 168.43 1.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 132.23 45.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.357 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.28 -20.2 33.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.452 HD21 ' HA ' ' A' ' 43' ' ' ARG . 62.0 mt -95.27 167.42 11.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.116 . . . . 0.0 109.356 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.43 149.76 51.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 m -121.87 138.89 54.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -124.29 165.86 16.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.6 t -91.89 176.52 6.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.557 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 6.7 m-85 -75.29 -67.39 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.553 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 163.3 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.909 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.7 Cg_endo -78.23 70.34 7.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.171 1.914 . . . . 0.0 110.908 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 41.28 43.29 3.54 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.45 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.61 125.93 35.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.42 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 ' O ' HG21 ' A' ' 13' ' ' VAL . 14.5 t -69.26 -23.66 63.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.505 ' CD2' ' O ' ' A' ' 11' ' ' CYS . 2.1 m-85 -113.58 160.85 18.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.58 -145.38 4.12 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -117.31 169.76 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.141 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 47.8 t -126.4 141.62 51.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.65 -177.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.686 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.452 ' HA ' HD21 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -90.14 41.44 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.509 179.925 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.486 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t -121.99 52.93 1.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.6 39.33 3.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' GLN . 51.3 t -157.95 129.58 6.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.202 -0.936 . . . . 0.0 109.507 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -53.61 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.53 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 164.88 12.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.685 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.36 139.09 38.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.91 56.41 3.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 16.7 m-85 -143.02 -175.95 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 109.168 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 39' ' ' GLY . 16.3 p-10 -81.9 152.57 26.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.96 156.57 36.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.7 136.58 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.549 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 31' ' ' SER . 11.3 m -97.04 -25.55 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.271 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' NH1' ' OG1' ' A' ' 37' ' ' THR . 1.5 ttm180 -96.99 -65.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.368 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.43 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 64.05 170.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.729 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 3.8 p90 -149.85 68.21 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.61 25.74 6.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.545 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.7 mt 51.66 59.06 15.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.446 -1.032 . . . . 0.0 109.886 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.7 Cg_endo -79.01 -68.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.583 2.188 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.442 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.5 m -64.7 151.23 45.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.46 113.7 12.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.1 Cg_endo -77.83 169.37 20.79 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.344 2.03 . . . . 0.0 110.234 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.76 164.47 25.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.0 166.53 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -56.55 147.42 22.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.847 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.42 -26.41 17.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 136.04 38.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -1.129 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 153.07 31.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.7 114.69 27.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.68 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 4.7 tpt180 -101.96 152.62 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.314 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.472 ' HB3' HG12 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.92 168.64 10.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 109.468 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 13.2 m-85 -62.65 -65.01 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 166.8 -52.29 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -79.46 60.64 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.166 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.14 42.73 2.44 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.8 p -75.88 -5.57 46.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -1.109 . . . . 0.0 109.626 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.575 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 98.3 m 48.36 23.57 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.118 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 37' ' ' THR . 6.3 m-85 -160.26 138.32 9.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 108.983 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -155.62 -139.76 2.84 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.467 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 17.1 mtp180 -121.51 -169.74 1.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' PHE . 2.6 t -134.79 125.75 27.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.395 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -120.82 176.37 5.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -100.44 62.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -157.95 64.38 0.46 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.46 164.46 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 t -155.53 138.98 15.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.12 152.87 38.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 18.1 mt -104.09 -178.38 3.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.47 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 14.9 tt0 -67.96 155.4 39.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.47 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 67.28 29.65 74.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.67 -164.53 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -1.092 . . . . 0.0 109.351 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.09 159.17 15.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.387 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.33 175.87 9.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.324 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.447 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -139.43 114.49 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.47 -11.17 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.474 ' HD3' ' CG2' ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.68 23.45 14.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.447 ' OG ' ' HB ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -88.81 109.89 20.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 23.7 p90 -156.02 101.49 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 109.334 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.47 41.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 158.29 34.17 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 4.64 6.01 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.648 2.232 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.7 m -52.34 108.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.415 ' HA ' HD11 ' A' ' 21' ' ' ILE . 26.9 mm -63.22 117.18 31.0 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.29 179.27 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.424 2.083 . . . . 0.0 110.16 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.403 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 11.1 m -65.06 169.36 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.434 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ARG . 14.1 m -69.19 151.79 45.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.45 ' HG2' ' N ' ' A' ' 26' ' ' GLY . 4.6 ttm180 -43.08 138.75 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.45 ' N ' ' HG2' ' A' ' 25' ' ' ARG . . . 96.25 5.86 59.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.403 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 1.1 mt -125.5 128.05 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.7 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -108.92 -168.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 88.2 m -142.06 158.77 43.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.539 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.05 124.44 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -49.98 150.87 2.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.413 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 26.9 m-85 -50.17 -30.96 12.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 171.43 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.005 . . . . 0.0 109.713 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 34.9 Cg_endo -77.24 -167.94 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.43 2.086 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.6 32.68 4.41 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -56.84 164.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -1.107 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.474 ' CG2' ' HD3' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -93.11 -6.88 47.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 131.53 53.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.08 -166.16 11.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.29 53.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -1.191 . . . . 0.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.86 130.34 34.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.366 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.76 -178.96 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.77 50.59 1.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.843 . . . . 0.0 109.453 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.09 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 12.1 mmm-85 -100.27 60.23 1.03 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 3' ' ' ARG . 31.3 m -151.19 156.18 40.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 109.514 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.08 -157.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -107.2 159.44 16.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.535 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -66.86 138.38 57.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.466 ' HA2' ' O ' ' A' ' 41' ' ' CYS . . . 78.36 40.14 20.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.429 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -125.06 -160.57 0.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.39 142.51 27.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -135.44 151.09 50.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.473 HG21 ' N ' ' A' ' 13' ' ' VAL . 10.9 p -97.01 151.39 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.156 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 14' ' ' ARG . 3.6 m -122.5 -41.2 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.503 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -118.01 86.31 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.604 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -78.71 167.75 20.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.344 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -156.54 64.85 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.435 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.27 42.57 6.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.529 ' CD2' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -136.53 149.32 67.05 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.262 -1.14 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 18' ' ' LEU . 35.9 Cg_endo -78.09 4.85 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.669 2.246 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -42.39 111.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.418 HG21 ' HD2' ' A' ' 22' ' ' PRO . 6.9 mt -90.04 131.47 39.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' HG21 ' A' ' 21' ' ' ILE . 36.2 Cg_endo -79.05 178.59 7.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.385 2.057 . . . . 0.0 110.453 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.4 m -68.18 156.67 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 166.45 5.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.053 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -56.22 150.32 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.14 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.427 HD21 ' C ' ' A' ' 42' ' ' GLN . 1.5 mt -115.03 147.67 39.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 157.61 24.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -116.18 124.93 51.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 110.3 20.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.838 . . . . 0.0 109.631 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.06 150.46 46.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 23.2 m-85 -61.94 -72.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 109.656 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER 169.73 -55.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.6 Cg_endo -77.42 114.41 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.386 2.058 . . . . 0.0 110.248 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 57.03 15.46 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -45.75 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -1.139 . . . . 0.0 109.749 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.541 HG21 ' CE1' ' A' ' 38' ' ' TYR . 2.4 m -137.53 -47.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 0.0 109.251 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.541 ' CE1' HG21 ' A' ' 37' ' ' THR . 81.6 m-85 -143.87 133.52 23.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 -156.79 8.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -95.56 165.98 12.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -1.157 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.466 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 17.0 t -125.07 132.44 53.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.427 ' C ' HD21 ' A' ' 27' ' ' LEU . 1.9 tt0 -133.88 159.92 39.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -89.6 50.23 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 t -158.15 81.78 0.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 37.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 35.8 t -143.06 28.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER 55.16 169.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.392 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.65 144.47 42.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -47.99 114.93 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.303 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.6 51.34 1.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.509 ' CB ' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -123.62 -163.44 1.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -1.095 . . . . 0.0 109.401 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -99.26 124.86 44.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -108.22 156.28 19.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.522 HG13 ' CA ' ' A' ' 15' ' ' SER . 43.0 t -97.09 121.56 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.2 m -97.55 -12.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -119.49 18.19 12.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.47 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.522 ' CA ' HG13 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -45.12 127.62 6.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.68 101.55 6.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 109.504 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 18' ' ' LEU . . . 71.6 7.24 64.42 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.516 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 70.01 62.6 0.51 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.105 -1.233 . . . . 0.0 109.554 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.516 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.55 -24.83 7.19 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.659 2.239 . . . . 0.0 110.342 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -97.53 -179.83 4.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.915 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.505 HD11 HG22 ' A' ' 21' ' ' ILE . 31.0 mm -86.81 140.16 33.15 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.449 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.6 Cg_endo -78.16 162.68 28.5 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.545 2.163 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -67.33 169.73 8.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.462 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 38.5 m -71.42 172.9 8.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.256 -0.902 . . . . 0.0 109.101 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -66.6 146.98 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.237 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.87 -12.33 59.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' A' ' 23' ' ' CYS . 4.4 mm? -86.0 163.56 17.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -1.101 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 139.37 30.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.583 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.6 m -100.22 108.05 20.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -107.94 122.78 47.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 32' ' ' TYR . 3.5 p -77.16 132.58 38.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 22.9 m-85 -44.13 -65.96 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.399 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.54 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.79 -53.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.667 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.54 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.2 Cg_endo -78.04 114.65 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.362 2.041 . . . . 0.0 110.396 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 61.86 60.6 7.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -44.95 110.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.525 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -163.16 -37.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.977 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.36 105.13 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.835 . . . . 0.0 109.552 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.6 -160.89 12.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -113.06 172.97 6.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -1.18 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.45 120.37 34.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 3.3 mm-40 -114.11 168.98 9.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.555 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.89 54.97 2.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.524 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.97 135.3 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.55 42.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.059 -1.026 . . . . 0.0 109.796 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -86.0 147.39 26.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.35 153.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.8 mt -81.62 -173.81 4.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.412 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -81.88 141.16 33.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.494 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.11 75.43 0.46 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -154.24 -171.86 4.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -1.199 . . . . 0.0 109.561 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.45 102.55 13.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.604 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.5 t -89.07 153.9 20.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -96.39 142.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -123.37 7.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 109.546 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 36.96 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.7 t -93.66 97.0 10.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 77.54 1.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.54 55.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.3 153.11 48.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 111.85 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.525 2.15 . . . . 0.0 110.349 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.459 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -148.36 162.31 39.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 13.4 mm -110.32 96.57 27.21 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.374 -0.829 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 20' ' ' THR . 34.4 Cg_endo -76.98 -163.05 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.51 2.14 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.478 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -73.61 176.3 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 176.07 8.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -68.94 134.14 49.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.91 -7.82 49.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.478 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 16.9 mt -103.21 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.538 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 132.07 32.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.5 t -98.99 141.62 31.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.257 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.442 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -147.0 144.71 29.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.086 -1.009 . . . . 0.0 109.773 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 p -97.11 154.72 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.333 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 23.4 m-85 -62.05 -70.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.0 109.364 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.5 -53.48 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -79.0 87.18 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.457 2.105 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 120.77 -36.58 3.3 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 11.5 p 47.36 49.37 15.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 109.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 52.5 m -120.99 -41.66 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -143.74 116.23 8.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -114.13 -138.24 6.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 11.1 mtt180 -125.82 163.76 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -1.097 . . . . 0.0 109.518 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.27 154.15 35.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.337 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -154.27 -174.82 5.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' CG ' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.05 75.85 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.365 -0.835 . . . . 0.0 109.39 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.742 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -115.95 67.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.64 161.65 33.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 -151.74 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.239 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.13 158.82 43.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.44 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.46 134.78 34.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.85 152.09 7.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 109.255 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.83 21.28 66.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.44 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 3.0 m-85 -106.25 -167.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -97.99 160.68 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.263 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -126.36 172.37 10.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.413 ' HB ' ' HB2' ' A' ' 15' ' ' SER . 5.1 t -111.48 85.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 m -52.25 -21.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -100.96 -80.63 0.49 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.413 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 13.0 t 52.09 22.45 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -97.86 110.39 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.19 -16.37 35.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.4 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.5 mt -134.0 143.95 49.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.419 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.34 145.76 21.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.554 2.169 . . . . 0.0 110.385 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -154.64 -172.92 4.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.63 106.98 51.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.43 152.47 30.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.346 2.03 . . . . 0.0 110.461 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 79.8 m -59.31 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.94 168.07 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.788 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.77 124.96 15.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 43' ' ' ARG . . . 103.22 12.18 32.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.475 ' N ' HD21 ' A' ' 27' ' ' LEU . 4.1 mm? -116.73 100.64 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -1.017 . . . . 0.0 109.386 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 147.0 28.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.3 m -110.07 146.83 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.574 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.41 134.45 19.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.7 m -59.58 159.51 8.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.534 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.58 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 23.7 t80 160.38 -47.28 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.586 . . . . 0.0 109.69 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -77.89 -169.2 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.959 1.772 . . . . 0.0 110.39 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.42 17.13 58.25 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -51.43 155.62 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -1.197 . . . . 0.0 109.493 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.0 t -89.22 23.26 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.77 153.91 40.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.23 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 10' ' ' ASN . . . -155.02 -140.64 3.05 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.416 ' HA ' ' HA ' ' A' ' 10' ' ' ASN . 2.7 ttt85 -118.32 176.0 5.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 109.508 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 25.0 t -142.84 124.22 14.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -145.53 174.49 11.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.455 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -97.35 -8.76 28.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 0.0 109.473 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 41.7 t80 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 2' ' ' SER . 97.0 m-85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.226 0.536 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 1' ' ' TYR . 12.7 m 66.02 95.05 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.7 164.89 18.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 109.181 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLN . 57.6 m -147.6 153.92 40.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 0.0 109.718 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 4' ' ' CYS . 46.0 mt-30 -50.38 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -160.45 168.97 23.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 109.582 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.382 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 9' ' ' PHE . . . 105.24 48.54 1.05 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.408 ' CD1' ' C ' ' A' ' 8' ' ' GLY . 38.6 m-85 -141.59 -165.31 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 17.5 p30 -79.62 138.14 37.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.489 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 42.5 t -121.57 154.0 37.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 12' ' ' VAL . 14.1 p -103.61 113.48 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 m -78.68 -20.12 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.64 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.445 ' HB2' HG21 ' A' ' 37' ' ' THR . 6.6 tpp180 -99.28 57.7 1.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' HB3' HG22 ' A' ' 20' ' ' THR . 0.2 OUTLIER -103.78 5.27 35.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -95.52 107.03 19.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.23 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.25 26.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.75 151.14 38.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -1.199 . . . . 0.0 109.391 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.22 123.57 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.572 2.181 . . . . 0.0 110.539 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.433 HG22 ' HB3' ' A' ' 15' ' ' SER . 11.4 t -162.85 178.87 8.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.317 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -115.56 90.16 24.97 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.137 -0.977 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.06 -159.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.575 2.184 . . . . 0.0 110.128 179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 11' ' ' CYS . 89.4 m -86.69 164.83 16.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -179.48 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -73.42 136.03 44.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 -24.19 31.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 19.8 mt -85.64 142.79 28.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -1.134 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.43 153.54 23.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.757 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.1 m -124.34 150.84 45.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -0.813 . . . . 0.0 109.131 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -148.62 108.38 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 32' ' ' TYR . 2.9 p -50.02 133.23 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.294 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' SER . 27.9 m-85 -43.96 -53.12 6.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.569 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -106.33 172.27 4.06 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.28 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 35.1 Cg_endo -78.79 74.2 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.534 2.156 . . . . 0.0 110.275 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' SER . . . 146.5 -24.06 1.68 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.6 m -50.49 -179.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -1.133 . . . . 0.0 109.457 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 HG21 ' HB2' ' A' ' 14' ' ' ARG . 51.0 m -123.2 -12.29 7.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 118.86 23.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 -150.02 7.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.9 174.03 6.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -1.098 . . . . 0.0 109.131 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.62 119.07 19.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 109.777 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -111.4 -173.18 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.257 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.7 68.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.448 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.286 0.565 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -135.83 96.7 3.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -138.79 75.81 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 5' ' ' GLN . 28.6 t -117.23 156.83 27.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.394 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -85.36 172.32 11.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.333 -0.854 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.572 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -115.71 -174.87 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.372 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.32 136.73 46.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.513 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.55 65.83 2.65 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.572 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 2.8 m-85 -140.35 -167.11 2.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 109.373 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . 0.419 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 4.7 m-20 -90.92 116.13 28.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.45 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 35.8 t -109.01 152.61 24.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 0.0 109.406 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' HB2' ' A' ' 15' ' ' SER . 8.3 p -106.39 131.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.1 m -102.1 -18.94 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -86.51 48.2 1.59 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.636 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB2' HG12 ' A' ' 12' ' ' VAL . 36.4 t -113.55 101.02 8.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.039 -1.038 . . . . 0.0 109.544 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 5.3 p90 -144.54 70.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.304 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.42 -27.58 5.75 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -96.96 143.45 26.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.305 -1.115 . . . . 0.0 109.388 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.2 Cg_endo -78.53 127.12 7.9 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.576 2.184 . . . . 0.0 110.43 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -141.62 -148.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 29.0 mm -124.99 84.15 59.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.143 -0.973 . . . . 0.0 109.385 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 156.14 30.61 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.651 2.234 . . . . 0.0 110.46 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 60.9 m -63.16 164.87 7.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 m -61.66 169.93 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.704 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -66.63 124.87 24.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.828 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.19 -2.11 31.29 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' CD2' ' O ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.76 152.26 21.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -1.142 . . . . 0.0 109.467 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.22 137.65 41.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.392 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 41' ' ' CYS . 1.6 p -128.6 140.07 51.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.057 -1.027 . . . . 0.0 109.866 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 31' ' ' SER . 1.1 ttp180 -127.72 142.26 51.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.317 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -44.08 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.709 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.417 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 18.1 m-85 -61.79 -39.16 90.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.57 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 172.76 -54.16 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.827 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 37.5 Cg_endo -82.0 52.19 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.561 2.174 . . . . 0.0 110.577 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.37 32.08 1.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 31' ' ' SER . 6.5 t -52.0 146.4 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -1.086 . . . . 0.0 109.793 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 99.0 m -66.69 -33.18 75.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.189 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -112.71 124.38 52.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.053 179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.05 -153.12 11.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -120.8 139.61 52.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.277 -1.131 . . . . 0.0 109.438 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -94.83 155.64 16.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.431 ' O ' ' CD2' ' A' ' 27' ' ' LEU . 31.9 mt-30 -148.69 172.2 14.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.85 35.64 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.302 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.415 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.49 67.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.714 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.36 135.64 33.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.385 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 11.3 p -126.43 -174.03 3.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 4' ' ' CYS . 7.5 mm-40 -53.41 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 121.57 31.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -60.57 149.0 36.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.42 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.99 62.95 5.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 -151.81 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -1.152 . . . . 0.0 109.343 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.66 138.31 35.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.354 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 159.15 19.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.622 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -118.42 127.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.0 m -117.12 -2.7 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.461 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -89.66 54.41 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 109.459 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 t -114.02 123.81 50.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.451 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 2.2 p90 -129.56 93.82 3.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.44 17.11 78.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.8 164.16 15.59 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.97 -83.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.625 2.217 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m 48.18 69.98 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 16.4 mm -45.41 109.35 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.8 Cg_endo -77.63 -177.25 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.488 2.126 . . . . 0.0 110.571 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.466 ' O ' ' O ' ' A' ' 22' ' ' PRO . 77.7 m -48.05 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 54.9 m -74.21 174.69 8.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -67.92 137.29 55.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.96 -16.74 30.33 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.6 mp -93.88 167.82 11.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.88 167.81 20.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 18.6 t -123.67 128.95 50.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.24 110.86 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.509 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.6 m -68.01 162.29 24.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.446 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 27.9 m-85 -75.86 -71.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.541 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 164.72 -52.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.0 109.474 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.76 100.3 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.469 2.113 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.449 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 95.93 -33.58 5.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 2.6 p 48.53 71.12 0.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -1.091 . . . . 0.0 109.532 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 9.6 m -128.25 -74.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 3.2 m-85 -109.49 117.87 35.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.88 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.434 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -112.76 -128.3 4.93 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.25 144.37 49.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.378 -1.072 . . . . 0.0 109.479 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.5 t -106.64 120.86 43.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.218 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.94 175.21 5.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.187 -0.946 . . . . 0.0 109.748 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -117.91 67.87 0.76 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.18 77.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.41 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -163.29 36.25 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.261 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.46 -177.24 6.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -104.25 179.69 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.321 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.44 173.11 12.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.967 . . . . 0.0 109.412 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.65 138.4 35.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.77 74.26 1.19 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -156.15 -159.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.314 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -104.64 134.78 47.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -131.88 151.32 51.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 t -95.1 145.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.471 HG12 ' CB ' ' A' ' 31' ' ' SER . 31.3 m -101.68 16.09 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -140.74 17.55 2.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.367 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -44.81 -29.68 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.561 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -48.35 98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.244 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 15' ' ' SER . . . 140.35 -51.83 0.71 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.12 150.82 37.83 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.343 -1.092 . . . . 0.0 109.094 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.2 113.82 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.399 2.066 . . . . 0.0 110.357 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.423 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -140.06 160.82 39.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.773 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.17 109.82 53.56 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.1 Cg_endo -77.48 160.15 32.09 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.348 2.032 . . . . 0.0 110.434 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' PRO . 35.4 m -51.88 -175.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.24 168.75 15.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -59.69 135.28 57.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.84 -3.67 41.91 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.428 HD21 ' SG ' ' A' ' 41' ' ' CYS . 2.2 mp -114.53 170.56 8.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -1.149 . . . . 0.0 109.313 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.48 163.67 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 109.897 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.1 m -106.92 135.62 48.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 111.11 14.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.471 ' CB ' HG12 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -66.19 140.41 58.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -57.58 -64.35 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.466 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 97.8 m-85 -108.08 159.59 30.02 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.762 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.5 Cg_endo -78.4 78.93 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.708 2.272 . . . . 0.0 110.457 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.44 -25.44 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -178.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.166 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.402 HG21 ' O ' ' A' ' 37' ' ' THR . 15.3 m -124.71 38.2 4.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.74 20.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.464 ' CA ' ' HA ' ' A' ' 31' ' ' SER . . . -146.63 -154.11 6.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.479 ' HG2' ' N ' ' A' ' 41' ' ' CYS . 5.8 ttm180 -139.88 142.77 36.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 109.389 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.479 ' N ' ' HG2' ' A' ' 40' ' ' ARG . 47.7 t -83.47 141.14 31.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.68 -174.26 4.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.445 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 3.5 ttp85 -93.12 49.3 1.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 11.6 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 50.8 p90 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.404 ' O ' ' HB2' ' A' ' 3' ' ' ARG . 0.4 OUTLIER -151.16 -178.42 6.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 -179.935 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.404 ' HB2' ' O ' ' A' ' 2' ' ' SER . 3.2 mtp180 66.01 38.93 4.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.88 . . . . 0.0 109.459 -179.941 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.66 159.59 35.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.77 -173.61 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.329 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 1.6 mt -96.25 170.77 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.22 133.43 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.365 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.79 68.59 1.53 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.79 -165.41 2.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -1.127 . . . . 0.0 109.529 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -87.76 136.18 33.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.5 t -134.84 147.17 49.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 2.2 p -89.37 150.2 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.325 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -112.71 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.663 -179.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.443 ' HB3' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -113.36 -67.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 70.53 85.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.131 -179.76 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -127.2 71.24 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 -179.702 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.49 -56.79 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.71 149.09 72.03 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.305 -1.115 . . . . 0.0 109.494 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 96.89 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.702 2.268 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ILE . 61.3 m -76.55 129.5 36.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' THR . 52.8 mt -43.92 110.17 0.93 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.217 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.96 167.62 24.84 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.355 2.037 . . . . 0.0 110.571 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.3 -176.46 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.47 -161.67 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.59 140.79 46.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.84 -9.5 76.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 27' ' ' LEU . 3.7 mm? -99.73 96.61 7.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -1.104 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.72 139.54 36.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.216 -0.928 . . . . 0.0 109.56 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 12' ' ' VAL . 8.6 t -88.85 148.94 23.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.305 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -154.67 140.66 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.14 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.679 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 25.4 m-85 -62.06 -47.13 86.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.559 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 169.32 -53.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.7 Cg_endo -80.82 58.08 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.529 2.152 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 43.51 28.06 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.34 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.385 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.5 m -92.4 -16.9 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -135.38 141.84 45.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.644 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -142.17 -128.86 2.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -143.77 176.26 9.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -1.169 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 120.42 32.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -0.88 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -111.16 176.05 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.492 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 18.33 14.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 179.862 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.452 ' O ' ' OG ' ' A' ' 2' ' ' SER . 14.6 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 1' ' ' TYR . 2.7 p 67.31 139.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -0.962 . . . . 0.0 109.619 -179.935 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.5 112.47 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 2.6 m -128.76 180.0 5.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.64 164.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.305 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 137.65 32.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.663 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -52.86 103.03 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.23 44.18 0.8 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -163.48 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -1.101 . . . . 0.0 109.377 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -84.46 175.57 9.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.089 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 26.5 t -155.2 156.73 36.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.04 . . . . 0.0 109.768 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 2.9 t -112.99 105.69 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.1 m -88.74 15.04 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -0.996 . . . . 0.0 109.542 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.92 -5.04 7.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 2.6 p -48.15 148.1 1.93 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 9.3 p90 -127.36 106.25 9.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' LEU . . . 97.22 30.42 7.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.544 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 42.21 59.17 10.22 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.975 . . . . 0.0 109.724 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.544 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.4 Cg_endo -78.58 -60.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.154 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 21' ' ' ILE . 5.5 t -63.26 -164.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.425 ' N ' HG22 ' A' ' 20' ' ' THR . 3.2 mt -123.62 98.18 40.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 109.388 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 35.7 Cg_endo -77.19 158.11 33.66 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.492 2.128 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.483 ' HB3' ' CD1' ' A' ' 27' ' ' LEU . 94.8 m -43.85 154.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.2 m -55.62 166.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.54 145.53 22.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.82 -34.9 5.27 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.483 ' CD1' ' HB3' ' A' ' 23' ' ' CYS . 1.8 mt -86.35 167.75 14.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -1.06 . . . . 0.0 109.294 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 135.88 41.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.841 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.7 t -90.53 146.43 24.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 109.076 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 ttt-85 -145.4 134.93 23.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.74 144.76 25.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.675 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' OH ' ' HG3' ' A' ' 40' ' ' ARG . 6.0 m-85 -47.16 -61.89 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.4 166.64 10.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.02 93.19 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.751 2.301 . . . . 0.0 110.443 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.58 -33.49 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.46 163.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -1.07 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.6 m -103.93 -21.03 13.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -124.33 172.85 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.522 -179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -141.24 3.68 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.455 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 13.8 mtt180 -141.31 155.25 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -1.107 . . . . 0.0 109.371 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.57 128.39 50.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -149.82 179.36 8.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.76 47.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.43 -179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' ' OXT' ' A' ' 44' ' ' TYR . 82.3 t80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.506 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.8 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 1' ' ' TYR . 1.2 m 75.75 122.17 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.409 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -97.72 87.04 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.156 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 t -143.7 41.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 55.12 -178.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 109.634 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -112.0 128.21 56.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 147.56 40.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.65 53.28 39.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -142.57 -161.21 1.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -1.197 . . . . 0.0 109.486 179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.8 149.52 31.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 t -144.65 147.96 33.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.4 t -96.16 149.47 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.179 -0.951 . . . . 0.0 109.171 179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.73 -20.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -133.06 -49.77 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.616 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.433 ' O ' ' O ' ' A' ' 14' ' ' ARG . 1.2 t 62.27 127.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 109.436 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 7.1 p90 -138.91 84.65 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.427 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.409 ' C ' ' HG ' ' A' ' 18' ' ' LEU . . . 159.83 -53.62 0.36 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.439 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.9 mt -137.29 157.99 73.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.439 ' HD2' ' HB3' ' A' ' 18' ' ' LEU . 34.8 Cg_endo -77.02 95.21 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.358 2.039 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.1 t -69.07 153.49 43.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 4.2 mp -86.26 126.35 65.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 109.419 -179.887 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 169.5 19.58 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.436 2.09 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.2 m -68.72 163.8 23.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.36 167.85 4.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -65.34 129.52 40.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.42 -1.97 32.71 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -100.12 -167.82 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.35 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -153.8 136.87 15.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 109.626 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.4 t -124.97 128.67 48.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 109.235 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.463 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.0 ttp85 -144.88 153.85 42.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 109.819 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.437 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.9 p -95.41 149.82 20.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.309 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -65.15 -65.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.109 -0.994 . . . . 0.0 109.497 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.07 157.08 37.11 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 109.674 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.89 81.86 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.558 2.172 . . . . 0.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.99 -35.97 0.61 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 m -61.17 146.0 49.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -1.041 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.21 27.79 3.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.98 159.01 43.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -164.57 -135.31 1.8 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -148.87 155.12 40.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 28' ' ' THR . 7.8 t -117.39 144.04 45.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.895 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.437 ' O ' HD21 ' A' ' 27' ' ' LEU . 90.1 mt-30 -142.6 178.33 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 109.665 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.406 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.52 39.68 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.917 . . . . 0.0 109.505 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 2' ' ' SER . 9.1 m-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 1' ' ' TYR . 1.1 m 58.11 111.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.386 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.63 154.03 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 109.424 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HB2' ' N ' ' A' ' 24' ' ' CYS . 11.4 p -105.91 62.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.586 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.462 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 60.88 -175.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.847 . . . . 0.0 109.733 179.818 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.6 171.56 11.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.66 144.71 43.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.37 77.62 0.15 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.37 -163.41 1.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.497 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -95.2 141.49 28.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -143.17 148.1 35.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 109.299 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.448 HG23 ' N ' ' A' ' 15' ' ' SER . 6.2 p -91.8 154.52 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.34 -27.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -36.36 3.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 109.591 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.448 ' N ' HG23 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 59.29 159.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.637 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.448 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 5.9 p90 -153.0 79.44 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.842 . . . . 0.0 109.509 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.03 56.02 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -150.57 143.88 16.84 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.124 . . . . 0.0 109.413 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.81 101.15 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.609 2.206 . . . . 0.0 110.429 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -135.18 116.8 14.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 23.0 mt -84.51 125.45 71.58 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.351 179.888 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 173.28 14.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.381 2.054 . . . . 0.0 110.342 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HB3' HD11 ' A' ' 27' ' ' LEU . 7.3 m -67.53 153.27 44.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.893 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.519 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 7.9 p -87.35 -179.28 6.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.71 143.71 9.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.8 -33.63 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.432 ' HB3' ' SG ' ' A' ' 41' ' ' CYS . 36.0 mt -105.24 -168.79 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 119.41 2.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -82.72 105.53 13.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 139.78 46.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 p -73.96 166.01 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 109.575 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 54.3 m-85 -58.54 -56.22 24.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.958 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.97 -51.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.012 . . . . 0.0 110.024 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 37.0 Cg_endo -80.25 57.32 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.775 2.316 . . . . 0.0 111.177 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.41 47.73 5.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.5 144.73 39.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -1.101 . . . . 0.0 109.571 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 88.8 m -71.12 -10.31 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 0.0 109.339 179.947 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -129.5 -175.47 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.47 -151.79 8.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.5 mtp85 -134.51 161.32 35.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -1.121 . . . . 0.0 109.391 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 11.9 t -109.93 128.48 55.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.489 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.7 175.36 6.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.41 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -92.82 40.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HB3' ' N ' ' A' ' 24' ' ' CYS . 55.5 m -118.99 172.87 7.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.18 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -63.69 -168.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.146 -0.971 . . . . 0.0 109.317 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.96 179.85 3.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.66 150.38 23.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.52 34.62 89.63 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.87 -166.88 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -1.133 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -103.26 171.95 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.221 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 168.54 21.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.518 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 14' ' ' ARG . 3.7 t -121.76 112.84 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG21 ' OG ' ' A' ' 31' ' ' SER . 25.9 m -87.76 9.3 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.541 ' HD2' HG23 ' A' ' 37' ' ' THR . 9.7 ttt180 -120.01 -5.97 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -58.07 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 24.7 m-85 -72.64 141.2 48.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 109.321 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.53 87.0 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 12.8 mt 43.86 59.7 12.23 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.394 -1.062 . . . . 0.0 109.978 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.69 -40.65 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.467 2.112 . . . . 0.0 110.173 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.5 m -78.27 144.2 36.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.62 122.58 83.98 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.76 149.76 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.433 2.089 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.58 161.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -73.11 168.2 19.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.696 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -52.93 142.08 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.78 -20.25 41.97 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 HH21 ' A' ' 43' ' ' ARG . 1.1 mt -110.63 139.28 46.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -1.171 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.3 162.93 14.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.02 113.3 16.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 158.84 25.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' HG21 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -93.42 155.26 17.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 99.1 m-85 -62.44 -19.9 63.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.61 167.69 0.15 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.213 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 34.6 Cg_endo -77.27 120.56 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.541 2.161 . . . . 0.0 110.311 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.36 11.37 8.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 p -123.96 -167.38 1.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.541 HG23 ' HD2' ' A' ' 14' ' ' ARG . 3.4 m -142.03 25.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.667 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 176.44 9.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -173.32 -163.48 27.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 173.06 11.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.5 t -136.63 126.59 25.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.445 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.2 mt-30 -129.36 175.86 8.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.484 HH21 HD21 ' A' ' 27' ' ' LEU . 27.5 ttm-85 -86.03 43.74 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' OXT' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 p -138.8 151.1 46.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -61.78 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.892 . . . . 0.0 109.232 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.99 160.5 14.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.351 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' C ' ' OE1' ' A' ' 7' ' ' GLN . 3.1 tm0? -67.34 157.67 33.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.156 -0.965 . . . . 0.0 109.556 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.98 57.02 9.18 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.6 -164.27 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -1.111 . . . . 0.0 109.459 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.35 161.0 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 t -154.48 150.76 28.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 12' ' ' VAL . 12.2 p -103.09 119.37 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 109.643 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' THR . 4.8 m -81.52 -22.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 8.6 mmt180 -90.47 -84.27 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 62.65 106.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -101.51 93.51 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 104.05 8.59 38.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.9 mm? 61.65 60.9 2.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.181 -1.188 . . . . 0.0 109.532 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.7 Cg_endo -77.71 -66.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.426 2.084 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 21' ' ' ILE . 12.4 m -72.87 164.06 27.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 109.289 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 21' ' ' ILE . 5.0 mm -84.23 137.94 39.55 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.8 Cg_endo -78.64 -167.48 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.679 2.253 . . . . 0.0 110.48 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.5 m -98.64 156.68 16.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.38 161.62 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 139.09 55.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' OXT' ' A' ' 44' ' ' TYR . . . 108.84 -26.79 14.59 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -92.53 166.83 12.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -140.36 160.71 39.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.3 t -101.88 129.54 48.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.454 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.4 ttt180 -133.44 131.42 39.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -98.9 152.22 20.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m-85 -53.81 -69.87 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 109.32 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 172.06 -55.81 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 109.707 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.1 Cg_endo -78.29 127.0 8.01 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 110.322 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.18 48.41 79.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 37' ' ' THR . 97.6 p -45.75 113.18 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -1.075 . . . . 0.0 109.668 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 13' ' ' VAL . 28.2 m -166.08 -41.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -137.35 119.39 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.344 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -127.79 -143.58 5.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -124.25 162.9 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.32 131.65 55.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.78 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.7 OUTLIER -129.08 -172.1 2.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.37 -0.831 . . . . 0.0 109.404 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -100.11 61.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.462 ' OXT' ' O ' ' A' ' 26' ' ' GLY . 3.6 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.343 0.592 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -131.7 166.9 20.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.514 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -95.72 -170.79 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 1.9 mp -106.23 156.75 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -74.7 141.02 44.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 62.5 4.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 1.6 m-85 -141.52 -163.96 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.212 . . . . 0.0 109.433 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -79.53 130.5 35.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -124.64 176.49 6.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 109.626 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.694 HG13 ' CZ ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.51 167.59 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.198 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 31' ' ' SER . 35.6 m -138.32 6.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.736 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.72 33.95 5.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.62 58.79 2.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -102.38 72.67 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.18 -49.39 0.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 159.28 49.35 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.189 -1.183 . . . . 0.0 109.417 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.92 111.26 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.62 2.214 . . . . 0.0 110.472 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -156.66 128.49 7.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 21' ' ' ILE . 46.5 mm -85.15 117.66 69.23 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 -179.22 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.264 1.976 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' CYS . 12.5 m -71.2 155.83 40.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 7.7 m -43.65 161.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -62.74 144.84 56.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.409 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 96.29 -15.66 62.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 ' HG3' ' A' ' 43' ' ' ARG . 64.6 mt -105.65 173.24 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.98 -174.72 4.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 40.7 m -146.49 165.93 27.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.16 50.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.441 ' HB3' HG11 ' A' ' 13' ' ' VAL . 13.4 p -88.64 138.97 30.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.203 -0.936 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 34.2 m-85 -46.76 -68.91 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.081 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 165.0 -54.35 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.295 -0.878 . . . . 0.0 109.395 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.4 Cg_endo -79.85 116.62 3.48 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.465 2.11 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.62 59.49 7.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -48.0 102.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -1.016 . . . . 0.0 109.759 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -148.41 -52.27 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.328 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.694 ' CZ ' HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.85 142.06 51.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.71 -140.63 3.75 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.55 144.47 51.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.299 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -101.38 139.42 37.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.788 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -162.01 0.94 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 108.982 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.484 ' HG3' HD21 ' A' ' 27' ' ' LEU . 2.3 ttm180 -102.11 59.59 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.0 109.347 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.541 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 2.8 t -90.89 128.57 36.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.39 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.4 163.5 17.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -62.75 124.65 21.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.05 58.56 1.77 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.95 -166.55 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -1.072 . . . . 0.0 109.556 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.39 133.82 34.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.2 t -131.95 149.17 52.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG13 ' OG ' ' A' ' 15' ' ' SER . 4.3 p -85.08 140.12 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' THR . 26.6 m -106.21 -20.99 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.932 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 58.31 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.575 ' OG ' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -110.64 99.04 8.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 35.8 p90 -123.75 55.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.34 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.28 -35.91 3.47 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 153.82 3.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.171 -1.193 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.8 86.77 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.54 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' HG23 ' A' ' 20' ' ' THR . 2.0 t -148.03 97.51 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 tt -62.08 113.8 9.65 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.88 . . . . 0.0 109.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.72 -161.51 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.343 2.029 . . . . 0.0 110.147 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.95 -168.23 0.26 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.6 m -91.02 -179.1 5.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.55 127.72 33.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.382 -0.824 . . . . 0.0 109.703 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.476 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 109.28 -7.21 32.41 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 43' ' ' ARG . 22.1 mt -118.14 109.94 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -1.198 . . . . 0.0 109.556 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 p -83.59 174.39 10.59 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.186 -0.946 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.3 m -125.1 140.32 52.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.153 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 134.22 34.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 t -83.62 100.68 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 109.391 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.564 ' CE2' ' HA2' ' A' ' 39' ' ' GLY . 3.4 p90 -45.92 -27.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -0.976 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -127.79 145.86 56.61 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.416 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.42 93.15 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.644 2.229 . . . . 0.0 110.508 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.68 -30.9 1.93 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 p -79.11 104.13 9.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -1.223 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.766 ' O ' HG22 ' A' ' 13' ' ' VAL . 15.2 t -52.56 -22.81 5.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.632 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.53 131.37 49.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -129.37 -136.93 4.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -125.8 175.45 7.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.189 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -129.58 134.99 48.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 81.8 mt-30 -149.66 -177.2 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.945 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -88.22 38.67 0.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.566 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 35.4 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.889 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 m -141.13 142.84 34.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.555 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.38 -167.66 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.17 171.63 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -67.4 146.7 53.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.25 68.62 1.6 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 1.7 m-85 -146.41 -165.73 2.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -1.117 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -89.57 141.31 28.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 19.5 t -143.42 158.08 43.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 10.0 p -99.23 145.24 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 37' ' ' THR . 29.3 m -120.36 -21.6 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -130.69 52.48 2.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' ARG . 12.4 t -45.03 131.8 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.538 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -113.31 85.78 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.92 44.15 49.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.444 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -123.85 148.45 56.74 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.656 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.5 Cg_endo -78.6 91.86 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.588 2.192 . . . . 0.0 110.012 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 t -134.12 161.44 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.86 . . . . 0.0 109.735 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.889 HG21 ' O ' ' A' ' 3' ' ' ARG . 23.7 mm -127.47 128.15 24.04 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 109.088 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.57 167.01 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.388 2.058 . . . . 0.0 110.626 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 89.4 m -60.62 146.88 43.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.73 165.09 4.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -46.01 151.29 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.68 -6.23 79.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -125.36 124.81 42.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.246 . . . . 0.0 109.506 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.4 147.58 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.38 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.2 m -103.51 133.35 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -121.68 159.16 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.98 153.91 28.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 34.3 m-85 -58.3 -72.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 168.74 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -77.74 110.8 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.448 2.099 . . . . 0.0 110.345 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 65.96 62.99 4.29 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 35' ' ' GLY . 6.0 p -43.36 120.18 1.82 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -1.124 . . . . 0.0 109.568 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' VAL . 87.1 m -160.29 -81.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.61 122.24 45.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.4 -145.67 5.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -114.51 -173.27 2.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -1.204 . . . . 0.0 109.502 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.2 t -138.2 127.04 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.1 mm-40 -111.3 -178.3 3.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 3.0 ttp180 -103.87 47.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.972 . . . . 0.0 109.605 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.568 ' CD1' ' OXT' ' A' ' 44' ' ' TYR . 30.3 t80 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.2 mmm180 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' GLN . 40.0 t -143.3 99.34 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' CYS . 5.1 mt-30 -54.56 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -177.9 3.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.579 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' CD ' ' N ' ' A' ' 8' ' ' GLY . 18.2 tm0? -77.68 169.67 17.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 7' ' ' GLN . . . 44.61 48.67 8.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -164.19 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.372 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.39 122.94 45.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.561 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 43.0 t -132.2 157.36 44.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.4 p -89.62 136.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 37' ' ' THR . 6.6 m -97.44 -22.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.09 67.15 5.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.314 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -94.15 27.35 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -87.68 109.62 19.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -5.68 84.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.31 112.56 26.02 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.245 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.47 75.82 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.424 2.083 . . . . 0.0 110.361 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -166.82 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 21' ' ' ILE . 4.0 mp -116.3 94.04 41.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' SG ' ' A' ' 11' ' ' CYS . 35.0 Cg_endo -77.65 -179.12 5.14 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.622 2.215 . . . . 0.0 110.464 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.59 154.04 41.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.21 161.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -50.48 156.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 -49.2 1.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 43' ' ' ARG . 10.1 mt -91.16 135.33 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -1.099 . . . . 0.0 109.506 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 146.6 39.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.98 116.38 24.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 109.36 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 159.25 22.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.0 p -108.95 154.11 22.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.35 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.81 1.07 22.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -127.2 158.25 69.81 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.052 -1.03 . . . . 0.0 109.629 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -78.07 134.58 13.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.547 2.165 . . . . 0.0 110.525 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.53 47.11 64.27 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -162.29 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -1.19 . . . . 0.0 109.438 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 13' ' ' VAL . 55.4 m -135.68 -58.58 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.42 142.99 34.22 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.595 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -159.73 8.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -94.7 167.99 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -1.15 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.0 t -117.69 138.36 52.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.76 -175.48 4.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -85.98 50.2 1.93 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.97 -1.015 . . . . 0.0 109.477 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.407 0.622 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.74 170.2 21.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -91.21 156.51 17.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.98 154.97 21.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.544 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.15 115.18 9.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.41 41.4 1.15 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -120.59 -149.17 0.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.233 -1.157 . . . . 0.0 109.688 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -118.6 109.44 16.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.31 153.16 20.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 109.482 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 13' ' ' VAL . 2.7 t -80.83 170.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.868 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.876 HG11 ' HB3' ' A' ' 31' ' ' SER . 3.2 m -122.54 -15.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.628 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.402 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -134.24 42.53 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.674 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.426 ' OG ' HG21 ' A' ' 20' ' ' THR . 0.5 OUTLIER -92.1 100.95 13.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 6.2 p90 -150.83 122.29 7.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.57 -25.97 25.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.532 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.06 175.8 2.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 18' ' ' LEU . 34.6 Cg_endo -77.61 118.42 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.555 2.17 . . . . 0.0 110.397 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.426 HG21 ' OG ' ' A' ' 15' ' ' SER . 8.6 m -158.7 155.43 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -114.38 106.4 52.7 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 150.59 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.335 2.024 . . . . 0.0 110.422 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 90.1 m -51.32 163.53 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -178.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 4.5 tpm_? -69.39 146.59 51.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.743 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 91.24 -28.18 8.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -83.28 140.97 32.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.114 -1.227 . . . . 0.0 109.686 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.02 151.21 40.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.65 121.58 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' SER . 3.1 ttt180 -110.81 100.51 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.876 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -44.04 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 8.3 m-85 -59.51 -65.31 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.63 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.2 -53.78 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.02 . . . . 0.0 109.847 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.5 Cg_endo -78.86 66.99 8.64 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.584 2.189 . . . . 0.0 110.798 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.95 31.91 0.5 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 32' ' ' TYR . 19.3 p -61.06 145.59 50.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 m -83.37 -27.75 29.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.57 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -122.77 117.33 25.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -106.35 -157.62 21.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -110.54 175.3 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -1.109 . . . . 0.0 109.522 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.0 t -128.69 137.83 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.99 173.62 11.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' ' HG ' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -90.85 58.13 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.8 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.449 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.35 0.595 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' GLN . 26.4 p -152.39 156.66 39.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.483 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' CYS . 4.3 mt-30 -46.45 172.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.12 167.95 9.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.25 -0.907 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 3.0 tt0 -73.84 149.77 41.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.06 65.75 3.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -149.69 -161.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -1.186 . . . . 0.0 109.409 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.75 161.92 21.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 109.539 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 41' ' ' CYS . 48.7 t -153.85 159.44 41.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.895 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 38' ' ' TYR . 35.4 t -118.38 96.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 31' ' ' SER . 18.8 m -61.49 -26.74 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 15' ' ' SER . 0.2 OUTLIER -92.0 -84.56 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 63.89 84.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.378 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -78.14 107.6 10.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.695 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.4 17.19 67.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 55.22 66.52 3.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -1.125 . . . . 0.0 109.521 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 15' ' ' SER . 35.4 Cg_endo -78.04 -16.19 14.3 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.624 2.216 . . . . 0.0 110.551 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 21' ' ' ILE . 73.8 m -136.08 157.52 46.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 109.44 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 22' ' ' PRO . 60.7 mt -63.84 139.44 97.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 21' ' ' ILE . 36.2 Cg_endo -78.26 -174.09 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.65 145.55 26.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.385 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -44.15 168.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -64.75 145.59 56.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.43 -15.13 55.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -89.93 147.27 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -1.178 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.92 156.45 33.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.8 t -97.33 115.19 27.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 113.52 20.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 109.163 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.497 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.0 OUTLIER -92.9 179.13 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' ' HA2' ' A' ' 39' ' ' GLY . 4.9 p90 -129.45 12.32 5.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.936 . . . . 0.0 109.658 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.2 OUTLIER -127.55 162.52 48.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.31 73.27 5.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.512 2.141 . . . . 0.0 110.444 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.55 51.04 4.76 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' THR . 2.5 t -85.29 -8.86 58.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.561 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 36' ' ' SER . 1.3 m 72.5 3.05 4.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.501 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.48 ' CZ ' HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -153.83 157.1 38.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.188 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 32' ' ' TYR . . . -173.61 -147.59 6.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.04 168.23 11.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.589 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.3 t -120.69 161.16 21.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.871 ' O ' HD23 ' A' ' 27' ' ' LEU . 10.3 pt20 -151.4 -178.2 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' TYR . 12.9 ttt85 -105.77 46.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' CG ' ' OXT' ' A' ' 44' ' ' TYR . 79.6 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.485 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 40.64 3.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.0 109.559 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 7.0 tp60 51.35 -160.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -178.55 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 43' ' ' ARG . 46.7 tt0 -82.0 153.25 26.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 43.53 74.7 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 -163.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -1.125 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -84.72 117.58 23.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.392 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.6 t -105.25 154.55 20.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.613 HG21 HG21 ' A' ' 20' ' ' THR . 10.6 p -102.04 149.18 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.01 -30.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.868 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -154.01 63.86 0.71 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 109.681 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 20' ' ' THR . 35.7 t -109.59 66.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.687 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -78.32 149.48 33.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.83 -25.88 9.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.12 155.17 44.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.131 -1.217 . . . . 0.0 109.598 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.01 109.68 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.519 2.146 . . . . 0.0 110.063 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.613 HG21 HG21 ' A' ' 12' ' ' VAL . 9.1 t -135.97 129.88 32.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 6.4 mt -106.71 124.44 35.53 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.212 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 172.22 16.04 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.316 2.01 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 m -65.5 -171.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -178.27 4.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.95 133.87 51.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.82 -20.04 27.35 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -100.57 126.97 47.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -1.155 . . . . 0.0 109.531 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.98 160.1 17.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.6 127.6 55.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.377 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 111.15 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -0.971 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.491 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.8 t -63.33 145.06 56.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.575 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 34.7 m-85 -56.04 -72.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CB ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -116.29 172.45 3.8 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 33' ' ' PHE . 35.2 Cg_endo -77.52 123.24 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.532 2.154 . . . . 0.0 110.254 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.22 18.59 21.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -106.58 178.88 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -1.072 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 14' ' ' ARG . 12.1 m -121.09 -10.17 9.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.526 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 170.47 14.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -164.75 -138.89 2.51 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.99 166.22 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.344 -1.092 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.28 129.17 53.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 27' ' ' LEU . 16.1 pt20 -124.38 146.38 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.388 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -88.45 42.93 1.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.279 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.27 0.557 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.498 ' CB ' ' HA ' ' A' ' 24' ' ' CYS . 1.4 p -127.45 173.71 9.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -150.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 0.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.21 162.15 26.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -73.48 137.67 44.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.76 54.28 6.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.51 -165.25 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -1.125 . . . . 0.0 109.484 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -87.16 160.71 18.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.505 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -146.21 178.34 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 109.401 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 12' ' ' VAL . 2.4 p -121.71 95.65 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.27 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.96 HG22 ' O ' ' A' ' 37' ' ' THR . 3.2 m -67.95 -21.13 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 102.46 13.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.9 135.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.098 -1.001 . . . . 0.0 109.658 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 18.4 p90 -149.92 90.15 1.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -6.12 83.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.4 mt -76.34 152.95 83.98 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.215 -1.168 . . . . 0.0 109.48 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 37.0 Cg_endo -80.88 54.05 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.895 2.397 . . . . 0.0 110.644 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 t -86.59 -179.73 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.052 -1.03 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -118.52 86.95 29.96 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.88 -171.83 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 110.45 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -63.47 171.09 2.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -58.72 168.43 1.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 132.23 45.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.357 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.28 -20.2 33.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 62.0 mt -95.27 167.42 11.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.116 . . . . 0.0 109.356 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.43 149.76 51.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 m -121.87 138.89 54.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -124.29 165.86 16.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.689 ' CA ' HG11 ' A' ' 13' ' ' VAL . 33.6 t -91.89 176.52 6.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.557 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 6.7 m-85 -75.29 -67.39 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.572 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 163.3 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.909 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 35.7 Cg_endo -78.23 70.34 7.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.171 1.914 . . . . 0.0 110.908 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 41.28 43.29 3.54 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.61 125.93 35.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.42 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 13' ' ' VAL . 14.5 t -69.26 -23.66 63.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HD1' HG23 ' A' ' 37' ' ' THR . 2.1 m-85 -113.58 160.85 18.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.58 -145.38 4.12 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -117.31 169.76 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.141 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 47.8 t -126.4 141.62 51.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.65 -177.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.686 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 41.44 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.486 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' GLN . 51.3 t -157.95 129.58 6.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.202 -0.936 . . . . 0.0 109.507 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' CYS . 10.6 mm-40 -53.61 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 164.88 12.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.685 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.36 139.09 38.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.91 56.41 3.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 16.7 m-85 -143.02 -175.95 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 109.168 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 16.3 p-10 -81.9 152.57 26.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.96 156.57 36.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.7 136.58 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.549 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG11 ' CB ' ' A' ' 31' ' ' SER . 11.3 m -97.04 -25.55 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.271 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' NH1' ' OG1' ' A' ' 37' ' ' THR . 1.5 ttm180 -96.99 -65.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.368 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 64.05 170.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.729 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 3.8 p90 -149.85 68.21 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.61 25.74 6.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.7 mt 51.66 59.06 15.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.446 -1.032 . . . . 0.0 109.886 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.7 Cg_endo -79.01 -68.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.583 2.188 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.5 m -64.7 151.23 45.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.46 113.7 12.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.1 Cg_endo -77.83 169.37 20.79 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.344 2.03 . . . . 0.0 110.234 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.76 164.47 25.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.0 166.53 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -56.55 147.42 22.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.847 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.42 -26.41 17.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 136.04 38.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -1.129 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 153.07 31.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.7 114.69 27.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.68 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 4.7 tpt180 -101.96 152.62 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.314 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.713 ' CB ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.92 168.64 10.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 109.468 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 13.2 m-85 -62.65 -65.01 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 166.8 -52.29 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -79.46 60.64 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.166 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.14 42.73 2.44 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.8 p -75.88 -5.57 46.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -1.109 . . . . 0.0 109.626 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.73 ' O ' HG22 ' A' ' 37' ' ' THR . 98.3 m 48.36 23.57 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.118 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 37' ' ' THR . 6.3 m-85 -160.26 138.32 9.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 108.983 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -155.62 -139.76 2.84 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 17.1 mtp180 -121.51 -169.74 1.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' PHE . 2.6 t -134.79 125.75 27.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.395 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -120.82 176.37 5.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -100.44 62.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 t -155.53 138.98 15.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.12 152.87 38.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 18.1 mt -104.09 -178.38 3.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 14.9 tt0 -67.96 155.4 39.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 67.28 29.65 74.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.67 -164.53 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -1.092 . . . . 0.0 109.351 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.09 159.17 15.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.387 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.33 175.87 9.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.324 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -139.43 114.49 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.47 -11.17 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.919 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.68 23.45 14.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.454 ' OG ' ' HB ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -88.81 109.89 20.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 23.7 p90 -156.02 101.49 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 109.334 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.47 41.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 158.29 34.17 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 4.64 6.01 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.648 2.232 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.7 m -52.34 108.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mm -63.22 117.18 31.0 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.29 179.27 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.424 2.083 . . . . 0.0 110.16 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 11.1 m -65.06 169.36 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.434 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ARG . 14.1 m -69.19 151.79 45.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 26' ' ' GLY . 4.6 ttm180 -43.08 138.75 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 25' ' ' ARG . . . 96.25 5.86 59.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 42' ' ' GLN . 1.1 mt -125.5 128.05 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.7 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -108.92 -168.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' H ' HG22 ' A' ' 28' ' ' THR . 88.2 m -142.06 158.77 43.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.539 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.05 124.44 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -49.98 150.87 2.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -50.17 -30.96 12.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 171.43 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.005 . . . . 0.0 109.713 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 34.9 Cg_endo -77.24 -167.94 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.43 2.086 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.6 32.68 4.41 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -56.84 164.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -1.107 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.919 HG23 ' HD3' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -93.11 -6.88 47.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 131.53 53.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.08 -166.16 11.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.29 53.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -1.191 . . . . 0.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.86 130.34 34.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.366 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.905 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.76 -178.96 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.77 50.59 1.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.843 . . . . 0.0 109.453 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 12.1 mmm-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.26 0.553 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 3' ' ' ARG . 31.3 m -151.19 156.18 40.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 109.514 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.08 -157.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -107.2 159.44 16.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.535 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -66.86 138.38 57.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 41' ' ' CYS . . . 78.36 40.14 20.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -125.06 -160.57 0.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.39 142.51 27.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -135.44 151.09 50.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.01 151.39 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.156 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 14' ' ' ARG . 3.6 m -122.5 -41.2 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -118.01 86.31 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.604 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -78.71 167.75 20.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.344 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -156.54 64.85 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.435 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.27 42.57 6.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD22 HG23 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.53 149.32 67.05 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.262 -1.14 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.9 Cg_endo -78.09 4.85 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.669 2.246 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.694 HG23 HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -42.39 111.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.04 131.47 39.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.05 178.59 7.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.385 2.057 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.424 ' HB3' HD13 ' A' ' 27' ' ' LEU . 72.4 m -68.18 156.67 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 166.45 5.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.053 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -56.22 150.32 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.14 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.5 mt -115.03 147.67 39.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 157.61 24.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -116.18 124.93 51.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 110.3 20.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.838 . . . . 0.0 109.631 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.06 150.46 46.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 23.2 m-85 -61.94 -72.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 109.656 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER 169.73 -55.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.6 Cg_endo -77.42 114.41 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.386 2.058 . . . . 0.0 110.248 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 57.03 15.46 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -45.75 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -1.139 . . . . 0.0 109.749 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.4 m -137.53 -47.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 0.0 109.251 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 37' ' ' THR . 81.6 m-85 -143.87 133.52 23.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 -156.79 8.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -95.56 165.98 12.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -1.157 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.453 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 17.0 t -125.07 132.44 53.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.9 tt0 -133.88 159.92 39.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -89.6 50.23 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 35.8 t -143.06 28.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER 55.16 169.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.392 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.65 144.47 42.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -47.99 114.93 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.303 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.6 51.34 1.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.529 ' CB ' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -123.62 -163.44 1.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -1.095 . . . . 0.0 109.401 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -99.26 124.86 44.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -108.22 156.28 19.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 15' ' ' SER . 43.0 t -97.09 121.56 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 31' ' ' SER . 27.2 m -97.55 -12.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -119.49 18.19 12.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.47 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.57 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -45.12 127.62 6.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.68 101.55 6.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 109.504 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 18' ' ' LEU . . . 71.6 7.24 64.42 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 70.01 62.6 0.51 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.105 -1.233 . . . . 0.0 109.554 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.55 -24.83 7.19 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.659 2.239 . . . . 0.0 110.342 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -97.53 -179.83 4.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.915 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.661 HG23 ' HD2' ' A' ' 22' ' ' PRO . 31.0 mm -86.81 140.16 33.15 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 21' ' ' ILE . 35.6 Cg_endo -78.16 162.68 28.5 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.545 2.163 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -67.33 169.73 8.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.462 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 38.5 m -71.42 172.9 8.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.256 -0.902 . . . . 0.0 109.101 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -66.6 146.98 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.237 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.87 -12.33 59.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 42' ' ' GLN . 4.4 mm? -86.0 163.56 17.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -1.101 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 139.37 30.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.583 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.6 m -100.22 108.05 20.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -107.94 122.78 47.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' HG11 ' A' ' 13' ' ' VAL . 3.5 p -77.16 132.58 38.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 22.9 m-85 -44.13 -65.96 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.399 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.553 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.79 -53.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.667 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.2 Cg_endo -78.04 114.65 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.362 2.041 . . . . 0.0 110.396 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 61.86 60.6 7.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -44.95 110.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.525 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -163.16 -37.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.977 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.36 105.13 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.835 . . . . 0.0 109.552 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.6 -160.89 12.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -113.06 172.97 6.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -1.18 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.45 120.37 34.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD13 ' A' ' 27' ' ' LEU . 3.3 mm-40 -114.11 168.98 9.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.555 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.89 54.97 2.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.524 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ARG . . . . . 0.58 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.227 0.537 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -86.0 147.39 26.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.35 153.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 6' ' ' LEU . 7.8 mt -81.62 -173.81 4.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.412 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -81.88 141.16 33.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.494 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.11 75.43 0.46 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -154.24 -171.86 4.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -1.199 . . . . 0.0 109.561 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.45 102.55 13.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.604 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.5 t -89.07 153.9 20.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 14' ' ' ARG . 9.9 p -96.39 142.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 37' ' ' THR . 28.0 m -123.37 7.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.674 ' HD2' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.72 36.96 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.7 t -93.66 97.0 10.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 77.54 1.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.54 55.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.3 153.11 48.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 111.85 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.525 2.15 . . . . 0.0 110.349 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -148.36 162.31 39.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 3' ' ' ARG . 13.4 mm -110.32 96.57 27.21 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.374 -0.829 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 20' ' ' THR . 34.4 Cg_endo -76.98 -163.05 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.51 2.14 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -73.61 176.3 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 176.07 8.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -68.94 134.14 49.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.91 -7.82 49.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 16.9 mt -103.21 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.538 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 132.07 32.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.5 t -98.99 141.62 31.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.257 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -147.0 144.71 29.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.086 -1.009 . . . . 0.0 109.773 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 p -97.11 154.72 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.333 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 23.4 m-85 -62.05 -70.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.0 109.364 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.5 -53.48 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -79.0 87.18 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.457 2.105 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 120.77 -36.58 3.3 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 11.5 p 47.36 49.37 15.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 109.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.674 HG23 ' HD2' ' A' ' 14' ' ' ARG . 52.5 m -120.99 -41.66 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.505 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.1 m-85 -143.74 116.23 8.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -114.13 -138.24 6.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 11.1 mtt180 -125.82 163.76 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -1.097 . . . . 0.0 109.518 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.27 154.15 35.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.337 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -154.27 -174.82 5.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' CG ' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.05 75.85 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.365 -0.835 . . . . 0.0 109.39 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.742 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.307 0.575 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 -151.74 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.239 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.13 158.82 43.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.46 134.78 34.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.85 152.09 7.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 109.255 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.83 21.28 66.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 3.0 m-85 -106.25 -167.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -97.99 160.68 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.263 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -126.36 172.37 10.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 15' ' ' SER . 5.1 t -111.48 85.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.527 HG11 ' OG ' ' A' ' 31' ' ' SER . 2.6 m -52.25 -21.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -100.96 -80.63 0.49 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.565 ' N ' HG12 ' A' ' 12' ' ' VAL . 13.0 t 52.09 22.45 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -97.86 110.39 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.19 -16.37 35.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.5 mt -134.0 143.95 49.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.419 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.34 145.76 21.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.554 2.169 . . . . 0.0 110.385 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.64 -172.92 4.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.63 106.98 51.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.43 152.47 30.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.346 2.03 . . . . 0.0 110.461 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.498 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 79.8 m -59.31 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.94 168.07 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.788 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.77 124.96 15.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.67 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 103.22 12.18 32.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 26' ' ' GLY . 4.1 mm? -116.73 100.64 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -1.017 . . . . 0.0 109.386 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 147.0 28.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.3 m -110.07 146.83 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.574 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.41 134.45 19.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' HG11 ' A' ' 13' ' ' VAL . 66.7 m -59.58 159.51 8.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.534 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 23.7 t80 160.38 -47.28 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.586 . . . . 0.0 109.69 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -77.89 -169.2 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.959 1.772 . . . . 0.0 110.39 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.42 17.13 58.25 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -51.43 155.62 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -1.197 . . . . 0.0 109.493 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.0 t -89.22 23.26 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.77 153.91 40.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.23 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' ASN . . . -155.02 -140.64 3.05 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 10' ' ' ASN . 2.7 ttt85 -118.32 176.0 5.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 109.508 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 25.0 t -142.84 124.22 14.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.534 ' C ' HD13 ' A' ' 27' ' ' LEU . 4.7 mt-30 -145.53 174.49 11.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -97.35 -8.76 28.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 0.0 109.473 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 41.7 t80 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLN . 57.6 m -147.6 153.92 40.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 0.0 109.718 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 4' ' ' CYS . 46.0 mt-30 -50.38 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -160.45 168.97 23.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 109.582 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.382 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 9' ' ' PHE . . . 105.24 48.54 1.05 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 38.6 m-85 -141.59 -165.31 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 10' ' ' ASN . 17.5 p30 -79.62 138.14 37.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.489 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 42.5 t -121.57 154.0 37.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.681 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.1 p -103.61 113.48 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 37' ' ' THR . 12.4 m -78.68 -20.12 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.64 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HB2' HG23 ' A' ' 37' ' ' THR . 6.6 tpp180 -99.28 57.7 1.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB3' HG21 ' A' ' 20' ' ' THR . 0.2 OUTLIER -103.78 5.27 35.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -95.52 107.03 19.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.23 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.25 26.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -147.75 151.14 38.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -1.199 . . . . 0.0 109.391 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.6 Cg_endo -78.22 123.57 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.572 2.181 . . . . 0.0 110.539 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.442 HG21 ' HB3' ' A' ' 15' ' ' SER . 11.4 t -162.85 178.87 8.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.317 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -115.56 90.16 24.97 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.137 -0.977 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.8 Cg_endo -78.06 -159.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.575 2.184 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 89.4 m -86.69 164.83 16.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -179.48 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -73.42 136.03 44.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 -24.19 31.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 19.8 mt -85.64 142.79 28.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -1.134 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.43 153.54 23.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.757 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.1 m -124.34 150.84 45.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -0.813 . . . . 0.0 109.131 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -148.62 108.38 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 2.9 p -50.02 133.23 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.294 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' SER . 27.9 m-85 -43.96 -53.12 6.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.601 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -106.33 172.27 4.06 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.28 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 35.1 Cg_endo -78.79 74.2 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.534 2.156 . . . . 0.0 110.275 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' SER . . . 146.5 -24.06 1.68 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.6 m -50.49 -179.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -1.133 . . . . 0.0 109.457 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 14' ' ' ARG . 51.0 m -123.2 -12.29 7.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 118.86 23.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 -150.02 7.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.9 174.03 6.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -1.098 . . . . 0.0 109.131 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.62 119.07 19.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 109.777 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -111.4 -173.18 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.257 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.7 68.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.448 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.268 0.556 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 5' ' ' GLN . 28.6 t -117.23 156.83 27.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.394 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -85.36 172.32 11.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.333 -0.854 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.597 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -115.71 -174.87 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.372 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.32 136.73 46.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.513 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.55 65.83 2.65 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 2.8 m-85 -140.35 -167.11 2.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 109.373 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . 0.569 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 4.7 m-20 -90.92 116.13 28.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.45 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . 35.8 t -109.01 152.61 24.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 0.0 109.406 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HE1' ' A' ' 38' ' ' TYR . 8.3 p -106.39 131.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 37' ' ' THR . 19.1 m -102.1 -18.94 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -86.51 48.2 1.59 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.636 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -113.55 101.02 8.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.039 -1.038 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 5.3 p90 -144.54 70.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.304 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.42 -27.58 5.75 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -96.96 143.45 26.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.305 -1.115 . . . . 0.0 109.388 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.2 Cg_endo -78.53 127.12 7.9 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.576 2.184 . . . . 0.0 110.43 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -141.62 -148.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 20' ' ' THR . 29.0 mm -124.99 84.15 59.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.143 -0.973 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 156.14 30.61 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.651 2.234 . . . . 0.0 110.46 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 27' ' ' LEU . 60.9 m -63.16 164.87 7.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 m -61.66 169.93 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.704 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -66.63 124.87 24.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.828 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.19 -2.11 31.29 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.95 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.76 152.26 21.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -1.142 . . . . 0.0 109.467 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.22 137.65 41.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.392 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 41' ' ' CYS . 1.6 p -128.6 140.07 51.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.057 -1.027 . . . . 0.0 109.866 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 31' ' ' SER . 1.1 ttp180 -127.72 142.26 51.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.317 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -44.08 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.709 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 18.1 m-85 -61.79 -39.16 90.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.584 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 172.76 -54.16 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.827 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 37.5 Cg_endo -82.0 52.19 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.561 2.174 . . . . 0.0 110.577 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.37 32.08 1.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 31' ' ' SER . 6.5 t -52.0 146.4 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -1.086 . . . . 0.0 109.793 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 13' ' ' VAL . 99.0 m -66.69 -33.18 75.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.189 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.545 ' HE1' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -112.71 124.38 52.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.053 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.05 -153.12 11.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -120.8 139.61 52.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.277 -1.131 . . . . 0.0 109.438 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -94.83 155.64 16.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.95 ' O ' HD23 ' A' ' 27' ' ' LEU . 31.9 mt-30 -148.69 172.2 14.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.85 35.64 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.302 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.415 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 11.3 p -126.43 -174.03 3.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 4' ' ' CYS . 7.5 mm-40 -53.41 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 121.57 31.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -60.57 149.0 36.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.42 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.99 62.95 5.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 -151.81 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -1.152 . . . . 0.0 109.343 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.66 138.31 35.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.354 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 159.15 19.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.622 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.6 p -118.42 127.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 37' ' ' THR . 4.0 m -117.12 -2.7 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.461 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -89.66 54.41 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 109.459 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 t -114.02 123.81 50.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.451 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 2.2 p90 -129.56 93.82 3.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.44 17.11 78.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.8 164.16 15.59 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.97 -83.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.625 2.217 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.445 HG21 HG11 ' A' ' 12' ' ' VAL . 10.8 m 48.18 69.98 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 21' ' ' ILE . 16.4 mm -45.41 109.35 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.8 Cg_endo -77.63 -177.25 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.488 2.126 . . . . 0.0 110.571 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.596 ' HB3' HD13 ' A' ' 27' ' ' LEU . 77.7 m -48.05 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 54.9 m -74.21 174.69 8.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -67.92 137.29 55.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.96 -16.74 30.33 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.6 mp -93.88 167.82 11.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.88 167.81 20.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 13' ' ' VAL . 18.6 t -123.67 128.95 50.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.24 110.86 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.509 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 13' ' ' VAL . 13.6 m -68.01 162.29 24.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.446 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 27.9 m-85 -75.86 -71.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.541 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 164.72 -52.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.0 109.474 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.76 100.3 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.469 2.113 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 95.93 -33.58 5.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 2.6 p 48.53 71.12 0.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -1.091 . . . . 0.0 109.532 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.749 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.6 m -128.25 -74.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 3.2 m-85 -109.49 117.87 35.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.88 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -112.76 -128.3 4.93 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.25 144.37 49.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.378 -1.072 . . . . 0.0 109.479 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.5 t -106.64 120.86 43.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.218 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -114.94 175.21 5.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.187 -0.946 . . . . 0.0 109.748 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -117.91 67.87 0.76 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.46 -177.24 6.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -104.25 179.69 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.321 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD21 ' HE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -82.44 173.11 12.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.967 . . . . 0.0 109.412 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.65 138.4 35.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.77 74.26 1.19 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -156.15 -159.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.314 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -104.64 134.78 47.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -131.88 151.32 51.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 14' ' ' ARG . 7.2 t -95.1 145.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 31' ' ' SER . 31.3 m -101.68 16.09 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.56 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.74 17.55 2.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.367 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -44.81 -29.68 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.561 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -48.35 98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.244 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 15' ' ' SER . . . 140.35 -51.83 0.71 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.12 150.82 37.83 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.343 -1.092 . . . . 0.0 109.094 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.2 113.82 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.399 2.066 . . . . 0.0 110.357 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -140.06 160.82 39.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.773 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.17 109.82 53.56 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.1 Cg_endo -77.48 160.15 32.09 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.348 2.032 . . . . 0.0 110.434 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' PRO . 35.4 m -51.88 -175.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.24 168.75 15.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -59.69 135.28 57.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.84 -3.67 41.91 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.53 170.56 8.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -1.149 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.48 163.67 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 109.897 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.1 m -106.92 135.62 48.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 111.11 14.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -66.19 140.41 58.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -57.58 -64.35 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 97.8 m-85 -108.08 159.59 30.02 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.762 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.5 Cg_endo -78.4 78.93 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.708 2.272 . . . . 0.0 110.457 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.44 -25.44 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -178.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.166 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 37' ' ' THR . 15.3 m -124.71 38.2 4.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.74 20.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 31' ' ' SER . . . -146.63 -154.11 6.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 41' ' ' CYS . 5.8 ttm180 -139.88 142.77 36.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 109.389 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 40' ' ' ARG . 47.7 t -83.47 141.14 31.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.68 -174.26 4.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.445 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 3.5 ttp85 -93.12 49.3 1.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 11.6 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.66 159.59 35.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.77 -173.61 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.329 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 1.6 mt -96.25 170.77 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.22 133.43 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.365 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.79 68.59 1.53 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.79 -165.41 2.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -1.127 . . . . 0.0 109.529 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -87.76 136.18 33.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.5 t -134.84 147.17 49.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 2.2 p -89.37 150.2 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.325 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.71 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.663 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -113.36 -67.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 70.53 85.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.131 -179.76 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -127.2 71.24 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 -179.702 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.49 -56.79 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.71 149.09 72.03 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.305 -1.115 . . . . 0.0 109.494 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 96.89 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.702 2.268 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ILE . 61.3 m -76.55 129.5 36.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' THR . 52.8 mt -43.92 110.17 0.93 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.217 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.96 167.62 24.84 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.355 2.037 . . . . 0.0 110.571 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.3 -176.46 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.47 -161.67 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.59 140.79 46.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.563 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 88.84 -9.5 76.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.7 mm? -99.73 96.61 7.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -1.104 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -80.72 139.54 36.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.216 -0.928 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 12' ' ' VAL . 8.6 t -88.85 148.94 23.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.305 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -154.67 140.66 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.14 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.679 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 25.4 m-85 -62.06 -47.13 86.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 169.32 -53.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.7 Cg_endo -80.82 58.08 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.529 2.152 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 43.51 28.06 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.34 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.385 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.439 HG21 ' OH ' ' A' ' 16' ' ' TYR . 17.5 m -92.4 -16.9 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -135.38 141.84 45.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.644 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -142.17 -128.86 2.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -143.77 176.26 9.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -1.169 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 120.42 32.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -0.88 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -111.16 176.05 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.492 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 18.33 14.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 179.862 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.285 0.564 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 2.6 m -128.76 180.0 5.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.64 164.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.305 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 137.65 32.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.663 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -52.86 103.03 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.23 44.18 0.8 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -163.48 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -1.101 . . . . 0.0 109.377 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -84.46 175.57 9.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.089 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 26.5 t -155.2 156.73 36.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.04 . . . . 0.0 109.768 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.703 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.9 t -112.99 105.69 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 37' ' ' THR . 14.1 m -88.74 15.04 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -0.996 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -124.92 -5.04 7.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 2.6 p -48.15 148.1 1.93 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 9.3 p90 -127.36 106.25 9.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' LEU . . . 97.22 30.42 7.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 42.21 59.17 10.22 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.975 . . . . 0.0 109.724 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.4 Cg_endo -78.58 -60.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.154 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 21' ' ' ILE . 5.5 t -63.26 -164.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.452 ' N ' HG23 ' A' ' 20' ' ' THR . 3.2 mt -123.62 98.18 40.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 109.388 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 35.7 Cg_endo -77.19 158.11 33.66 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.492 2.128 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' HD13 ' A' ' 27' ' ' LEU . 94.8 m -43.85 154.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.2 m -55.62 166.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.54 145.53 22.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.82 -34.9 5.27 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 43' ' ' ARG . 1.8 mt -86.35 167.75 14.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -1.06 . . . . 0.0 109.294 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 135.88 41.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.841 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.7 t -90.53 146.43 24.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 109.076 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 ttt-85 -145.4 134.93 23.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -90.74 144.76 25.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.675 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' OH ' ' HG3' ' A' ' 40' ' ' ARG . 6.0 m-85 -47.16 -61.89 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.4 166.64 10.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.02 93.19 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.751 2.301 . . . . 0.0 110.443 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.58 -33.49 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.46 163.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -1.07 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 13' ' ' VAL . 20.6 m -103.93 -21.03 13.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.703 ' CE1' HG22 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.33 172.85 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.522 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -141.24 3.68 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 13.8 mtt180 -141.31 155.25 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -1.107 . . . . 0.0 109.371 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.57 128.39 50.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -149.82 179.36 8.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.76 47.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.43 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' ' OXT' ' A' ' 44' ' ' TYR . 82.3 t80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.506 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 t -143.7 41.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 55.12 -178.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 109.634 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -112.0 128.21 56.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 147.56 40.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.65 53.28 39.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -142.57 -161.21 1.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -1.197 . . . . 0.0 109.486 179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.8 149.52 31.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 t -144.65 147.96 33.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 15' ' ' SER . 58.4 t -96.16 149.47 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.179 -0.951 . . . . 0.0 109.171 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.73 -20.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -133.06 -49.77 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.616 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.2 t 62.27 127.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 109.436 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 7.1 p90 -138.91 84.65 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.427 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' C ' ' HG ' ' A' ' 18' ' ' LEU . . . 159.83 -53.62 0.36 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.9 mt -137.29 157.99 73.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 18' ' ' LEU . 34.8 Cg_endo -77.02 95.21 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.358 2.039 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.419 HG21 ' HB ' ' A' ' 12' ' ' VAL . 14.1 t -69.07 153.49 43.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 21' ' ' ILE . 4.2 mp -86.26 126.35 65.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 109.419 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 169.5 19.58 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.436 2.09 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.2 m -68.72 163.8 23.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.36 167.85 4.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -65.34 129.52 40.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.42 -1.97 32.71 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -100.12 -167.82 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.35 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -153.8 136.87 15.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 109.626 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.4 t -124.97 128.67 48.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 109.235 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.0 ttp85 -144.88 153.85 42.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 109.819 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.471 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.9 p -95.41 149.82 20.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.309 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -65.15 -65.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.109 -0.994 . . . . 0.0 109.497 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.07 157.08 37.11 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 109.674 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.89 81.86 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.558 2.172 . . . . 0.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.99 -35.97 0.61 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 m -61.17 146.0 49.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -1.041 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.21 27.79 3.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.98 159.01 43.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -164.57 -135.31 1.8 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -148.87 155.12 40.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' THR . 7.8 t -117.39 144.04 45.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.895 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.648 ' O ' HD23 ' A' ' 27' ' ' LEU . 90.1 mt-30 -142.6 178.33 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 109.665 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.52 39.68 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.917 . . . . 0.0 109.505 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 24' ' ' CYS . 11.4 p -105.91 62.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.586 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.6 mm-40 60.88 -175.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.847 . . . . 0.0 109.733 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.6 171.56 11.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.66 144.71 43.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.37 77.62 0.15 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.37 -163.41 1.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.497 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -95.2 141.49 28.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -143.17 148.1 35.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 109.299 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 38' ' ' TYR . 6.2 p -91.8 154.52 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.34 -27.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -36.36 3.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 109.591 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 59.29 159.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.637 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 18' ' ' LEU . 5.9 p90 -153.0 79.44 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.842 . . . . 0.0 109.509 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.03 56.02 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -150.57 143.88 16.84 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.124 . . . . 0.0 109.413 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.81 101.15 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.609 2.206 . . . . 0.0 110.429 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -135.18 116.8 14.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 21' ' ' ILE . 23.0 mt -84.51 125.45 71.58 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.351 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 173.28 14.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.381 2.054 . . . . 0.0 110.342 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' HD12 ' A' ' 27' ' ' LEU . 7.3 m -67.53 153.27 44.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.893 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 7.9 p -87.35 -179.28 6.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.71 143.71 9.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.8 -33.63 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 23' ' ' CYS . 36.0 mt -105.24 -168.79 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 119.41 2.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -82.72 105.53 13.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 139.78 46.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 p -73.96 166.01 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 109.575 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 54.3 m-85 -58.54 -56.22 24.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.958 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.97 -51.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.012 . . . . 0.0 110.024 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 37.0 Cg_endo -80.25 57.32 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.775 2.316 . . . . 0.0 111.177 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.41 47.73 5.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.5 144.73 39.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -1.101 . . . . 0.0 109.571 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 37' ' ' THR . 88.8 m -71.12 -10.31 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE1' HG23 ' A' ' 12' ' ' VAL . 1.4 m-85 -129.5 -175.47 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.47 -151.79 8.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 1.5 mtp85 -134.51 161.32 35.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -1.121 . . . . 0.0 109.391 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 11.9 t -109.93 128.48 55.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.489 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -122.7 175.36 6.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.41 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -92.82 40.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t 46.88 68.56 0.61 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.418 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 173.15 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HB3' ' N ' ' A' ' 24' ' ' CYS . 55.5 m -118.99 172.87 7.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.18 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -63.69 -168.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.146 -0.971 . . . . 0.0 109.317 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.96 179.85 3.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.66 150.38 23.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.52 34.62 89.63 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.87 -166.88 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -1.133 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -103.26 171.95 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.221 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 168.54 21.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.518 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 14' ' ' ARG . 3.7 t -121.76 112.84 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG21 ' OG ' ' A' ' 31' ' ' SER . 25.9 m -87.76 9.3 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.541 ' HD2' HG23 ' A' ' 37' ' ' THR . 9.7 ttt180 -120.01 -5.97 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -58.07 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 24.7 m-85 -72.64 141.2 48.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 109.321 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.53 87.0 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 12.8 mt 43.86 59.7 12.23 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.394 -1.062 . . . . 0.0 109.978 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.69 -40.65 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.467 2.112 . . . . 0.0 110.173 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.5 m -78.27 144.2 36.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.62 122.58 83.98 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.76 149.76 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.433 2.089 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.58 161.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -73.11 168.2 19.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.696 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -52.93 142.08 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.78 -20.25 41.97 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 HH21 ' A' ' 43' ' ' ARG . 1.1 mt -110.63 139.28 46.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -1.171 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.3 162.93 14.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.02 113.3 16.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 158.84 25.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' HG21 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -93.42 155.26 17.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 99.1 m-85 -62.44 -19.9 63.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.61 167.69 0.15 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.213 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 34.6 Cg_endo -77.27 120.56 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.541 2.161 . . . . 0.0 110.311 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.36 11.37 8.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 p -123.96 -167.38 1.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.541 HG23 ' HD2' ' A' ' 14' ' ' ARG . 3.4 m -142.03 25.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.667 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 176.44 9.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -173.32 -163.48 27.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 173.06 11.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.5 t -136.63 126.59 25.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.445 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.2 mt-30 -129.36 175.86 8.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.484 HH21 HD21 ' A' ' 27' ' ' LEU . 27.5 ttm-85 -86.03 43.74 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' OXT' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 42.07 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -110.12 126.2 53.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 p -138.8 151.1 46.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -61.78 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.892 . . . . 0.0 109.232 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.99 160.5 14.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.351 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' C ' ' OE1' ' A' ' 7' ' ' GLN . 3.1 tm0? -67.34 157.67 33.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.156 -0.965 . . . . 0.0 109.556 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.98 57.02 9.18 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.6 -164.27 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -1.111 . . . . 0.0 109.459 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.35 161.0 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 t -154.48 150.76 28.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.625 ' O ' HG13 ' A' ' 12' ' ' VAL . 12.2 p -103.09 119.37 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 109.643 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' THR . 4.8 m -81.52 -22.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 8.6 mmt180 -90.47 -84.27 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 62.65 106.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -101.51 93.51 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 104.05 8.59 38.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.9 mm? 61.65 60.9 2.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.181 -1.188 . . . . 0.0 109.532 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.7 Cg_endo -77.71 -66.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.426 2.084 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 21' ' ' ILE . 12.4 m -72.87 164.06 27.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 109.289 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.503 HD13 ' N ' ' A' ' 21' ' ' ILE . 5.0 mm -84.23 137.94 39.55 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.8 Cg_endo -78.64 -167.48 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.679 2.253 . . . . 0.0 110.48 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.5 m -98.64 156.68 16.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.38 161.62 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 139.09 55.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' OXT' ' A' ' 44' ' ' TYR . . . 108.84 -26.79 14.59 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -92.53 166.83 12.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -140.36 160.71 39.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.3 t -101.88 129.54 48.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.454 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.4 ttt180 -133.44 131.42 39.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -98.9 152.22 20.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m-85 -53.81 -69.87 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 109.32 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 172.06 -55.81 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 109.707 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.1 Cg_endo -78.29 127.0 8.01 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 110.322 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.18 48.41 79.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 37' ' ' THR . 97.6 p -45.75 113.18 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -1.075 . . . . 0.0 109.668 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 13' ' ' VAL . 28.2 m -166.08 -41.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -137.35 119.39 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.344 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -127.79 -143.58 5.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -124.25 162.9 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.32 131.65 55.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.78 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.7 OUTLIER -129.08 -172.1 2.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.37 -0.831 . . . . 0.0 109.404 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -100.11 61.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.462 ' OXT' ' O ' ' A' ' 26' ' ' GLY . 3.6 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.2 75.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -102.92 71.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.512 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -131.7 166.9 20.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.514 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -95.72 -170.79 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 1.9 mp -106.23 156.75 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -74.7 141.02 44.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 62.5 4.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 1.6 m-85 -141.52 -163.96 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.212 . . . . 0.0 109.433 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -79.53 130.5 35.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -124.64 176.49 6.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 109.626 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.694 HG13 ' CZ ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.51 167.59 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.198 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 31' ' ' SER . 35.6 m -138.32 6.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.736 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.72 33.95 5.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.62 58.79 2.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -102.38 72.67 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.18 -49.39 0.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 159.28 49.35 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.189 -1.183 . . . . 0.0 109.417 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.92 111.26 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.62 2.214 . . . . 0.0 110.472 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -156.66 128.49 7.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 21' ' ' ILE . 46.5 mm -85.15 117.66 69.23 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 -179.22 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.264 1.976 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' CYS . 12.5 m -71.2 155.83 40.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 7.7 m -43.65 161.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -62.74 144.84 56.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.409 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 96.29 -15.66 62.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 ' HG3' ' A' ' 43' ' ' ARG . 64.6 mt -105.65 173.24 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.98 -174.72 4.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 40.7 m -146.49 165.93 27.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.16 50.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.441 ' HB3' HG11 ' A' ' 13' ' ' VAL . 13.4 p -88.64 138.97 30.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.203 -0.936 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 34.2 m-85 -46.76 -68.91 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.081 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 165.0 -54.35 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.295 -0.878 . . . . 0.0 109.395 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.4 Cg_endo -79.85 116.62 3.48 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.465 2.11 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.62 59.49 7.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -48.0 102.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -1.016 . . . . 0.0 109.759 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -148.41 -52.27 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.328 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.694 ' CZ ' HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.85 142.06 51.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.71 -140.63 3.75 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.55 144.47 51.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.299 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -101.38 139.42 37.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.788 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -162.01 0.94 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 108.982 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' HG3' HD21 ' A' ' 27' ' ' LEU . 2.3 ttm180 -102.11 59.59 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.0 109.347 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.541 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.17 106.07 4.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.09 -178.53 5.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 2.8 t -90.89 128.57 36.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.39 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.4 163.5 17.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -62.75 124.65 21.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.05 58.56 1.77 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.95 -166.55 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -1.072 . . . . 0.0 109.556 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.39 133.82 34.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.2 t -131.95 149.17 52.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG13 ' OG ' ' A' ' 15' ' ' SER . 4.3 p -85.08 140.12 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' THR . 26.6 m -106.21 -20.99 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.932 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 58.31 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.575 ' OG ' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -110.64 99.04 8.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 35.8 p90 -123.75 55.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.34 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.28 -35.91 3.47 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 153.82 3.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.171 -1.193 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.8 86.77 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.54 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' HG23 ' A' ' 20' ' ' THR . 2.0 t -148.03 97.51 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 tt -62.08 113.8 9.65 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.88 . . . . 0.0 109.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.72 -161.51 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.343 2.029 . . . . 0.0 110.147 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.95 -168.23 0.26 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.6 m -91.02 -179.1 5.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.55 127.72 33.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.382 -0.824 . . . . 0.0 109.703 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.476 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 109.28 -7.21 32.41 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 43' ' ' ARG . 22.1 mt -118.14 109.94 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -1.198 . . . . 0.0 109.556 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 p -83.59 174.39 10.59 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.186 -0.946 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.3 m -125.1 140.32 52.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.153 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 134.22 34.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 t -83.62 100.68 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 109.391 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.564 ' CE2' ' HA2' ' A' ' 39' ' ' GLY . 3.4 p90 -45.92 -27.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -0.976 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -127.79 145.86 56.61 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.416 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.42 93.15 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.644 2.229 . . . . 0.0 110.508 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.68 -30.9 1.93 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 p -79.11 104.13 9.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -1.223 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.766 ' O ' HG22 ' A' ' 13' ' ' VAL . 15.2 t -52.56 -22.81 5.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.632 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.53 131.37 49.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -129.37 -136.93 4.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -125.8 175.45 7.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.189 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -129.58 134.99 48.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 81.8 mt-30 -149.66 -177.2 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.945 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -88.22 38.67 0.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.566 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 35.4 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -153.75 100.81 2.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.889 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -123.93 100.24 6.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.474 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 m -141.13 142.84 34.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.555 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -66.38 -167.66 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.17 171.63 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -67.4 146.7 53.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.25 68.62 1.6 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 1.7 m-85 -146.41 -165.73 2.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -1.117 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -89.57 141.31 28.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 19.5 t -143.42 158.08 43.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 10.0 p -99.23 145.24 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 37' ' ' THR . 29.3 m -120.36 -21.6 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -130.69 52.48 2.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' ARG . 12.4 t -45.03 131.8 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.538 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -113.31 85.78 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.92 44.15 49.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.444 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -123.85 148.45 56.74 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.656 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.5 Cg_endo -78.6 91.86 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.588 2.192 . . . . 0.0 110.012 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 t -134.12 161.44 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.86 . . . . 0.0 109.735 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.889 HG21 ' O ' ' A' ' 3' ' ' ARG . 23.7 mm -127.47 128.15 24.04 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 109.088 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.57 167.01 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.388 2.058 . . . . 0.0 110.626 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 89.4 m -60.62 146.88 43.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.73 165.09 4.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -46.01 151.29 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.68 -6.23 79.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -125.36 124.81 42.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.246 . . . . 0.0 109.506 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.4 147.58 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.38 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.2 m -103.51 133.35 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -121.68 159.16 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.98 153.91 28.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 34.3 m-85 -58.3 -72.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 168.74 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -77.74 110.8 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.448 2.099 . . . . 0.0 110.345 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 65.96 62.99 4.29 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 35' ' ' GLY . 6.0 p -43.36 120.18 1.82 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -1.124 . . . . 0.0 109.568 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' VAL . 87.1 m -160.29 -81.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.61 122.24 45.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.4 -145.67 5.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -114.51 -173.27 2.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -1.204 . . . . 0.0 109.502 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.2 t -138.2 127.04 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.1 mm-40 -111.3 -178.3 3.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 3.0 ttp180 -103.87 47.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.972 . . . . 0.0 109.605 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.568 ' CD1' ' OXT' ' A' ' 44' ' ' TYR . 30.3 t80 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.28 0.562 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t 54.2 76.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.2 mmm180 -85.98 84.56 7.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.39 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' GLN . 40.0 t -143.3 99.34 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' CYS . 5.1 mt-30 -54.56 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -177.9 3.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.579 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' CD ' ' N ' ' A' ' 8' ' ' GLY . 18.2 tm0? -77.68 169.67 17.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 7' ' ' GLN . . . 44.61 48.67 8.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -164.19 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.372 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.39 122.94 45.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.561 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 43.0 t -132.2 157.36 44.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.4 p -89.62 136.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 37' ' ' THR . 6.6 m -97.44 -22.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.09 67.15 5.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.314 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -94.15 27.35 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -87.68 109.62 19.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -5.68 84.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.31 112.56 26.02 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.245 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.47 75.82 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.424 2.083 . . . . 0.0 110.361 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -166.82 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.775 ' N ' HD12 ' A' ' 21' ' ' ILE . 4.0 mp -116.3 94.04 41.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' SG ' ' A' ' 11' ' ' CYS . 35.0 Cg_endo -77.65 -179.12 5.14 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.622 2.215 . . . . 0.0 110.464 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.59 154.04 41.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.21 161.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -50.48 156.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 -49.2 1.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 43' ' ' ARG . 10.1 mt -91.16 135.33 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -1.099 . . . . 0.0 109.506 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 146.6 39.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.98 116.38 24.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 109.36 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 159.25 22.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.0 p -108.95 154.11 22.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.35 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.81 1.07 22.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -127.2 158.25 69.81 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.052 -1.03 . . . . 0.0 109.629 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -78.07 134.58 13.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.547 2.165 . . . . 0.0 110.525 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.53 47.11 64.27 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -162.29 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -1.19 . . . . 0.0 109.438 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 13' ' ' VAL . 55.4 m -135.68 -58.58 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.42 142.99 34.22 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.595 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -159.73 8.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -94.7 167.99 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -1.15 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.0 t -117.69 138.36 52.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.76 -175.48 4.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -85.98 50.2 1.93 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.97 -1.015 . . . . 0.0 109.477 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -167.63 101.01 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.6 64.64 1.59 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.74 170.2 21.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -91.21 156.51 17.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.98 154.97 21.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.544 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.15 115.18 9.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.41 41.4 1.15 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -120.59 -149.17 0.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.233 -1.157 . . . . 0.0 109.688 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -118.6 109.44 16.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.31 153.16 20.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 109.482 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 13' ' ' VAL . 2.7 t -80.83 170.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.868 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.876 HG11 ' HB3' ' A' ' 31' ' ' SER . 3.2 m -122.54 -15.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.628 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.402 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -134.24 42.53 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.674 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.426 ' OG ' HG21 ' A' ' 20' ' ' THR . 0.5 OUTLIER -92.1 100.95 13.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' O ' ' CG ' ' A' ' 16' ' ' TYR . 6.2 p90 -150.83 122.29 7.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.57 -25.97 25.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.532 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.06 175.8 2.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 18' ' ' LEU . 34.6 Cg_endo -77.61 118.42 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.555 2.17 . . . . 0.0 110.397 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.426 HG21 ' OG ' ' A' ' 15' ' ' SER . 8.6 m -158.7 155.43 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -114.38 106.4 52.7 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 150.59 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.335 2.024 . . . . 0.0 110.422 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 90.1 m -51.32 163.53 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -178.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 4.5 tpm_? -69.39 146.59 51.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.743 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 91.24 -28.18 8.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -83.28 140.97 32.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.114 -1.227 . . . . 0.0 109.686 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.02 151.21 40.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.65 121.58 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' SER . 3.1 ttt180 -110.81 100.51 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.876 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -44.04 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 8.3 m-85 -59.51 -65.31 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.63 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.2 -53.78 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.02 . . . . 0.0 109.847 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.5 Cg_endo -78.86 66.99 8.64 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.584 2.189 . . . . 0.0 110.798 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.95 31.91 0.5 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 32' ' ' TYR . 19.3 p -61.06 145.59 50.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 m -83.37 -27.75 29.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.57 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -122.77 117.33 25.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -106.35 -157.62 21.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -110.54 175.3 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -1.109 . . . . 0.0 109.522 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.0 t -128.69 137.83 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.99 173.62 11.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' ' HG ' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -90.85 58.13 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.8 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.449 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.52 56.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.601 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -145.33 93.49 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.568 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' GLN . 26.4 p -152.39 156.66 39.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.483 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' CYS . 4.3 mt-30 -46.45 172.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.12 167.95 9.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.25 -0.907 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 3.0 tt0 -73.84 149.77 41.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.06 65.75 3.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -149.69 -161.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -1.186 . . . . 0.0 109.409 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.75 161.92 21.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 109.539 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 41' ' ' CYS . 48.7 t -153.85 159.44 41.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.895 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 38' ' ' TYR . 35.4 t -118.38 96.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 31' ' ' SER . 18.8 m -61.49 -26.74 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 15' ' ' SER . 0.2 OUTLIER -92.0 -84.56 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 63.89 84.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.378 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -78.14 107.6 10.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.695 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.4 17.19 67.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 55.22 66.52 3.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -1.125 . . . . 0.0 109.521 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 15' ' ' SER . 35.4 Cg_endo -78.04 -16.19 14.3 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.624 2.216 . . . . 0.0 110.551 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 21' ' ' ILE . 73.8 m -136.08 157.52 46.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 109.44 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 22' ' ' PRO . 60.7 mt -63.84 139.44 97.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 21' ' ' ILE . 36.2 Cg_endo -78.26 -174.09 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.65 145.55 26.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.385 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -44.15 168.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -64.75 145.59 56.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.43 -15.13 55.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -89.93 147.27 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -1.178 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.92 156.45 33.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.8 t -97.33 115.19 27.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 113.52 20.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 109.163 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.497 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.0 OUTLIER -92.9 179.13 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' ' HA2' ' A' ' 39' ' ' GLY . 4.9 p90 -129.45 12.32 5.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.936 . . . . 0.0 109.658 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.2 OUTLIER -127.55 162.52 48.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.31 73.27 5.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.512 2.141 . . . . 0.0 110.444 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.55 51.04 4.76 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' THR . 2.5 t -85.29 -8.86 58.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.561 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 36' ' ' SER . 1.3 m 72.5 3.05 4.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.501 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.48 ' CZ ' HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -153.83 157.1 38.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.188 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 32' ' ' TYR . . . -173.61 -147.59 6.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.04 168.23 11.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.589 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.3 t -120.69 161.16 21.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.871 ' O ' HD23 ' A' ' 27' ' ' LEU . 10.3 pt20 -151.4 -178.2 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' TYR . 12.9 ttt85 -105.77 46.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' CG ' ' OXT' ' A' ' 44' ' ' TYR . 79.6 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.485 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.412 ' C ' ' OG ' ' A' ' 2' ' ' SER . 2.2 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.294 0.568 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 1' ' ' TYR . 0.0 OUTLIER -176.2 43.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.405 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.43 38.14 4.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 40.64 3.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.0 109.559 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 7.0 tp60 51.35 -160.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -178.55 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 43' ' ' ARG . 46.7 tt0 -82.0 153.25 26.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 43.53 74.7 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 -163.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -1.125 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -84.72 117.58 23.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.392 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.6 t -105.25 154.55 20.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.613 HG21 HG21 ' A' ' 20' ' ' THR . 10.6 p -102.04 149.18 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.01 -30.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.868 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -154.01 63.86 0.71 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 109.681 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 20' ' ' THR . 35.7 t -109.59 66.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.687 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -78.32 149.48 33.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.83 -25.88 9.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.12 155.17 44.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.131 -1.217 . . . . 0.0 109.598 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.01 109.68 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.519 2.146 . . . . 0.0 110.063 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.613 HG21 HG21 ' A' ' 12' ' ' VAL . 9.1 t -135.97 129.88 32.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 6.4 mt -106.71 124.44 35.53 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.212 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 172.22 16.04 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.316 2.01 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 m -65.5 -171.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -178.27 4.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.95 133.87 51.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.82 -20.04 27.35 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -100.57 126.97 47.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -1.155 . . . . 0.0 109.531 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.98 160.1 17.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.6 127.6 55.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.377 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 111.15 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -0.971 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.491 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.8 t -63.33 145.06 56.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 34.7 m-85 -56.04 -72.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CB ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -116.29 172.45 3.8 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 33' ' ' PHE . 35.2 Cg_endo -77.52 123.24 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.532 2.154 . . . . 0.0 110.254 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.22 18.59 21.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -106.58 178.88 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -1.072 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 14' ' ' ARG . 12.1 m -121.09 -10.17 9.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.526 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 170.47 14.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -164.75 -138.89 2.51 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.99 166.22 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.344 -1.092 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.28 129.17 53.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 27' ' ' LEU . 16.1 pt20 -124.38 146.38 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.388 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -88.45 42.93 1.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.279 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.25 0.548 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.45 141.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.416 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 77.19 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.535 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.498 ' CB ' ' HA ' ' A' ' 24' ' ' CYS . 1.4 p -127.45 173.71 9.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -150.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 0.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.21 162.15 26.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -73.48 137.67 44.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.76 54.28 6.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.51 -165.25 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -1.125 . . . . 0.0 109.484 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -87.16 160.71 18.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.505 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -146.21 178.34 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 109.401 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' HG13 ' A' ' 12' ' ' VAL . 2.4 p -121.71 95.65 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.27 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.96 HG22 ' O ' ' A' ' 37' ' ' THR . 3.2 m -67.95 -21.13 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 102.46 13.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.9 135.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.098 -1.001 . . . . 0.0 109.658 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 18.4 p90 -149.92 90.15 1.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -6.12 83.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.4 mt -76.34 152.95 83.98 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.215 -1.168 . . . . 0.0 109.48 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 37.0 Cg_endo -80.88 54.05 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.895 2.397 . . . . 0.0 110.644 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 t -86.59 -179.73 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.052 -1.03 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -118.52 86.95 29.96 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.88 -171.83 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 110.45 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -63.47 171.09 2.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -58.72 168.43 1.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 132.23 45.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.357 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.28 -20.2 33.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 62.0 mt -95.27 167.42 11.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.116 . . . . 0.0 109.356 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.43 149.76 51.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 m -121.87 138.89 54.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -124.29 165.86 16.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.689 ' CA ' HG11 ' A' ' 13' ' ' VAL . 33.6 t -91.89 176.52 6.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.557 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 6.7 m-85 -75.29 -67.39 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.572 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 163.3 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.909 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 35.7 Cg_endo -78.23 70.34 7.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.171 1.914 . . . . 0.0 110.908 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 41.28 43.29 3.54 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.61 125.93 35.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.42 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 13' ' ' VAL . 14.5 t -69.26 -23.66 63.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HD1' HG23 ' A' ' 37' ' ' THR . 2.1 m-85 -113.58 160.85 18.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.58 -145.38 4.12 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -117.31 169.76 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.141 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 47.8 t -126.4 141.62 51.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.65 -177.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.686 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 41.44 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.486 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t -121.99 52.93 1.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.6 39.33 3.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' GLN . 51.3 t -157.95 129.58 6.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.202 -0.936 . . . . 0.0 109.507 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' CYS . 10.6 mm-40 -53.61 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 164.88 12.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.685 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -78.36 139.09 38.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.91 56.41 3.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 16.7 m-85 -143.02 -175.95 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 109.168 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 16.3 p-10 -81.9 152.57 26.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.96 156.57 36.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.7 136.58 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.549 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG11 ' CB ' ' A' ' 31' ' ' SER . 11.3 m -97.04 -25.55 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.271 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' NH1' ' OG1' ' A' ' 37' ' ' THR . 1.5 ttm180 -96.99 -65.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.368 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 64.05 170.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.729 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 3.8 p90 -149.85 68.21 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.61 25.74 6.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.7 mt 51.66 59.06 15.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.446 -1.032 . . . . 0.0 109.886 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.7 Cg_endo -79.01 -68.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.583 2.188 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.5 m -64.7 151.23 45.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.46 113.7 12.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.1 Cg_endo -77.83 169.37 20.79 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.344 2.03 . . . . 0.0 110.234 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.76 164.47 25.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.0 166.53 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -56.55 147.42 22.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.847 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.42 -26.41 17.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 136.04 38.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -1.129 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 153.07 31.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.7 114.69 27.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.68 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 4.7 tpt180 -101.96 152.62 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.314 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.713 ' CB ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.92 168.64 10.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 109.468 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 13.2 m-85 -62.65 -65.01 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 166.8 -52.29 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -79.46 60.64 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.166 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.14 42.73 2.44 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.8 p -75.88 -5.57 46.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -1.109 . . . . 0.0 109.626 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.73 ' O ' HG22 ' A' ' 37' ' ' THR . 98.3 m 48.36 23.57 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.118 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 37' ' ' THR . 6.3 m-85 -160.26 138.32 9.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 108.983 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -155.62 -139.76 2.84 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 17.1 mtp180 -121.51 -169.74 1.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' PHE . 2.6 t -134.79 125.75 27.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.395 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -120.82 176.37 5.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -100.44 62.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -157.95 64.38 0.46 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.46 164.46 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 t -155.53 138.98 15.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.12 152.87 38.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 18.1 mt -104.09 -178.38 3.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 14.9 tt0 -67.96 155.4 39.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 67.28 29.65 74.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.67 -164.53 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -1.092 . . . . 0.0 109.351 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.09 159.17 15.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.387 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.33 175.87 9.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.324 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -139.43 114.49 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.47 -11.17 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.919 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.68 23.45 14.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.454 ' OG ' ' HB ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -88.81 109.89 20.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 23.7 p90 -156.02 101.49 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 109.334 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.47 41.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 158.29 34.17 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 4.64 6.01 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.648 2.232 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.7 m -52.34 108.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mm -63.22 117.18 31.0 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.29 179.27 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.424 2.083 . . . . 0.0 110.16 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 11.1 m -65.06 169.36 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.434 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ARG . 14.1 m -69.19 151.79 45.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 26' ' ' GLY . 4.6 ttm180 -43.08 138.75 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 25' ' ' ARG . . . 96.25 5.86 59.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 42' ' ' GLN . 1.1 mt -125.5 128.05 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.7 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -108.92 -168.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' H ' HG22 ' A' ' 28' ' ' THR . 88.2 m -142.06 158.77 43.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.539 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.05 124.44 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -49.98 150.87 2.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -50.17 -30.96 12.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 171.43 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.005 . . . . 0.0 109.713 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 34.9 Cg_endo -77.24 -167.94 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.43 2.086 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.6 32.68 4.41 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -56.84 164.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -1.107 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.919 HG23 ' HD3' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -93.11 -6.88 47.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 131.53 53.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.08 -166.16 11.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.29 53.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -1.191 . . . . 0.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.86 130.34 34.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.366 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.905 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.76 -178.96 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.77 50.59 1.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.843 . . . . 0.0 109.453 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.09 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 12.1 mmm-85 -100.27 60.23 1.03 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 3' ' ' ARG . 31.3 m -151.19 156.18 40.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 109.514 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.08 -157.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -107.2 159.44 16.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.535 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -66.86 138.38 57.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 41' ' ' CYS . . . 78.36 40.14 20.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -125.06 -160.57 0.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.39 142.51 27.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -135.44 151.09 50.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.01 151.39 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.156 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 14' ' ' ARG . 3.6 m -122.5 -41.2 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -118.01 86.31 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.604 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -78.71 167.75 20.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.344 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -156.54 64.85 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.435 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.27 42.57 6.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD22 HG23 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.53 149.32 67.05 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.262 -1.14 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.9 Cg_endo -78.09 4.85 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.669 2.246 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.694 HG23 HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -42.39 111.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.04 131.47 39.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.05 178.59 7.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.385 2.057 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.424 ' HB3' HD13 ' A' ' 27' ' ' LEU . 72.4 m -68.18 156.67 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 166.45 5.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.053 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -56.22 150.32 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.14 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.5 mt -115.03 147.67 39.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 157.61 24.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -116.18 124.93 51.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 110.3 20.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.838 . . . . 0.0 109.631 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.06 150.46 46.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 23.2 m-85 -61.94 -72.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 109.656 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER 169.73 -55.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.6 Cg_endo -77.42 114.41 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.386 2.058 . . . . 0.0 110.248 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 57.03 15.46 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -45.75 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -1.139 . . . . 0.0 109.749 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.4 m -137.53 -47.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 0.0 109.251 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 37' ' ' THR . 81.6 m-85 -143.87 133.52 23.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 -156.79 8.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -95.56 165.98 12.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -1.157 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.453 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 17.0 t -125.07 132.44 53.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.9 tt0 -133.88 159.92 39.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -89.6 50.23 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 t -158.15 81.78 0.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 37.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 35.8 t -143.06 28.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER 55.16 169.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.392 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.65 144.47 42.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -47.99 114.93 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.303 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.6 51.34 1.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.529 ' CB ' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -123.62 -163.44 1.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -1.095 . . . . 0.0 109.401 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -99.26 124.86 44.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -108.22 156.28 19.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 15' ' ' SER . 43.0 t -97.09 121.56 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 31' ' ' SER . 27.2 m -97.55 -12.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -119.49 18.19 12.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.47 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.57 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -45.12 127.62 6.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.68 101.55 6.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 109.504 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 18' ' ' LEU . . . 71.6 7.24 64.42 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 70.01 62.6 0.51 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.105 -1.233 . . . . 0.0 109.554 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.55 -24.83 7.19 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.659 2.239 . . . . 0.0 110.342 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -97.53 -179.83 4.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.915 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.661 HG23 ' HD2' ' A' ' 22' ' ' PRO . 31.0 mm -86.81 140.16 33.15 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 21' ' ' ILE . 35.6 Cg_endo -78.16 162.68 28.5 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.545 2.163 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -67.33 169.73 8.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.462 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 38.5 m -71.42 172.9 8.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.256 -0.902 . . . . 0.0 109.101 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -66.6 146.98 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.237 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.87 -12.33 59.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 42' ' ' GLN . 4.4 mm? -86.0 163.56 17.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -1.101 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 139.37 30.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.583 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.6 m -100.22 108.05 20.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -107.94 122.78 47.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' HG11 ' A' ' 13' ' ' VAL . 3.5 p -77.16 132.58 38.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 22.9 m-85 -44.13 -65.96 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.399 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.553 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.79 -53.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.667 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.2 Cg_endo -78.04 114.65 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.362 2.041 . . . . 0.0 110.396 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 61.86 60.6 7.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -44.95 110.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.525 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -163.16 -37.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.977 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.36 105.13 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.835 . . . . 0.0 109.552 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.6 -160.89 12.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -113.06 172.97 6.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -1.18 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.45 120.37 34.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD13 ' A' ' 27' ' ' LEU . 3.3 mm-40 -114.11 168.98 9.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.555 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.89 54.97 2.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.524 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.97 135.3 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.58 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -143.55 42.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.059 -1.026 . . . . 0.0 109.796 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -86.0 147.39 26.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.35 153.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 6' ' ' LEU . 7.8 mt -81.62 -173.81 4.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.412 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -81.88 141.16 33.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.494 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.11 75.43 0.46 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -154.24 -171.86 4.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -1.199 . . . . 0.0 109.561 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.45 102.55 13.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.604 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.5 t -89.07 153.9 20.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 14' ' ' ARG . 9.9 p -96.39 142.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 37' ' ' THR . 28.0 m -123.37 7.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.674 ' HD2' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.72 36.96 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.7 t -93.66 97.0 10.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 77.54 1.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.54 55.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.3 153.11 48.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 111.85 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.525 2.15 . . . . 0.0 110.349 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -148.36 162.31 39.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 3' ' ' ARG . 13.4 mm -110.32 96.57 27.21 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.374 -0.829 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 20' ' ' THR . 34.4 Cg_endo -76.98 -163.05 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.51 2.14 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -73.61 176.3 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 176.07 8.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -68.94 134.14 49.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.91 -7.82 49.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 16.9 mt -103.21 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.538 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 132.07 32.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.5 t -98.99 141.62 31.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.257 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -147.0 144.71 29.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.086 -1.009 . . . . 0.0 109.773 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 p -97.11 154.72 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.333 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 23.4 m-85 -62.05 -70.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.0 109.364 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.5 -53.48 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -79.0 87.18 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.457 2.105 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 120.77 -36.58 3.3 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 11.5 p 47.36 49.37 15.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 109.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.674 HG23 ' HD2' ' A' ' 14' ' ' ARG . 52.5 m -120.99 -41.66 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.505 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.1 m-85 -143.74 116.23 8.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -114.13 -138.24 6.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 11.1 mtt180 -125.82 163.76 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -1.097 . . . . 0.0 109.518 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.27 154.15 35.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.337 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -154.27 -174.82 5.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' CG ' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.05 75.85 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.365 -0.835 . . . . 0.0 109.39 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.742 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -115.95 67.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.64 161.65 33.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 -151.74 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.239 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.13 158.82 43.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.46 134.78 34.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.85 152.09 7.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 109.255 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.83 21.28 66.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 3.0 m-85 -106.25 -167.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -97.99 160.68 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.263 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -126.36 172.37 10.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 15' ' ' SER . 5.1 t -111.48 85.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.527 HG11 ' OG ' ' A' ' 31' ' ' SER . 2.6 m -52.25 -21.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -100.96 -80.63 0.49 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.565 ' N ' HG12 ' A' ' 12' ' ' VAL . 13.0 t 52.09 22.45 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -97.86 110.39 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.19 -16.37 35.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.5 mt -134.0 143.95 49.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.419 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.34 145.76 21.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.554 2.169 . . . . 0.0 110.385 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.64 -172.92 4.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.63 106.98 51.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.43 152.47 30.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.346 2.03 . . . . 0.0 110.461 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.498 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 79.8 m -59.31 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.94 168.07 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.788 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.77 124.96 15.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.67 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 103.22 12.18 32.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 26' ' ' GLY . 4.1 mm? -116.73 100.64 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -1.017 . . . . 0.0 109.386 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 147.0 28.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.3 m -110.07 146.83 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.574 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.41 134.45 19.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' HG11 ' A' ' 13' ' ' VAL . 66.7 m -59.58 159.51 8.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.534 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 23.7 t80 160.38 -47.28 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.586 . . . . 0.0 109.69 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -77.89 -169.2 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.959 1.772 . . . . 0.0 110.39 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.42 17.13 58.25 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -51.43 155.62 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -1.197 . . . . 0.0 109.493 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.0 t -89.22 23.26 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.77 153.91 40.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.23 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' ASN . . . -155.02 -140.64 3.05 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 10' ' ' ASN . 2.7 ttt85 -118.32 176.0 5.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 109.508 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 25.0 t -142.84 124.22 14.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.534 ' C ' HD13 ' A' ' 27' ' ' LEU . 4.7 mt-30 -145.53 174.49 11.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -97.35 -8.76 28.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 0.0 109.473 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 41.7 t80 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' SER . 97.0 m-85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.226 0.536 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 1' ' ' TYR . 12.7 m 66.02 95.05 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.7 164.89 18.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 109.181 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLN . 57.6 m -147.6 153.92 40.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 0.0 109.718 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 4' ' ' CYS . 46.0 mt-30 -50.38 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -160.45 168.97 23.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 109.582 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.382 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 9' ' ' PHE . . . 105.24 48.54 1.05 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 38.6 m-85 -141.59 -165.31 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 10' ' ' ASN . 17.5 p30 -79.62 138.14 37.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.489 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 42.5 t -121.57 154.0 37.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.681 ' O ' HG13 ' A' ' 12' ' ' VAL . 14.1 p -103.61 113.48 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 37' ' ' THR . 12.4 m -78.68 -20.12 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.64 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HB2' HG23 ' A' ' 37' ' ' THR . 6.6 tpp180 -99.28 57.7 1.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB3' HG21 ' A' ' 20' ' ' THR . 0.2 OUTLIER -103.78 5.27 35.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -95.52 107.03 19.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.23 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.25 26.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -147.75 151.14 38.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -1.199 . . . . 0.0 109.391 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.6 Cg_endo -78.22 123.57 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.572 2.181 . . . . 0.0 110.539 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.442 HG21 ' HB3' ' A' ' 15' ' ' SER . 11.4 t -162.85 178.87 8.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.317 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -115.56 90.16 24.97 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.137 -0.977 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.8 Cg_endo -78.06 -159.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.575 2.184 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 89.4 m -86.69 164.83 16.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -179.48 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -73.42 136.03 44.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 -24.19 31.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 19.8 mt -85.64 142.79 28.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -1.134 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.43 153.54 23.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.757 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.1 m -124.34 150.84 45.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -0.813 . . . . 0.0 109.131 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -148.62 108.38 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 2.9 p -50.02 133.23 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.294 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' SER . 27.9 m-85 -43.96 -53.12 6.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.601 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -106.33 172.27 4.06 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.28 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 35.1 Cg_endo -78.79 74.2 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.534 2.156 . . . . 0.0 110.275 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' SER . . . 146.5 -24.06 1.68 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.6 m -50.49 -179.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -1.133 . . . . 0.0 109.457 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 14' ' ' ARG . 51.0 m -123.2 -12.29 7.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 118.86 23.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 -150.02 7.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.9 174.03 6.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -1.098 . . . . 0.0 109.131 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.62 119.07 19.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 109.777 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -111.4 -173.18 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.257 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.7 68.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.448 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.286 0.565 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -135.83 96.7 3.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -138.79 75.81 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 5' ' ' GLN . 28.6 t -117.23 156.83 27.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.394 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.569 ' NE2' ' O ' ' A' ' 10' ' ' ASN . 0.9 OUTLIER -85.36 172.32 11.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.333 -0.854 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.597 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -115.71 -174.87 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.372 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.32 136.73 46.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.513 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.55 65.83 2.65 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 2.8 m-85 -140.35 -167.11 2.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 109.373 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . 0.569 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 4.7 m-20 -90.92 116.13 28.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.45 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . 35.8 t -109.01 152.61 24.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 0.0 109.406 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HE1' ' A' ' 38' ' ' TYR . 8.3 p -106.39 131.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 37' ' ' THR . 19.1 m -102.1 -18.94 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -86.51 48.2 1.59 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.636 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -113.55 101.02 8.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.039 -1.038 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.538 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 5.3 p90 -144.54 70.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.304 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.42 -27.58 5.75 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -96.96 143.45 26.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.305 -1.115 . . . . 0.0 109.388 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.2 Cg_endo -78.53 127.12 7.9 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.576 2.184 . . . . 0.0 110.43 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -141.62 -148.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 20' ' ' THR . 29.0 mm -124.99 84.15 59.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.143 -0.973 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 156.14 30.61 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.651 2.234 . . . . 0.0 110.46 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 27' ' ' LEU . 60.9 m -63.16 164.87 7.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 m -61.66 169.93 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.704 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -66.63 124.87 24.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.828 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.19 -2.11 31.29 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.95 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.76 152.26 21.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -1.142 . . . . 0.0 109.467 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.22 137.65 41.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.392 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 41' ' ' CYS . 1.6 p -128.6 140.07 51.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.057 -1.027 . . . . 0.0 109.866 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 31' ' ' SER . 1.1 ttp180 -127.72 142.26 51.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.317 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -44.08 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.709 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 18.1 m-85 -61.79 -39.16 90.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.584 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 172.76 -54.16 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.827 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 37.5 Cg_endo -82.0 52.19 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.561 2.174 . . . . 0.0 110.577 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.37 32.08 1.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 31' ' ' SER . 6.5 t -52.0 146.4 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -1.086 . . . . 0.0 109.793 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 13' ' ' VAL . 99.0 m -66.69 -33.18 75.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.189 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.545 ' HE1' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -112.71 124.38 52.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.053 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.05 -153.12 11.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -120.8 139.61 52.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.277 -1.131 . . . . 0.0 109.438 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -94.83 155.64 16.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.95 ' O ' HD23 ' A' ' 27' ' ' LEU . 31.9 mt-30 -148.69 172.2 14.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.85 35.64 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.302 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.415 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.49 67.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.714 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.36 135.64 33.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.385 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 11.3 p -126.43 -174.03 3.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 4' ' ' CYS . 7.5 mm-40 -53.41 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 121.57 31.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -60.57 149.0 36.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.42 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.99 62.95 5.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 -151.81 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -1.152 . . . . 0.0 109.343 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.66 138.31 35.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.354 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 159.15 19.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.622 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.519 ' O ' HG13 ' A' ' 12' ' ' VAL . 11.6 p -118.42 127.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 37' ' ' THR . 4.0 m -117.12 -2.7 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.461 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -89.66 54.41 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 109.459 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 t -114.02 123.81 50.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.451 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 2.2 p90 -129.56 93.82 3.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.44 17.11 78.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.8 164.16 15.59 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.97 -83.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.625 2.217 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.445 HG21 HG11 ' A' ' 12' ' ' VAL . 10.8 m 48.18 69.98 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 21' ' ' ILE . 16.4 mm -45.41 109.35 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.8 Cg_endo -77.63 -177.25 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.488 2.126 . . . . 0.0 110.571 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.596 ' HB3' HD13 ' A' ' 27' ' ' LEU . 77.7 m -48.05 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 54.9 m -74.21 174.69 8.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -67.92 137.29 55.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.96 -16.74 30.33 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.6 mp -93.88 167.82 11.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.88 167.81 20.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 13' ' ' VAL . 18.6 t -123.67 128.95 50.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.24 110.86 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.509 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 13' ' ' VAL . 13.6 m -68.01 162.29 24.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.446 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 27.9 m-85 -75.86 -71.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.541 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 164.72 -52.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.0 109.474 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.76 100.3 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.469 2.113 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 95.93 -33.58 5.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 2.6 p 48.53 71.12 0.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -1.091 . . . . 0.0 109.532 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.749 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.6 m -128.25 -74.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 3.2 m-85 -109.49 117.87 35.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.88 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -112.76 -128.3 4.93 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.25 144.37 49.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.378 -1.072 . . . . 0.0 109.479 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.5 t -106.64 120.86 43.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.218 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -114.94 175.21 5.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.187 -0.946 . . . . 0.0 109.748 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -117.91 67.87 0.76 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.18 77.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.41 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -163.29 36.25 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.261 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.46 -177.24 6.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -104.25 179.69 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.321 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD21 ' HE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -82.44 173.11 12.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.967 . . . . 0.0 109.412 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.65 138.4 35.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.77 74.26 1.19 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -156.15 -159.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.314 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -104.64 134.78 47.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -131.88 151.32 51.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 14' ' ' ARG . 7.2 t -95.1 145.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 31' ' ' SER . 31.3 m -101.68 16.09 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.56 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.74 17.55 2.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.367 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -44.81 -29.68 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.561 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -48.35 98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.244 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 15' ' ' SER . . . 140.35 -51.83 0.71 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.12 150.82 37.83 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.343 -1.092 . . . . 0.0 109.094 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.2 113.82 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.399 2.066 . . . . 0.0 110.357 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -140.06 160.82 39.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.773 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.17 109.82 53.56 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.1 Cg_endo -77.48 160.15 32.09 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.348 2.032 . . . . 0.0 110.434 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' PRO . 35.4 m -51.88 -175.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.24 168.75 15.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -59.69 135.28 57.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.84 -3.67 41.91 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.53 170.56 8.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -1.149 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.48 163.67 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 109.897 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.1 m -106.92 135.62 48.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 111.11 14.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -66.19 140.41 58.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -57.58 -64.35 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 97.8 m-85 -108.08 159.59 30.02 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.762 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.5 Cg_endo -78.4 78.93 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.708 2.272 . . . . 0.0 110.457 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.44 -25.44 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -178.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.166 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.459 HG22 ' O ' ' A' ' 37' ' ' THR . 15.3 m -124.71 38.2 4.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.74 20.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 31' ' ' SER . . . -146.63 -154.11 6.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 41' ' ' CYS . 5.8 ttm180 -139.88 142.77 36.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 109.389 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 40' ' ' ARG . 47.7 t -83.47 141.14 31.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.68 -174.26 4.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.445 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 3.5 ttp85 -93.12 49.3 1.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 11.6 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 50.8 p90 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.16 -178.42 6.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 66.01 38.93 4.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.88 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.66 159.59 35.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.77 -173.61 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.329 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 1.6 mt -96.25 170.77 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.22 133.43 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.365 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.79 68.59 1.53 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.79 -165.41 2.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -1.127 . . . . 0.0 109.529 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -87.76 136.18 33.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.5 t -134.84 147.17 49.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 2.2 p -89.37 150.2 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.325 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.71 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.663 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -113.36 -67.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 70.53 85.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.131 -179.76 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.624 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -127.2 71.24 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 -179.702 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.49 -56.79 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.71 149.09 72.03 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.305 -1.115 . . . . 0.0 109.494 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 96.89 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.702 2.268 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ILE . 61.3 m -76.55 129.5 36.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' THR . 52.8 mt -43.92 110.17 0.93 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.217 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.96 167.62 24.84 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.355 2.037 . . . . 0.0 110.571 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.3 -176.46 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.47 -161.67 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.59 140.79 46.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.563 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 88.84 -9.5 76.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.7 mm? -99.73 96.61 7.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -1.104 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -80.72 139.54 36.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.216 -0.928 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 12' ' ' VAL . 8.6 t -88.85 148.94 23.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.305 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -154.67 140.66 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.14 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.679 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 25.4 m-85 -62.06 -47.13 86.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 169.32 -53.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.7 Cg_endo -80.82 58.08 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.529 2.152 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 43.51 28.06 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.34 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.385 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.439 HG21 ' OH ' ' A' ' 16' ' ' TYR . 17.5 m -92.4 -16.9 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -135.38 141.84 45.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.644 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -142.17 -128.86 2.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -143.77 176.26 9.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -1.169 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 120.42 32.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -0.88 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -111.16 176.05 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.492 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 18.33 14.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 179.862 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.431 ' H1 ' ' HD1' ' A' ' 1' ' ' TYR . 14.6 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p 67.31 139.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -0.962 . . . . 0.0 109.619 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.5 112.47 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 2.6 m -128.76 180.0 5.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.64 164.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.305 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 137.65 32.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.663 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -52.86 103.03 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.23 44.18 0.8 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -163.48 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -1.101 . . . . 0.0 109.377 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -84.46 175.57 9.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.089 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 26.5 t -155.2 156.73 36.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.04 . . . . 0.0 109.768 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.703 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.9 t -112.99 105.69 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 37' ' ' THR . 14.1 m -88.74 15.04 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -0.996 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -124.92 -5.04 7.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 2.6 p -48.15 148.1 1.93 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 9.3 p90 -127.36 106.25 9.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' LEU . . . 97.22 30.42 7.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 42.21 59.17 10.22 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.975 . . . . 0.0 109.724 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.4 Cg_endo -78.58 -60.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.154 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 21' ' ' ILE . 5.5 t -63.26 -164.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.452 ' N ' HG23 ' A' ' 20' ' ' THR . 3.2 mt -123.62 98.18 40.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 109.388 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 35.7 Cg_endo -77.19 158.11 33.66 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.492 2.128 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' HD13 ' A' ' 27' ' ' LEU . 94.8 m -43.85 154.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.2 m -55.62 166.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.54 145.53 22.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.82 -34.9 5.27 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 43' ' ' ARG . 1.8 mt -86.35 167.75 14.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -1.06 . . . . 0.0 109.294 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 135.88 41.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.841 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.7 t -90.53 146.43 24.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 109.076 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 ttt-85 -145.4 134.93 23.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -90.74 144.76 25.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.675 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' OH ' ' HG3' ' A' ' 40' ' ' ARG . 6.0 m-85 -47.16 -61.89 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.4 166.64 10.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.02 93.19 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.751 2.301 . . . . 0.0 110.443 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.58 -33.49 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.46 163.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -1.07 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 13' ' ' VAL . 20.6 m -103.93 -21.03 13.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.703 ' CE1' HG22 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.33 172.85 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.522 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -141.24 3.68 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 13.8 mtt180 -141.31 155.25 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -1.107 . . . . 0.0 109.371 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.57 128.39 50.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -149.82 179.36 8.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.76 47.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.43 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' CD2' ' OXT' ' A' ' 44' ' ' TYR . 82.3 t80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.506 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.8 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 1' ' ' TYR . 1.2 m 75.75 122.17 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.409 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -97.72 87.04 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.156 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 t -143.7 41.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 55.12 -178.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 109.634 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -112.0 128.21 56.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 147.56 40.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.65 53.28 39.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -142.57 -161.21 1.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -1.197 . . . . 0.0 109.486 179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.8 149.52 31.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 t -144.65 147.96 33.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 15' ' ' SER . 58.4 t -96.16 149.47 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.179 -0.951 . . . . 0.0 109.171 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.73 -20.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -133.06 -49.77 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.616 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.2 t 62.27 127.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 109.436 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.531 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 7.1 p90 -138.91 84.65 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.427 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' C ' ' HG ' ' A' ' 18' ' ' LEU . . . 159.83 -53.62 0.36 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.9 mt -137.29 157.99 73.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 18' ' ' LEU . 34.8 Cg_endo -77.02 95.21 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.358 2.039 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.419 HG21 ' HB ' ' A' ' 12' ' ' VAL . 14.1 t -69.07 153.49 43.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 21' ' ' ILE . 4.2 mp -86.26 126.35 65.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 109.419 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 169.5 19.58 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.436 2.09 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.2 m -68.72 163.8 23.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.36 167.85 4.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -65.34 129.52 40.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.42 -1.97 32.71 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -100.12 -167.82 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.35 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -153.8 136.87 15.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 109.626 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.4 t -124.97 128.67 48.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 109.235 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.0 ttp85 -144.88 153.85 42.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 109.819 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.471 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.9 p -95.41 149.82 20.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.309 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -65.15 -65.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.109 -0.994 . . . . 0.0 109.497 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.07 157.08 37.11 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 109.674 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.89 81.86 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.558 2.172 . . . . 0.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.99 -35.97 0.61 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 m -61.17 146.0 49.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -1.041 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.21 27.79 3.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.98 159.01 43.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -164.57 -135.31 1.8 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -148.87 155.12 40.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' THR . 7.8 t -117.39 144.04 45.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.895 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.648 ' O ' HD23 ' A' ' 27' ' ' LEU . 90.1 mt-30 -142.6 178.33 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 109.665 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.52 39.68 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.917 . . . . 0.0 109.505 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 2' ' ' SER . 9.1 m-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 1' ' ' TYR . 1.1 m 58.11 111.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.386 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.63 154.03 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 109.424 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 24' ' ' CYS . 11.4 p -105.91 62.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.586 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 9.6 mm-40 60.88 -175.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.847 . . . . 0.0 109.733 179.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.6 171.56 11.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.66 144.71 43.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.37 77.62 0.15 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.37 -163.41 1.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.497 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -95.2 141.49 28.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -143.17 148.1 35.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 109.299 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 38' ' ' TYR . 6.2 p -91.8 154.52 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.34 -27.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -36.36 3.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 109.591 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 59.29 159.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.637 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 18' ' ' LEU . 5.9 p90 -153.0 79.44 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.842 . . . . 0.0 109.509 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.03 56.02 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -150.57 143.88 16.84 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.124 . . . . 0.0 109.413 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.81 101.15 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.609 2.206 . . . . 0.0 110.429 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -135.18 116.8 14.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 21' ' ' ILE . 23.0 mt -84.51 125.45 71.58 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.351 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 173.28 14.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.381 2.054 . . . . 0.0 110.342 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' HD12 ' A' ' 27' ' ' LEU . 7.3 m -67.53 153.27 44.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.893 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 7.9 p -87.35 -179.28 6.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.71 143.71 9.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.8 -33.63 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 23' ' ' CYS . 36.0 mt -105.24 -168.79 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 119.41 2.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -82.72 105.53 13.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 139.78 46.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 p -73.96 166.01 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 109.575 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 54.3 m-85 -58.54 -56.22 24.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.958 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.97 -51.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.012 . . . . 0.0 110.024 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 37.0 Cg_endo -80.25 57.32 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.775 2.316 . . . . 0.0 111.177 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.41 47.73 5.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.5 144.73 39.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -1.101 . . . . 0.0 109.571 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 37' ' ' THR . 88.8 m -71.12 -10.31 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE1' HG23 ' A' ' 12' ' ' VAL . 1.4 m-85 -129.5 -175.47 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.47 -151.79 8.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 1.5 mtp85 -134.51 161.32 35.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -1.121 . . . . 0.0 109.391 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 11.9 t -109.93 128.48 55.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.489 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -122.7 175.36 6.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.41 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -92.82 40.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.282 0.563 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HB3' ' N ' ' A' ' 24' ' ' CYS . 55.5 m -118.99 172.87 7.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.18 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -63.69 -168.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.146 -0.971 . . . . 0.0 109.317 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.96 179.85 3.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.66 150.38 23.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.52 34.62 89.63 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.87 -166.88 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -1.133 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -103.26 171.95 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.221 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 168.54 21.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.518 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 14' ' ' ARG . 3.7 t -121.76 112.84 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.437 HG21 ' OG ' ' A' ' 31' ' ' SER . 25.9 m -87.76 9.3 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.541 ' HD2' HG23 ' A' ' 37' ' ' THR . 9.7 ttt180 -120.01 -5.97 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -58.07 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 24.7 m-85 -72.64 141.2 48.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 109.321 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.53 87.0 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.558 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 12.8 mt 43.86 59.7 12.23 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.394 -1.062 . . . . 0.0 109.978 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.69 -40.65 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.467 2.112 . . . . 0.0 110.173 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.5 m -78.27 144.2 36.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.62 122.58 83.98 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.76 149.76 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.433 2.089 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.58 161.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -73.11 168.2 19.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.696 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -52.93 142.08 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.78 -20.25 41.97 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 HH21 ' A' ' 43' ' ' ARG . 1.1 mt -110.63 139.28 46.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -1.171 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.3 162.93 14.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.02 113.3 16.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 158.84 25.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' HG21 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -93.42 155.26 17.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 99.1 m-85 -62.44 -19.9 63.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.61 167.69 0.15 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.213 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 34.6 Cg_endo -77.27 120.56 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.541 2.161 . . . . 0.0 110.311 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.36 11.37 8.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 p -123.96 -167.38 1.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.541 HG23 ' HD2' ' A' ' 14' ' ' ARG . 3.4 m -142.03 25.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.667 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 176.44 9.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -173.32 -163.48 27.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 173.06 11.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.5 t -136.63 126.59 25.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.445 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.2 mt-30 -129.36 175.86 8.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.484 HH21 HD21 ' A' ' 27' ' ' LEU . 27.5 ttm-85 -86.03 43.74 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' OXT' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 p -138.8 151.1 46.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -61.78 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.892 . . . . 0.0 109.232 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.99 160.5 14.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.351 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.42 ' OE1' ' C ' ' A' ' 7' ' ' GLN . 3.1 tm0? -67.34 157.67 33.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.156 -0.965 . . . . 0.0 109.556 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.98 57.02 9.18 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.6 -164.27 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -1.111 . . . . 0.0 109.459 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.35 161.0 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 t -154.48 150.76 28.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 12' ' ' VAL . 12.2 p -103.09 119.37 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 109.643 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' THR . 4.8 m -81.52 -22.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 8.6 mmt180 -90.47 -84.27 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 62.65 106.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -101.51 93.51 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 104.05 8.59 38.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.9 mm? 61.65 60.9 2.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.181 -1.188 . . . . 0.0 109.532 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.7 Cg_endo -77.71 -66.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.426 2.084 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 21' ' ' ILE . 12.4 m -72.87 164.06 27.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 109.289 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.503 ' N ' HD13 ' A' ' 21' ' ' ILE . 5.0 mm -84.23 137.94 39.55 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.8 Cg_endo -78.64 -167.48 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.679 2.253 . . . . 0.0 110.48 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.5 m -98.64 156.68 16.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.38 161.62 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 139.09 55.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' OXT' ' A' ' 44' ' ' TYR . . . 108.84 -26.79 14.59 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -92.53 166.83 12.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -140.36 160.71 39.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.3 t -101.88 129.54 48.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.454 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.4 ttt180 -133.44 131.42 39.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -98.9 152.22 20.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m-85 -53.81 -69.87 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 109.32 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 172.06 -55.81 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 109.707 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.1 Cg_endo -78.29 127.0 8.01 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 110.322 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.18 48.41 79.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 37' ' ' THR . 97.6 p -45.75 113.18 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -1.075 . . . . 0.0 109.668 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 13' ' ' VAL . 28.2 m -166.08 -41.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -137.35 119.39 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.344 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -127.79 -143.58 5.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -124.25 162.9 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.32 131.65 55.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.78 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.7 OUTLIER -129.08 -172.1 2.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.37 -0.831 . . . . 0.0 109.404 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -100.11 61.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.462 ' OXT' ' O ' ' A' ' 26' ' ' GLY . 3.6 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.343 0.592 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -131.7 166.9 20.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.514 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -95.72 -170.79 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 1.9 mp -106.23 156.75 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -74.7 141.02 44.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 62.5 4.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 1.6 m-85 -141.52 -163.96 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.212 . . . . 0.0 109.433 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 10' ' ' ASN . 1.8 p30 -79.53 130.5 35.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -124.64 176.49 6.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 109.626 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.694 HG13 ' CZ ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.51 167.59 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.198 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 31' ' ' SER . 35.6 m -138.32 6.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.736 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.72 33.95 5.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.62 58.79 2.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -102.38 72.67 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.18 -49.39 0.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 159.28 49.35 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.189 -1.183 . . . . 0.0 109.417 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.92 111.26 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.62 2.214 . . . . 0.0 110.472 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -156.66 128.49 7.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 21' ' ' ILE . 46.5 mm -85.15 117.66 69.23 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 -179.22 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.264 1.976 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' CYS . 12.5 m -71.2 155.83 40.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 7.7 m -43.65 161.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -62.74 144.84 56.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.409 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 96.29 -15.66 62.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 ' HG3' ' A' ' 43' ' ' ARG . 64.6 mt -105.65 173.24 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.98 -174.72 4.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 40.7 m -146.49 165.93 27.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.16 50.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.441 ' HB3' HG11 ' A' ' 13' ' ' VAL . 13.4 p -88.64 138.97 30.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.203 -0.936 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 34.2 m-85 -46.76 -68.91 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.081 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 165.0 -54.35 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.295 -0.878 . . . . 0.0 109.395 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.4 Cg_endo -79.85 116.62 3.48 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.465 2.11 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.62 59.49 7.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -48.0 102.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -1.016 . . . . 0.0 109.759 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -148.41 -52.27 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.328 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.694 ' CZ ' HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.85 142.06 51.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.71 -140.63 3.75 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.55 144.47 51.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.299 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -101.38 139.42 37.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.788 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -162.01 0.94 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 108.982 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.484 ' HG3' HD21 ' A' ' 27' ' ' LEU . 2.3 ttm180 -102.11 59.59 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.0 109.347 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.541 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 2.8 t -90.89 128.57 36.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.39 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.4 163.5 17.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -62.75 124.65 21.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.05 58.56 1.77 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.95 -166.55 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -1.072 . . . . 0.0 109.556 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.39 133.82 34.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.2 t -131.95 149.17 52.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.575 HG13 ' OG ' ' A' ' 15' ' ' SER . 4.3 p -85.08 140.12 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' THR . 26.6 m -106.21 -20.99 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.932 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 58.31 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.575 ' OG ' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -110.64 99.04 8.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 35.8 p90 -123.75 55.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.34 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.28 -35.91 3.47 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 153.82 3.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.171 -1.193 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.8 86.77 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.54 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' HG23 ' A' ' 20' ' ' THR . 2.0 t -148.03 97.51 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 tt -62.08 113.8 9.65 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.88 . . . . 0.0 109.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.72 -161.51 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.343 2.029 . . . . 0.0 110.147 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.95 -168.23 0.26 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.6 m -91.02 -179.1 5.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.55 127.72 33.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.382 -0.824 . . . . 0.0 109.703 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.476 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 109.28 -7.21 32.41 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 43' ' ' ARG . 22.1 mt -118.14 109.94 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -1.198 . . . . 0.0 109.556 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 p -83.59 174.39 10.59 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.186 -0.946 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.3 m -125.1 140.32 52.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.153 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 134.22 34.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 t -83.62 100.68 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 109.391 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.564 ' CE2' ' HA2' ' A' ' 39' ' ' GLY . 3.4 p90 -45.92 -27.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -0.976 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -127.79 145.86 56.61 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.416 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.42 93.15 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.644 2.229 . . . . 0.0 110.508 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.68 -30.9 1.93 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 p -79.11 104.13 9.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -1.223 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.766 ' O ' HG22 ' A' ' 13' ' ' VAL . 15.2 t -52.56 -22.81 5.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.632 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.53 131.37 49.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -129.37 -136.93 4.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -125.8 175.45 7.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.189 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -129.58 134.99 48.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 18.8 mt-30 -149.66 -177.2 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.945 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -88.22 38.67 0.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.566 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 35.4 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.889 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 m -141.13 142.84 34.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.555 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 10' ' ' ASN . 2.7 mt-30 -66.38 -167.66 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.17 171.63 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -67.4 146.7 53.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.25 68.62 1.6 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 1.7 m-85 -146.41 -165.73 2.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -1.117 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.464 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 6.1 m-20 -89.57 141.31 28.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 19.5 t -143.42 158.08 43.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 10.0 p -99.23 145.24 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 37' ' ' THR . 29.3 m -120.36 -21.6 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -130.69 52.48 2.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' ARG . 12.4 t -45.03 131.8 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.538 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -113.31 85.78 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.92 44.15 49.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.444 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -123.85 148.45 56.74 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.656 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.5 Cg_endo -78.6 91.86 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.588 2.192 . . . . 0.0 110.012 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 t -134.12 161.44 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.86 . . . . 0.0 109.735 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.889 HG21 ' O ' ' A' ' 3' ' ' ARG . 23.7 mm -127.47 128.15 24.04 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 109.088 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.57 167.01 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.388 2.058 . . . . 0.0 110.626 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 89.4 m -60.62 146.88 43.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.73 165.09 4.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -46.01 151.29 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.68 -6.23 79.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -125.36 124.81 42.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.246 . . . . 0.0 109.506 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.4 147.58 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.38 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.2 m -103.51 133.35 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -121.68 159.16 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.98 153.91 28.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 34.3 m-85 -58.3 -72.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 168.74 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -77.74 110.8 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.448 2.099 . . . . 0.0 110.345 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 65.96 62.99 4.29 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 35' ' ' GLY . 6.0 p -43.36 120.18 1.82 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -1.124 . . . . 0.0 109.568 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' VAL . 87.1 m -160.29 -81.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.61 122.24 45.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.4 -145.67 5.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -114.51 -173.27 2.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -1.204 . . . . 0.0 109.502 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.2 t -138.2 127.04 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.1 mm-40 -111.3 -178.3 3.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 3.0 ttp180 -103.87 47.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.972 . . . . 0.0 109.605 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.568 ' OXT' ' CD1' ' A' ' 44' ' ' TYR . 30.3 t80 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.2 mmm180 . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' GLN . 40.0 t -143.3 99.34 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' CYS . 5.1 mt-30 -54.56 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -177.9 3.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.579 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.43 ' CD ' ' N ' ' A' ' 8' ' ' GLY . 18.2 tm0? -77.68 169.67 17.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 7' ' ' GLN . . . 44.61 48.67 8.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -164.19 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.372 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.39 122.94 45.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.561 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 43.0 t -132.2 157.36 44.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.4 p -89.62 136.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 37' ' ' THR . 6.6 m -97.44 -22.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.09 67.15 5.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.314 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -94.15 27.35 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -87.68 109.62 19.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -5.68 84.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.31 112.56 26.02 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.245 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.47 75.82 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.424 2.083 . . . . 0.0 110.361 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -166.82 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.775 HD12 ' N ' ' A' ' 21' ' ' ILE . 4.0 mp -116.3 94.04 41.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' SG ' ' A' ' 11' ' ' CYS . 35.0 Cg_endo -77.65 -179.12 5.14 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.622 2.215 . . . . 0.0 110.464 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.59 154.04 41.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.21 161.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -50.48 156.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 -49.2 1.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 43' ' ' ARG . 10.1 mt -91.16 135.33 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -1.099 . . . . 0.0 109.506 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 146.6 39.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.98 116.38 24.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 109.36 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 159.25 22.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.0 p -108.95 154.11 22.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.35 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.81 1.07 22.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -127.2 158.25 69.81 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.052 -1.03 . . . . 0.0 109.629 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -78.07 134.58 13.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.547 2.165 . . . . 0.0 110.525 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.53 47.11 64.27 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -162.29 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -1.19 . . . . 0.0 109.438 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 13' ' ' VAL . 55.4 m -135.68 -58.58 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.42 142.99 34.22 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.595 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -159.73 8.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -94.7 167.99 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -1.15 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.0 t -117.69 138.36 52.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.76 -175.48 4.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -85.98 50.2 1.93 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.97 -1.015 . . . . 0.0 109.477 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 121.407 0.622 . . . . 0.0 109.368 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.74 170.2 21.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -91.21 156.51 17.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.98 154.97 21.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.544 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.15 115.18 9.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.41 41.4 1.15 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -120.59 -149.17 0.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.233 -1.157 . . . . 0.0 109.688 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -118.6 109.44 16.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.31 153.16 20.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 109.482 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 13' ' ' VAL . 2.7 t -80.83 170.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.868 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.876 HG11 ' HB3' ' A' ' 31' ' ' SER . 3.2 m -122.54 -15.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.628 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.402 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -134.24 42.53 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.674 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.426 ' OG ' HG21 ' A' ' 20' ' ' THR . 0.5 OUTLIER -92.1 100.95 13.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' CG ' ' O ' ' A' ' 16' ' ' TYR . 6.2 p90 -150.83 122.29 7.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.57 -25.97 25.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.532 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.06 175.8 2.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 18' ' ' LEU . 34.6 Cg_endo -77.61 118.42 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.555 2.17 . . . . 0.0 110.397 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.426 HG21 ' OG ' ' A' ' 15' ' ' SER . 8.6 m -158.7 155.43 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -114.38 106.4 52.7 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 150.59 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.335 2.024 . . . . 0.0 110.422 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 90.1 m -51.32 163.53 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -178.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 4.5 tpm_? -69.39 146.59 51.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.743 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 91.24 -28.18 8.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -83.28 140.97 32.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.114 -1.227 . . . . 0.0 109.686 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.02 151.21 40.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.65 121.58 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' SER . 3.1 ttt180 -110.81 100.51 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.876 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -44.04 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 8.3 m-85 -59.51 -65.31 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.63 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.2 -53.78 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.02 . . . . 0.0 109.847 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.5 Cg_endo -78.86 66.99 8.64 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.584 2.189 . . . . 0.0 110.798 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.95 31.91 0.5 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 32' ' ' TYR . 19.3 p -61.06 145.59 50.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 m -83.37 -27.75 29.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.57 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -122.77 117.33 25.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -106.35 -157.62 21.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -110.54 175.3 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -1.109 . . . . 0.0 109.522 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.0 t -128.69 137.83 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.99 173.62 11.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' ' HG ' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -90.85 58.13 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.8 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.449 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.35 0.595 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' GLN . 26.4 p -152.39 156.66 39.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.483 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' CYS . 4.3 mt-30 -46.45 172.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.12 167.95 9.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.25 -0.907 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 3.0 tt0 -73.84 149.77 41.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.06 65.75 3.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -149.69 -161.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -1.186 . . . . 0.0 109.409 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.75 161.92 21.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 109.539 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 41' ' ' CYS . 48.7 t -153.85 159.44 41.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.895 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 38' ' ' TYR . 35.4 t -118.38 96.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 31' ' ' SER . 18.8 m -61.49 -26.74 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 15' ' ' SER . 0.2 OUTLIER -92.0 -84.56 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 63.89 84.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.378 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -78.14 107.6 10.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.695 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.4 17.19 67.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 55.22 66.52 3.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -1.125 . . . . 0.0 109.521 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 15' ' ' SER . 35.4 Cg_endo -78.04 -16.19 14.3 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.624 2.216 . . . . 0.0 110.551 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 21' ' ' ILE . 73.8 m -136.08 157.52 46.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 109.44 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 22' ' ' PRO . 60.7 mt -63.84 139.44 97.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 21' ' ' ILE . 36.2 Cg_endo -78.26 -174.09 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.506 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.65 145.55 26.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.385 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -44.15 168.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -64.75 145.59 56.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.43 -15.13 55.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -89.93 147.27 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -1.178 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.92 156.45 33.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.8 t -97.33 115.19 27.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 113.52 20.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 109.163 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.497 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.0 OUTLIER -92.9 179.13 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' ' HA2' ' A' ' 39' ' ' GLY . 4.9 p90 -129.45 12.32 5.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.936 . . . . 0.0 109.658 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.2 OUTLIER -127.55 162.52 48.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.31 73.27 5.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.512 2.141 . . . . 0.0 110.444 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.55 51.04 4.76 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' THR . 2.5 t -85.29 -8.86 58.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.561 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 36' ' ' SER . 1.3 m 72.5 3.05 4.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.501 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.48 ' CZ ' HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -153.83 157.1 38.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.188 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 32' ' ' TYR . . . -173.61 -147.59 6.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.04 168.23 11.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.589 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.3 t -120.69 161.16 21.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.871 ' O ' HD23 ' A' ' 27' ' ' LEU . 10.3 pt20 -151.4 -178.2 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' TYR . 12.9 ttt85 -105.77 46.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.509 ' OXT' ' CG ' ' A' ' 44' ' ' TYR . 79.6 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.485 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 40.64 3.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.0 109.559 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 7.0 tp60 51.35 -160.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -178.55 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 43' ' ' ARG . 46.7 tt0 -82.0 153.25 26.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 43.53 74.7 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 -163.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -1.125 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -84.72 117.58 23.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.392 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.6 t -105.25 154.55 20.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.613 HG21 HG21 ' A' ' 20' ' ' THR . 10.6 p -102.04 149.18 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.01 -30.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.868 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -154.01 63.86 0.71 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 109.681 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 20' ' ' THR . 35.7 t -109.59 66.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.687 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -78.32 149.48 33.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.83 -25.88 9.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.12 155.17 44.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.131 -1.217 . . . . 0.0 109.598 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.01 109.68 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.519 2.146 . . . . 0.0 110.063 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.613 HG21 HG21 ' A' ' 12' ' ' VAL . 9.1 t -135.97 129.88 32.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 6.4 mt -106.71 124.44 35.53 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.212 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 172.22 16.04 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.316 2.01 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 m -65.5 -171.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -178.27 4.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.95 133.87 51.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.82 -20.04 27.35 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -100.57 126.97 47.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -1.155 . . . . 0.0 109.531 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.98 160.1 17.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.6 127.6 55.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.377 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 111.15 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -0.971 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.491 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.8 t -63.33 145.06 56.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.575 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 34.7 m-85 -56.04 -72.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CB ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -116.29 172.45 3.8 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 33' ' ' PHE . 35.2 Cg_endo -77.52 123.24 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.532 2.154 . . . . 0.0 110.254 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.22 18.59 21.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -106.58 178.88 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -1.072 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 14' ' ' ARG . 12.1 m -121.09 -10.17 9.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.526 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 170.47 14.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -164.75 -138.89 2.51 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.99 166.22 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.344 -1.092 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.28 129.17 53.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 27' ' ' LEU . 16.1 pt20 -124.38 146.38 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.388 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -88.45 42.93 1.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.279 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.27 0.557 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.498 ' CB ' ' HA ' ' A' ' 24' ' ' CYS . 1.4 p -127.45 173.71 9.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -150.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 0.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.21 162.15 26.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -73.48 137.67 44.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.76 54.28 6.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.51 -165.25 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -1.125 . . . . 0.0 109.484 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -87.16 160.71 18.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.505 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -146.21 178.34 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 109.401 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -121.71 95.65 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.27 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.96 HG22 ' O ' ' A' ' 37' ' ' THR . 3.2 m -67.95 -21.13 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 102.46 13.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.9 135.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.098 -1.001 . . . . 0.0 109.658 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 18.4 p90 -149.92 90.15 1.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -6.12 83.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.4 mt -76.34 152.95 83.98 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.215 -1.168 . . . . 0.0 109.48 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 37.0 Cg_endo -80.88 54.05 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.895 2.397 . . . . 0.0 110.644 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 t -86.59 -179.73 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.052 -1.03 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -118.52 86.95 29.96 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.88 -171.83 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 110.45 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -63.47 171.09 2.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -58.72 168.43 1.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 132.23 45.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.357 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.28 -20.2 33.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 62.0 mt -95.27 167.42 11.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.116 . . . . 0.0 109.356 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.43 149.76 51.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 m -121.87 138.89 54.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -124.29 165.86 16.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.689 ' CA ' HG11 ' A' ' 13' ' ' VAL . 33.6 t -91.89 176.52 6.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.557 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 6.7 m-85 -75.29 -67.39 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.572 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 163.3 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.909 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 35.7 Cg_endo -78.23 70.34 7.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.171 1.914 . . . . 0.0 110.908 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 41.28 43.29 3.54 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.61 125.93 35.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.42 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 13' ' ' VAL . 14.5 t -69.26 -23.66 63.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HD1' HG23 ' A' ' 37' ' ' THR . 2.1 m-85 -113.58 160.85 18.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.58 -145.38 4.12 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -117.31 169.76 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.141 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 47.8 t -126.4 141.62 51.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.65 -177.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.686 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 41.44 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.486 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' GLN . 51.3 t -157.95 129.58 6.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.202 -0.936 . . . . 0.0 109.507 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -53.61 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.53 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 164.88 12.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.685 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.36 139.09 38.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.91 56.41 3.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 16.7 m-85 -143.02 -175.95 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 109.168 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 16.3 p-10 -81.9 152.57 26.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.96 156.57 36.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.7 136.58 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.549 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.713 HG11 ' CB ' ' A' ' 31' ' ' SER . 11.3 m -97.04 -25.55 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.271 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.464 ' NH1' ' OG1' ' A' ' 37' ' ' THR . 1.5 ttm180 -96.99 -65.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.368 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 64.05 170.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.729 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 3.8 p90 -149.85 68.21 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.61 25.74 6.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.7 mt 51.66 59.06 15.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.446 -1.032 . . . . 0.0 109.886 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.7 Cg_endo -79.01 -68.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.583 2.188 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.5 m -64.7 151.23 45.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.46 113.7 12.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.1 Cg_endo -77.83 169.37 20.79 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.344 2.03 . . . . 0.0 110.234 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.76 164.47 25.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.0 166.53 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -56.55 147.42 22.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.847 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.42 -26.41 17.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 136.04 38.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -1.129 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 153.07 31.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.7 114.69 27.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.68 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 4.7 tpt180 -101.96 152.62 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.314 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.713 ' CB ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.92 168.64 10.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 109.468 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 13.2 m-85 -62.65 -65.01 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 166.8 -52.29 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -79.46 60.64 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.166 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.14 42.73 2.44 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.8 p -75.88 -5.57 46.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -1.109 . . . . 0.0 109.626 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.73 HG22 ' O ' ' A' ' 37' ' ' THR . 98.3 m 48.36 23.57 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.118 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 37' ' ' THR . 6.3 m-85 -160.26 138.32 9.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 108.983 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -155.62 -139.76 2.84 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 17.1 mtp180 -121.51 -169.74 1.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' PHE . 2.6 t -134.79 125.75 27.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.395 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -120.82 176.37 5.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -100.44 62.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 t -155.53 138.98 15.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.12 152.87 38.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 18.1 mt -104.09 -178.38 3.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 14.9 tt0 -67.96 155.4 39.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 67.28 29.65 74.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.67 -164.53 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -1.092 . . . . 0.0 109.351 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.09 159.17 15.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.387 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.33 175.87 9.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.324 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -139.43 114.49 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.47 -11.17 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.919 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.68 23.45 14.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.454 ' OG ' ' HB ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -88.81 109.89 20.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 23.7 p90 -156.02 101.49 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 109.334 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.47 41.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 158.29 34.17 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 4.64 6.01 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.648 2.232 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.7 m -52.34 108.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mm -63.22 117.18 31.0 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.29 179.27 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.424 2.083 . . . . 0.0 110.16 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 11.1 m -65.06 169.36 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.434 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ARG . 14.1 m -69.19 151.79 45.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 26' ' ' GLY . 4.6 ttm180 -43.08 138.75 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 25' ' ' ARG . . . 96.25 5.86 59.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 42' ' ' GLN . 1.1 mt -125.5 128.05 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.7 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -108.92 -168.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' H ' HG22 ' A' ' 28' ' ' THR . 88.2 m -142.06 158.77 43.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.539 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.05 124.44 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -49.98 150.87 2.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -50.17 -30.96 12.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 171.43 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.005 . . . . 0.0 109.713 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 34.9 Cg_endo -77.24 -167.94 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.43 2.086 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.6 32.68 4.41 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -56.84 164.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -1.107 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.919 HG23 ' HD3' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -93.11 -6.88 47.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 131.53 53.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.08 -166.16 11.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.29 53.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -1.191 . . . . 0.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.86 130.34 34.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.366 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.905 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.76 -178.96 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.77 50.59 1.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.843 . . . . 0.0 109.453 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 12.1 mmm-85 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 121.26 0.553 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 3' ' ' ARG . 31.3 m -151.19 156.18 40.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 109.514 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.08 -157.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -107.2 159.44 16.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.535 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -66.86 138.38 57.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 41' ' ' CYS . . . 78.36 40.14 20.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -125.06 -160.57 0.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.39 142.51 27.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -135.44 151.09 50.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.01 151.39 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.156 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 14' ' ' ARG . 3.6 m -122.5 -41.2 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -118.01 86.31 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.604 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -78.71 167.75 20.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.344 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -156.54 64.85 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.435 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.27 42.57 6.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.694 HD22 HG23 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.53 149.32 67.05 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.262 -1.14 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.9 Cg_endo -78.09 4.85 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.669 2.246 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.694 HG23 HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -42.39 111.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.04 131.47 39.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.05 178.59 7.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.385 2.057 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.424 ' HB3' HD13 ' A' ' 27' ' ' LEU . 72.4 m -68.18 156.67 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 166.45 5.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.053 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -56.22 150.32 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.14 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.5 mt -115.03 147.67 39.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 157.61 24.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -116.18 124.93 51.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 110.3 20.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.838 . . . . 0.0 109.631 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.06 150.46 46.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 23.2 m-85 -61.94 -72.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 109.656 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER 169.73 -55.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.6 Cg_endo -77.42 114.41 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.386 2.058 . . . . 0.0 110.248 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 57.03 15.46 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -45.75 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -1.139 . . . . 0.0 109.749 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.4 m -137.53 -47.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 0.0 109.251 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 37' ' ' THR . 81.6 m-85 -143.87 133.52 23.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 -156.79 8.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -95.56 165.98 12.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -1.157 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.453 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 17.0 t -125.07 132.44 53.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.424 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.9 tt0 -133.88 159.92 39.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -89.6 50.23 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 35.8 t -143.06 28.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER 55.16 169.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.392 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.65 144.47 42.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -47.99 114.93 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.303 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.6 51.34 1.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.529 ' CB ' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -123.62 -163.44 1.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -1.095 . . . . 0.0 109.401 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -99.26 124.86 44.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -108.22 156.28 19.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 15' ' ' SER . 43.0 t -97.09 121.56 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 31' ' ' SER . 27.2 m -97.55 -12.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -119.49 18.19 12.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.47 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.57 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -45.12 127.62 6.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.68 101.55 6.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 109.504 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 18' ' ' LEU . . . 71.6 7.24 64.42 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 70.01 62.6 0.51 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.105 -1.233 . . . . 0.0 109.554 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.55 -24.83 7.19 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.659 2.239 . . . . 0.0 110.342 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -97.53 -179.83 4.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.915 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.661 HG23 ' HD2' ' A' ' 22' ' ' PRO . 31.0 mm -86.81 140.16 33.15 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 21' ' ' ILE . 35.6 Cg_endo -78.16 162.68 28.5 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.545 2.163 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -67.33 169.73 8.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.462 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 38.5 m -71.42 172.9 8.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.256 -0.902 . . . . 0.0 109.101 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -66.6 146.98 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.237 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.87 -12.33 59.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 42' ' ' GLN . 4.4 mm? -86.0 163.56 17.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -1.101 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 139.37 30.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.583 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.6 m -100.22 108.05 20.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -107.94 122.78 47.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' HG11 ' A' ' 13' ' ' VAL . 3.5 p -77.16 132.58 38.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 22.9 m-85 -44.13 -65.96 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.399 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.553 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.79 -53.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.667 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.2 Cg_endo -78.04 114.65 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.362 2.041 . . . . 0.0 110.396 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 61.86 60.6 7.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -44.95 110.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.525 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -163.16 -37.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.977 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.454 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.36 105.13 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.835 . . . . 0.0 109.552 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.6 -160.89 12.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -113.06 172.97 6.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -1.18 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.45 120.37 34.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD13 ' A' ' 27' ' ' LEU . 3.3 mm-40 -114.11 168.98 9.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.555 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.89 54.97 2.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.524 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . 0.58 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.48 0 CA-C-O 121.227 0.537 . . . . 0.0 109.796 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -86.0 147.39 26.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.35 153.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 6' ' ' LEU . 7.8 mt -81.62 -173.81 4.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.412 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -81.88 141.16 33.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.494 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.11 75.43 0.46 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -154.24 -171.86 4.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -1.199 . . . . 0.0 109.561 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.45 102.55 13.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.604 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.5 t -89.07 153.9 20.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 14' ' ' ARG . 9.9 p -96.39 142.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 37' ' ' THR . 28.0 m -123.37 7.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.674 ' HD2' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.72 36.96 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.7 t -93.66 97.0 10.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 77.54 1.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.54 55.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.3 153.11 48.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 111.85 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.525 2.15 . . . . 0.0 110.349 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -148.36 162.31 39.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 3' ' ' ARG . 13.4 mm -110.32 96.57 27.21 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.374 -0.829 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 20' ' ' THR . 34.4 Cg_endo -76.98 -163.05 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.51 2.14 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -73.61 176.3 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 176.07 8.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -68.94 134.14 49.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.91 -7.82 49.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 16.9 mt -103.21 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.538 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 132.07 32.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.5 t -98.99 141.62 31.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.257 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -147.0 144.71 29.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.086 -1.009 . . . . 0.0 109.773 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 p -97.11 154.72 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.333 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 23.4 m-85 -62.05 -70.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.0 109.364 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.5 -53.48 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -79.0 87.18 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.457 2.105 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 120.77 -36.58 3.3 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 11.5 p 47.36 49.37 15.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 109.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.674 HG23 ' HD2' ' A' ' 14' ' ' ARG . 52.5 m -120.99 -41.66 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.505 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.1 m-85 -143.74 116.23 8.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -114.13 -138.24 6.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 11.1 mtt180 -125.82 163.76 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -1.097 . . . . 0.0 109.518 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.27 154.15 35.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.337 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -154.27 -174.82 5.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' CG ' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.05 75.85 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.365 -0.835 . . . . 0.0 109.39 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.742 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.307 0.575 . . . . 0.0 109.69 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 -151.74 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.239 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.13 158.82 43.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.46 134.78 34.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.85 152.09 7.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 109.255 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.83 21.28 66.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 3.0 m-85 -106.25 -167.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -97.99 160.68 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.263 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -126.36 172.37 10.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 15' ' ' SER . 5.1 t -111.48 85.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.527 HG11 ' OG ' ' A' ' 31' ' ' SER . 2.6 m -52.25 -21.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -100.96 -80.63 0.49 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.565 ' N ' HG12 ' A' ' 12' ' ' VAL . 13.0 t 52.09 22.45 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -97.86 110.39 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.19 -16.37 35.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.5 mt -134.0 143.95 49.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.419 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.34 145.76 21.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.554 2.169 . . . . 0.0 110.385 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.64 -172.92 4.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.63 106.98 51.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.43 152.47 30.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.346 2.03 . . . . 0.0 110.461 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.498 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 79.8 m -59.31 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.94 168.07 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.788 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.77 124.96 15.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.67 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 103.22 12.18 32.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 26' ' ' GLY . 4.1 mm? -116.73 100.64 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -1.017 . . . . 0.0 109.386 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 147.0 28.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.3 m -110.07 146.83 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.574 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.41 134.45 19.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' HG11 ' A' ' 13' ' ' VAL . 66.7 m -59.58 159.51 8.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.534 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 23.7 t80 160.38 -47.28 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.586 . . . . 0.0 109.69 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -77.89 -169.2 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.959 1.772 . . . . 0.0 110.39 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.42 17.13 58.25 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -51.43 155.62 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -1.197 . . . . 0.0 109.493 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.0 t -89.22 23.26 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.77 153.91 40.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.23 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' ASN . . . -155.02 -140.64 3.05 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 10' ' ' ASN . 2.7 ttt85 -118.32 176.0 5.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 109.508 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 25.0 t -142.84 124.22 14.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.534 ' C ' HD13 ' A' ' 27' ' ' LEU . 4.7 mt-30 -145.53 174.49 11.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -97.35 -8.76 28.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 0.0 109.473 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 41.7 t80 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLN . 57.6 m -147.6 153.92 40.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 0.0 109.718 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 4' ' ' CYS . 46.0 mt-30 -50.38 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -160.45 168.97 23.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 109.582 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.382 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 9' ' ' PHE . . . 105.24 48.54 1.05 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 38.6 m-85 -141.59 -165.31 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 17.5 p30 -79.62 138.14 37.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.489 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 42.5 t -121.57 154.0 37.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 12' ' ' VAL . 14.1 p -103.61 113.48 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 37' ' ' THR . 12.4 m -78.68 -20.12 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.64 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HB2' HG23 ' A' ' 37' ' ' THR . 6.6 tpp180 -99.28 57.7 1.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB3' HG21 ' A' ' 20' ' ' THR . 0.2 OUTLIER -103.78 5.27 35.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -95.52 107.03 19.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.23 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.25 26.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.465 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -147.75 151.14 38.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -1.199 . . . . 0.0 109.391 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.6 Cg_endo -78.22 123.57 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.572 2.181 . . . . 0.0 110.539 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.442 HG21 ' HB3' ' A' ' 15' ' ' SER . 11.4 t -162.85 178.87 8.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.317 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -115.56 90.16 24.97 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.137 -0.977 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.8 Cg_endo -78.06 -159.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.575 2.184 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 89.4 m -86.69 164.83 16.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -179.48 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -73.42 136.03 44.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 -24.19 31.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 19.8 mt -85.64 142.79 28.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -1.134 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.43 153.54 23.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.757 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.1 m -124.34 150.84 45.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -0.813 . . . . 0.0 109.131 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -148.62 108.38 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 2.9 p -50.02 133.23 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.294 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' SER . 27.9 m-85 -43.96 -53.12 6.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.601 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -106.33 172.27 4.06 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.28 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 35.1 Cg_endo -78.79 74.2 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.534 2.156 . . . . 0.0 110.275 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' SER . . . 146.5 -24.06 1.68 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.6 m -50.49 -179.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -1.133 . . . . 0.0 109.457 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 14' ' ' ARG . 51.0 m -123.2 -12.29 7.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 118.86 23.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 -150.02 7.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.9 174.03 6.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -1.098 . . . . 0.0 109.131 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.62 119.07 19.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 109.777 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -111.4 -173.18 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.257 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.7 68.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.448 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.268 0.556 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 5' ' ' GLN . 28.6 t -117.23 156.83 27.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.394 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.443 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -85.36 172.32 11.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.333 -0.854 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.597 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -115.71 -174.87 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.372 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.32 136.73 46.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.513 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.55 65.83 2.65 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 2.8 m-85 -140.35 -167.11 2.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 109.373 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . 0.419 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 4.7 m-20 -90.92 116.13 28.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.45 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . 35.8 t -109.01 152.61 24.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 0.0 109.406 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HE1' ' A' ' 38' ' ' TYR . 8.3 p -106.39 131.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 37' ' ' THR . 19.1 m -102.1 -18.94 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -86.51 48.2 1.59 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.636 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -113.55 101.02 8.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.039 -1.038 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 5.3 p90 -144.54 70.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.304 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.42 -27.58 5.75 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -96.96 143.45 26.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.305 -1.115 . . . . 0.0 109.388 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.2 Cg_endo -78.53 127.12 7.9 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.576 2.184 . . . . 0.0 110.43 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -141.62 -148.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 20' ' ' THR . 29.0 mm -124.99 84.15 59.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.143 -0.973 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 156.14 30.61 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.651 2.234 . . . . 0.0 110.46 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 27' ' ' LEU . 60.9 m -63.16 164.87 7.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 m -61.66 169.93 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.704 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -66.63 124.87 24.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.828 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.19 -2.11 31.29 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.95 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.76 152.26 21.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -1.142 . . . . 0.0 109.467 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.22 137.65 41.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.392 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 41' ' ' CYS . 1.6 p -128.6 140.07 51.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.057 -1.027 . . . . 0.0 109.866 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 31' ' ' SER . 1.1 ttp180 -127.72 142.26 51.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.317 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -44.08 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.709 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 18.1 m-85 -61.79 -39.16 90.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.584 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 172.76 -54.16 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.827 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 37.5 Cg_endo -82.0 52.19 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.561 2.174 . . . . 0.0 110.577 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.37 32.08 1.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 31' ' ' SER . 6.5 t -52.0 146.4 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -1.086 . . . . 0.0 109.793 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 13' ' ' VAL . 99.0 m -66.69 -33.18 75.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.189 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.545 ' HE1' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -112.71 124.38 52.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.053 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.05 -153.12 11.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -120.8 139.61 52.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.277 -1.131 . . . . 0.0 109.438 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -94.83 155.64 16.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.95 ' O ' HD23 ' A' ' 27' ' ' LEU . 31.9 mt-30 -148.69 172.2 14.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.85 35.64 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.302 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.415 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 11.3 p -126.43 -174.03 3.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 4' ' ' CYS . 7.5 mm-40 -53.41 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 121.57 31.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -60.57 149.0 36.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.42 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.99 62.95 5.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 -151.81 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -1.152 . . . . 0.0 109.343 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.66 138.31 35.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.354 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 159.15 19.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.622 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -118.42 127.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 37' ' ' THR . 4.0 m -117.12 -2.7 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.461 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -89.66 54.41 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 109.459 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 t -114.02 123.81 50.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.451 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 2.2 p90 -129.56 93.82 3.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.44 17.11 78.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.8 164.16 15.59 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.97 -83.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.625 2.217 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.445 HG21 HG11 ' A' ' 12' ' ' VAL . 10.8 m 48.18 69.98 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 21' ' ' ILE . 16.4 mm -45.41 109.35 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.8 Cg_endo -77.63 -177.25 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.488 2.126 . . . . 0.0 110.571 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.596 ' HB3' HD13 ' A' ' 27' ' ' LEU . 77.7 m -48.05 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 54.9 m -74.21 174.69 8.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -67.92 137.29 55.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.96 -16.74 30.33 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.6 mp -93.88 167.82 11.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.88 167.81 20.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 13' ' ' VAL . 18.6 t -123.67 128.95 50.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.24 110.86 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.509 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 13' ' ' VAL . 13.6 m -68.01 162.29 24.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.446 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 27.9 m-85 -75.86 -71.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.541 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 164.72 -52.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.0 109.474 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.76 100.3 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.469 2.113 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 95.93 -33.58 5.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 2.6 p 48.53 71.12 0.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -1.091 . . . . 0.0 109.532 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.749 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.6 m -128.25 -74.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 3.2 m-85 -109.49 117.87 35.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.88 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -112.76 -128.3 4.93 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.25 144.37 49.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.378 -1.072 . . . . 0.0 109.479 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.5 t -106.64 120.86 43.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.218 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.509 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -114.94 175.21 5.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.187 -0.946 . . . . 0.0 109.748 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -117.91 67.87 0.76 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.46 -177.24 6.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -104.25 179.69 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.321 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD21 ' HE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -82.44 173.11 12.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.967 . . . . 0.0 109.412 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.65 138.4 35.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.77 74.26 1.19 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -156.15 -159.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.314 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -104.64 134.78 47.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -131.88 151.32 51.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 14' ' ' ARG . 7.2 t -95.1 145.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 31' ' ' SER . 31.3 m -101.68 16.09 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.56 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.74 17.55 2.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.367 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -44.81 -29.68 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.561 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -48.35 98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.244 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 15' ' ' SER . . . 140.35 -51.83 0.71 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.12 150.82 37.83 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.343 -1.092 . . . . 0.0 109.094 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.2 113.82 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.399 2.066 . . . . 0.0 110.357 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -140.06 160.82 39.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.773 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.17 109.82 53.56 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.1 Cg_endo -77.48 160.15 32.09 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.348 2.032 . . . . 0.0 110.434 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' PRO . 35.4 m -51.88 -175.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.24 168.75 15.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -59.69 135.28 57.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.84 -3.67 41.91 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.53 170.56 8.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -1.149 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.48 163.67 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 109.897 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.1 m -106.92 135.62 48.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 111.11 14.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -66.19 140.41 58.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -57.58 -64.35 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 97.8 m-85 -108.08 159.59 30.02 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.762 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.5 Cg_endo -78.4 78.93 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.708 2.272 . . . . 0.0 110.457 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.44 -25.44 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -178.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.166 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 37' ' ' THR . 15.3 m -124.71 38.2 4.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.74 20.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 31' ' ' SER . . . -146.63 -154.11 6.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 41' ' ' CYS . 5.8 ttm180 -139.88 142.77 36.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 109.389 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 40' ' ' ARG . 47.7 t -83.47 141.14 31.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.68 -174.26 4.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.445 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 3.5 ttp85 -93.12 49.3 1.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 11.6 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.31 0.576 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.66 159.59 35.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.77 -173.61 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.329 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 1.6 mt -96.25 170.77 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.22 133.43 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.365 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.79 68.59 1.53 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.79 -165.41 2.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -1.127 . . . . 0.0 109.529 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -87.76 136.18 33.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.5 t -134.84 147.17 49.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 2.2 p -89.37 150.2 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.325 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.71 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.663 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -113.36 -67.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 70.53 85.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.131 -179.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -127.2 71.24 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 -179.702 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.49 -56.79 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.71 149.09 72.03 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.305 -1.115 . . . . 0.0 109.494 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 96.89 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.702 2.268 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ILE . 61.3 m -76.55 129.5 36.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' THR . 52.8 mt -43.92 110.17 0.93 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.217 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.96 167.62 24.84 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.355 2.037 . . . . 0.0 110.571 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.3 -176.46 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.47 -161.67 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.59 140.79 46.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.563 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 88.84 -9.5 76.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.7 mm? -99.73 96.61 7.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -1.104 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -80.72 139.54 36.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.216 -0.928 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 12' ' ' VAL . 8.6 t -88.85 148.94 23.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.305 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -154.67 140.66 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.14 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.679 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 25.4 m-85 -62.06 -47.13 86.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 169.32 -53.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.7 Cg_endo -80.82 58.08 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.529 2.152 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 43.51 28.06 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.34 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.385 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.439 HG21 ' OH ' ' A' ' 16' ' ' TYR . 17.5 m -92.4 -16.9 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -135.38 141.84 45.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.644 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -142.17 -128.86 2.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -143.77 176.26 9.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -1.169 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 120.42 32.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -0.88 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -111.16 176.05 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.492 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 18.33 14.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 179.862 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.285 0.564 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 2.6 m -128.76 180.0 5.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.64 164.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.305 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 137.65 32.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.663 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -52.86 103.03 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.23 44.18 0.8 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -163.48 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -1.101 . . . . 0.0 109.377 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -84.46 175.57 9.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.089 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 26.5 t -155.2 156.73 36.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.04 . . . . 0.0 109.768 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.703 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.9 t -112.99 105.69 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 37' ' ' THR . 14.1 m -88.74 15.04 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -0.996 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -124.92 -5.04 7.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 2.6 p -48.15 148.1 1.93 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 9.3 p90 -127.36 106.25 9.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' LEU . . . 97.22 30.42 7.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 42.21 59.17 10.22 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.975 . . . . 0.0 109.724 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.4 Cg_endo -78.58 -60.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.154 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 21' ' ' ILE . 5.5 t -63.26 -164.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.452 ' N ' HG23 ' A' ' 20' ' ' THR . 3.2 mt -123.62 98.18 40.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 109.388 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 35.7 Cg_endo -77.19 158.11 33.66 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.492 2.128 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' HD13 ' A' ' 27' ' ' LEU . 94.8 m -43.85 154.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.2 m -55.62 166.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.54 145.53 22.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.82 -34.9 5.27 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 43' ' ' ARG . 1.8 mt -86.35 167.75 14.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -1.06 . . . . 0.0 109.294 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 135.88 41.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.841 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.7 t -90.53 146.43 24.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 109.076 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 ttt-85 -145.4 134.93 23.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -90.74 144.76 25.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.477 ' OH ' ' HG3' ' A' ' 40' ' ' ARG . 6.0 m-85 -47.16 -61.89 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.4 166.64 10.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.02 93.19 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.751 2.301 . . . . 0.0 110.443 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.58 -33.49 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.46 163.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -1.07 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 13' ' ' VAL . 20.6 m -103.93 -21.03 13.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.703 ' CE1' HG22 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.33 172.85 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.522 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -141.24 3.68 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 13.8 mtt180 -141.31 155.25 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -1.107 . . . . 0.0 109.371 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.57 128.39 50.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -149.82 179.36 8.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.76 47.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.43 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.489 ' OXT' ' CD2' ' A' ' 44' ' ' TYR . 82.3 t80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.506 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 t -143.7 41.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 55.12 -178.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 109.634 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -112.0 128.21 56.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 147.56 40.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.65 53.28 39.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -142.57 -161.21 1.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -1.197 . . . . 0.0 109.486 179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.8 149.52 31.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 t -144.65 147.96 33.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 15' ' ' SER . 58.4 t -96.16 149.47 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.179 -0.951 . . . . 0.0 109.171 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.73 -20.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -133.06 -49.77 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.616 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.2 t 62.27 127.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 109.436 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 7.1 p90 -138.91 84.65 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.427 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.415 ' C ' ' HG ' ' A' ' 18' ' ' LEU . . . 159.83 -53.62 0.36 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.9 mt -137.29 157.99 73.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 18' ' ' LEU . 34.8 Cg_endo -77.02 95.21 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.358 2.039 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.419 HG21 ' HB ' ' A' ' 12' ' ' VAL . 14.1 t -69.07 153.49 43.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 21' ' ' ILE . 4.2 mp -86.26 126.35 65.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 109.419 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 169.5 19.58 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.436 2.09 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.2 m -68.72 163.8 23.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.36 167.85 4.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -65.34 129.52 40.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.42 -1.97 32.71 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -100.12 -167.82 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.35 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -153.8 136.87 15.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 109.626 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.4 t -124.97 128.67 48.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 109.235 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.0 ttp85 -144.88 153.85 42.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 109.819 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.471 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.9 p -95.41 149.82 20.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.309 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -65.15 -65.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.109 -0.994 . . . . 0.0 109.497 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.07 157.08 37.11 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 109.674 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.89 81.86 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.558 2.172 . . . . 0.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.99 -35.97 0.61 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 m -61.17 146.0 49.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -1.041 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.21 27.79 3.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.98 159.01 43.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -164.57 -135.31 1.8 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -148.87 155.12 40.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' THR . 7.8 t -117.39 144.04 45.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.895 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.648 ' O ' HD23 ' A' ' 27' ' ' LEU . 90.1 mt-30 -142.6 178.33 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 109.665 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.52 39.68 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.917 . . . . 0.0 109.505 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 24' ' ' CYS . 11.4 p -105.91 62.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.586 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 60.88 -175.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.847 . . . . 0.0 109.733 179.818 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.6 171.56 11.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.66 144.71 43.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.37 77.62 0.15 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.37 -163.41 1.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.497 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -95.2 141.49 28.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -143.17 148.1 35.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 109.299 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 38' ' ' TYR . 6.2 p -91.8 154.52 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.34 -27.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -36.36 3.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 109.591 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 59.29 159.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.637 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 18' ' ' LEU . 5.9 p90 -153.0 79.44 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.842 . . . . 0.0 109.509 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.03 56.02 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -150.57 143.88 16.84 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.124 . . . . 0.0 109.413 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.81 101.15 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.609 2.206 . . . . 0.0 110.429 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -135.18 116.8 14.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 21' ' ' ILE . 23.0 mt -84.51 125.45 71.58 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.351 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 173.28 14.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.381 2.054 . . . . 0.0 110.342 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' HD12 ' A' ' 27' ' ' LEU . 7.3 m -67.53 153.27 44.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.893 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.527 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 7.9 p -87.35 -179.28 6.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.71 143.71 9.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.8 -33.63 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 23' ' ' CYS . 36.0 mt -105.24 -168.79 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 119.41 2.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -82.72 105.53 13.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 139.78 46.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 p -73.96 166.01 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 109.575 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 54.3 m-85 -58.54 -56.22 24.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.958 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.97 -51.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.012 . . . . 0.0 110.024 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 37.0 Cg_endo -80.25 57.32 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.775 2.316 . . . . 0.0 111.177 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.41 47.73 5.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.5 144.73 39.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -1.101 . . . . 0.0 109.571 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 37' ' ' THR . 88.8 m -71.12 -10.31 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE1' HG23 ' A' ' 12' ' ' VAL . 1.4 m-85 -129.5 -175.47 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.47 -151.79 8.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 1.5 mtp85 -134.51 161.32 35.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -1.121 . . . . 0.0 109.391 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 11.9 t -109.93 128.48 55.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.489 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.7 175.36 6.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.41 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -92.82 40.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.0 t 46.88 68.56 0.61 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.197 -0.94 . . . . 0.0 109.418 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.57 173.15 6.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 0.0 109.611 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HB3' ' N ' ' A' ' 24' ' ' CYS . 55.5 m -118.99 172.87 7.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.18 179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -63.69 -168.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.146 -0.971 . . . . 0.0 109.317 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -111.96 179.85 3.89 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.505 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -88.66 150.38 23.04 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.563 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 65.52 34.62 89.63 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.87 -166.88 1.18 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.274 -1.133 . . . . 0.0 109.446 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 46.3 p30 -103.26 171.95 7.09 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.221 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.7 168.54 21.08 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.144 -0.973 . . . . 0.0 109.518 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 14' ' ' ARG . 3.7 t -121.76 112.84 36.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.409 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.437 HG21 ' OG ' ' A' ' 31' ' ' SER . 25.9 m -87.76 9.3 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.517 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.541 ' HD2' HG23 ' A' ' 37' ' ' THR . 9.7 ttt180 -120.01 -5.97 10.02 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.34 -0.85 . . . . 0.0 109.542 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.478 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 0.1 OUTLIER -58.07 90.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 0.0 109.584 -179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.465 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 24.7 m-85 -72.64 141.2 48.31 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.225 -0.922 . . . . 0.0 109.321 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 78.81 9.53 87.0 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 12.8 mt 43.86 59.7 12.23 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.394 -1.062 . . . . 0.0 109.978 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.69 -40.65 0.3 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.467 2.112 . . . . 0.0 110.173 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.5 m -78.27 144.2 36.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.339 -0.851 . . . . 0.0 109.492 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 92.4 mt -67.62 122.58 83.98 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.23 -0.919 . . . . 0.0 109.396 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.76 149.76 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.433 2.089 . . . . 0.0 110.481 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 72.7 m -47.58 161.47 0.09 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.303 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.469 ' N ' ' HB3' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -73.11 168.2 19.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.221 -0.925 . . . . 0.0 109.696 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -52.93 142.08 20.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.388 -0.82 . . . . 0.0 109.58 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.78 -20.25 41.97 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 HH21 ' A' ' 43' ' ' ARG . 1.1 mt -110.63 139.28 46.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -1.171 . . . . 0.0 109.458 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.3 162.93 14.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.887 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.2 m -127.02 113.3 16.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.132 -0.98 . . . . 0.0 109.406 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.93 158.84 25.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.371 -0.831 . . . . 0.0 109.467 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' OG ' HG21 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -93.42 155.26 17.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.157 -0.964 . . . . 0.0 109.501 -179.831 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.496 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 99.1 m-85 -62.44 -19.9 63.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.232 -0.917 . . . . 0.0 109.625 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.576 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.61 167.69 0.15 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.326 -0.859 . . . . 0.0 109.213 -179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 34.6 Cg_endo -77.27 120.56 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.541 2.161 . . . . 0.0 110.311 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 118.36 11.37 8.12 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.2 p -123.96 -167.38 1.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.366 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.541 HG23 ' HD2' ' A' ' 14' ' ' ARG . 3.4 m -142.03 25.65 1.92 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.152 -0.968 . . . . 0.0 109.667 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -145.53 176.44 9.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 109.384 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -173.32 -163.48 27.04 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.86 173.06 11.56 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -1.16 . . . . 0.0 109.502 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 25.5 t -136.63 126.59 25.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.162 -0.961 . . . . 0.0 109.413 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.445 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.2 mt-30 -129.36 175.86 8.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.167 -0.958 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.484 HH21 HD21 ' A' ' 27' ' ' LEU . 27.5 ttm-85 -86.03 43.74 1.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.861 . . . . 0.0 109.427 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' OXT' ' O ' ' A' ' 43' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.506 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 6.5 p90 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -130.01 42.07 3.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.136 -0.977 . . . . 0.0 109.701 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -110.12 126.2 53.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.237 -0.914 . . . . 0.0 109.315 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 22.9 p -138.8 151.1 46.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.142 -0.974 . . . . 0.0 109.664 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -61.78 -166.87 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.892 . . . . 0.0 109.232 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.99 160.5 14.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.204 -0.935 . . . . 0.0 109.351 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.42 ' OE1' ' C ' ' A' ' 7' ' ' GLN . 3.1 tm0? -67.34 157.67 33.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.156 -0.965 . . . . 0.0 109.556 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.98 57.02 9.18 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -142.6 -164.27 1.79 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.311 -1.111 . . . . 0.0 109.459 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -83.35 161.0 21.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.227 -0.921 . . . . 0.0 109.464 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 22.0 t -154.48 150.76 28.17 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 12' ' ' VAL . 12.2 p -103.09 119.37 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.197 -0.939 . . . . 0.0 109.643 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 37' ' ' THR . 4.8 m -81.52 -22.83 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.228 -0.92 . . . . 0.0 109.379 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' ARG . 8.6 mmt180 -90.47 -84.27 0.24 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.306 -0.871 . . . . 0.0 109.488 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.407 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.5 OUTLIER 62.65 106.59 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.241 -0.912 . . . . 0.0 109.356 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -101.51 93.51 5.41 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.278 -0.889 . . . . 0.0 109.607 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 18' ' ' LEU . . . 104.05 8.59 38.75 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.535 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 3.9 mm? 61.65 60.9 2.79 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.181 -1.188 . . . . 0.0 109.532 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.7 Cg_endo -77.71 -66.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.426 2.084 . . . . 0.0 110.484 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.431 HG22 ' N ' ' A' ' 21' ' ' ILE . 12.4 m -72.87 164.06 27.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.179 -0.951 . . . . 0.0 109.289 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.503 ' N ' HD13 ' A' ' 21' ' ' ILE . 5.0 mm -84.23 137.94 39.55 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.44 ' HD2' ' CG2' ' A' ' 21' ' ' ILE . 35.8 Cg_endo -78.64 -167.48 0.5 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.679 2.253 . . . . 0.0 110.48 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 54.5 m -98.64 156.68 16.69 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.328 -0.857 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.38 161.62 2.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.21 139.09 55.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.417 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.462 ' O ' ' OXT' ' A' ' 44' ' ' TYR . . . 108.84 -26.79 14.59 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.78 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.7 OUTLIER -92.53 166.83 12.32 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -1.117 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 m -140.36 160.71 39.39 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 5.3 t -101.88 129.54 48.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.379 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.454 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.4 ttt180 -133.44 131.42 39.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.219 -0.926 . . . . 0.0 109.32 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.469 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 0.3 OUTLIER -98.9 152.22 20.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.517 -179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 5.8 m-85 -53.81 -69.87 0.11 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 109.32 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.582 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.4 OUTLIER 172.06 -55.81 0.0 OUTLIER Pre-proline 0 C--N 1.303 -1.431 0 O-C-N 121.321 -0.862 . . . . 0.0 109.707 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.1 Cg_endo -78.29 127.0 8.01 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.305 2.003 . . . . 0.0 110.322 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.18 48.41 79.87 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.412 ' O ' ' OG1' ' A' ' 37' ' ' THR . 97.6 p -45.75 113.18 0.56 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -1.075 . . . . 0.0 109.668 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.416 ' O ' HG22 ' A' ' 13' ' ' VAL . 28.2 m -166.08 -41.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -137.35 119.39 15.43 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.369 -0.832 . . . . 0.0 109.344 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -127.79 -143.58 5.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -124.25 162.9 22.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -1.139 . . . . 0.0 109.5 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -112.32 131.65 55.4 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.252 -0.905 . . . . 0.0 109.324 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.78 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.7 OUTLIER -129.08 -172.1 2.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.37 -0.831 . . . . 0.0 109.404 -179.729 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -100.11 61.74 1.1 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.597 -179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.462 ' OXT' ' O ' ' A' ' 26' ' ' GLY . 3.6 m-85 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.417 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -152.2 75.18 1.12 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.2 mmm-85 -102.92 71.34 1.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.424 -0.798 . . . . 0.0 109.512 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 1.8 t -131.7 166.9 20.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.514 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.7 mm-40 -95.72 -170.79 2.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.362 -0.836 . . . . 0.0 109.45 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HB3' ' CD1' ' A' ' 9' ' ' PHE . 1.9 mp -106.23 156.75 18.15 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.331 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.3 tt0 -74.7 141.02 44.55 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.315 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.06 62.5 4.42 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.46 ' CD1' ' HB3' ' A' ' 6' ' ' LEU . 1.6 m-85 -141.52 -163.96 1.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.139 -1.212 . . . . 0.0 109.433 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.407 ' ND2' ' H ' ' A' ' 10' ' ' ASN . 1.8 p30 -79.53 130.5 35.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.257 -0.902 . . . . 0.0 109.392 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.489 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.6 OUTLIER -124.64 176.49 6.52 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.183 -0.948 . . . . 0.0 109.626 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.694 HG13 ' CZ ' ' A' ' 38' ' ' TYR . 0.0 OUTLIER -133.51 167.59 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.198 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.441 HG11 ' HB3' ' A' ' 31' ' ' SER . 35.6 m -138.32 6.79 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.736 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -122.72 33.95 5.28 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.213 -0.929 . . . . 0.0 109.435 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -95.62 58.79 2.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.141 -0.974 . . . . 0.0 109.567 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -102.38 72.67 1.29 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.155 -0.966 . . . . 0.0 109.319 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 133.18 -49.39 0.92 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.15 159.28 49.35 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.189 -1.183 . . . . 0.0 109.417 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.92 111.26 3.07 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.62 2.214 . . . . 0.0 110.472 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.0 m -156.66 128.49 7.25 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 0.0 109.38 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 HG23 HD12 ' A' ' 21' ' ' ILE . 46.5 mm -85.15 117.66 69.23 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.145 -0.972 . . . . 0.0 109.511 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.37 -179.22 5.22 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.264 1.976 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 24' ' ' CYS . 12.5 m -71.2 155.83 40.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 109.345 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.442 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 7.7 m -43.65 161.38 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.209 -0.932 . . . . 0.0 109.719 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -62.74 144.84 56.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.409 179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 96.29 -15.66 62.47 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.484 HD21 ' HG3' ' A' ' 43' ' ' ARG . 64.6 mt -105.65 173.24 6.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.23 -1.159 . . . . 0.0 109.584 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.98 -174.72 4.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.192 -0.943 . . . . 0.0 109.35 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 40.7 m -146.49 165.93 27.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.82 144.16 50.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.441 ' HB3' HG11 ' A' ' 13' ' ' VAL . 13.4 p -88.64 138.97 30.95 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.203 -0.936 . . . . 0.0 109.581 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.535 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 34.2 m-85 -46.76 -68.91 0.15 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.165 -0.96 . . . . 0.0 109.081 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.574 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 165.0 -54.35 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.475 0 O-C-N 121.295 -0.878 . . . . 0.0 109.395 179.778 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.574 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.4 Cg_endo -79.85 116.62 3.48 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.465 2.11 . . . . 0.0 110.249 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 66.62 59.49 7.12 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.9 p -48.0 102.9 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.472 -1.016 . . . . 0.0 109.759 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.5 m -148.41 -52.27 0.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.238 -0.914 . . . . 0.0 109.328 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.694 ' CZ ' HG13 ' A' ' 12' ' ' VAL . 0.8 OUTLIER -127.85 142.06 51.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.373 -0.829 . . . . 0.0 109.502 -179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.71 -140.63 3.75 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -130.55 144.47 51.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -1.172 . . . . 0.0 109.299 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 44.1 t -101.38 139.42 37.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.233 -0.917 . . . . 0.0 109.788 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.23 -162.01 0.94 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 108.982 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.484 ' HG3' HD21 ' A' ' 27' ' ' LEU . 2.3 ttm180 -102.11 59.59 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.0 109.347 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.541 -180.0 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -141.17 106.07 4.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -142.09 -178.53 5.75 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.306 -0.871 . . . . 0.0 109.318 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 2.8 t -90.89 128.57 36.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.459 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -61.39 -164.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.964 . . . . 0.0 109.308 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 tp -120.4 163.5 17.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -62.75 124.65 21.57 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.196 -0.94 . . . . 0.0 109.424 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 88.05 58.56 1.77 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -143.95 -166.55 2.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.378 -1.072 . . . . 0.0 109.556 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -89.39 133.82 34.35 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.198 -0.939 . . . . 0.0 109.386 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 17.2 t -131.95 149.17 52.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.18 -0.95 . . . . 0.0 109.568 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.575 HG13 ' OG ' ' A' ' 15' ' ' SER . 4.3 p -85.08 140.12 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.223 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.766 HG22 ' O ' ' A' ' 37' ' ' THR . 26.6 m -106.21 -20.99 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.208 -0.932 . . . . 0.0 109.638 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.13 58.31 0.88 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.451 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.575 ' OG ' HG13 ' A' ' 12' ' ' VAL . 0.6 OUTLIER -110.64 99.04 8.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.335 -0.853 . . . . 0.0 109.505 -179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.568 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 35.8 p90 -123.75 55.74 1.25 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.17 -0.956 . . . . 0.0 109.34 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.28 -35.91 3.47 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 153.82 3.17 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.171 -1.193 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.8 86.77 1.6 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.651 2.234 . . . . 0.0 110.54 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.522 ' O ' HG23 ' A' ' 20' ' ' THR . 2.0 t -148.03 97.51 2.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.674 HG23 ' O ' ' A' ' 21' ' ' ILE . 3.3 tt -62.08 113.8 9.65 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.293 -0.88 . . . . 0.0 109.74 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.72 -161.51 0.14 Allowed 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.343 2.029 . . . . 0.0 110.147 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 56.5 m -70.95 -168.23 0.26 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.983 . . . . 0.0 109.406 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.6 m -91.02 -179.1 5.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.55 127.72 33.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.382 -0.824 . . . . 0.0 109.703 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.476 ' O ' HD23 ' A' ' 27' ' ' LEU . . . 109.28 -7.21 32.41 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' CD2' ' HG2' ' A' ' 43' ' ' ARG . 22.1 mt -118.14 109.94 17.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.163 -1.198 . . . . 0.0 109.556 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.6 p -83.59 174.39 10.59 Favored 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.186 -0.946 . . . . 0.0 109.585 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.3 m -125.1 140.32 52.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.162 -0.961 . . . . 0.0 109.153 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.25 134.22 34.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.201 -0.937 . . . . 0.0 109.596 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 t -83.62 100.68 10.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.123 -0.985 . . . . 0.0 109.391 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.564 ' CE2' ' HA2' ' A' ' 39' ' ' GLY . 3.4 p90 -45.92 -27.39 0.88 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.138 -0.976 . . . . 0.0 109.59 -179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.414 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -127.79 145.86 56.61 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.416 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.42 93.15 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.644 2.229 . . . . 0.0 110.508 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 143.68 -30.9 1.93 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.556 -1.417 . . . . 0.0 109.556 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 11.8 p -79.11 104.13 9.52 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.12 -1.223 . . . . 0.0 109.368 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.766 ' O ' HG22 ' A' ' 13' ' ' VAL . 15.2 t -52.56 -22.81 5.35 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.835 . . . . 0.0 109.632 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -102.53 131.37 49.29 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.153 -0.967 . . . . 0.0 109.512 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.564 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -129.37 -136.93 4.18 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.1 ttt-85 -125.8 175.45 7.63 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.18 -1.189 . . . . 0.0 109.398 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 0.9 OUTLIER -129.58 134.99 48.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.922 . . . . 0.0 109.542 179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 41' ' ' CYS . 18.8 mt-30 -149.66 -177.2 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.945 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' HG2' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -88.22 38.67 0.87 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.894 . . . . 0.0 109.566 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.445 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 35.4 p90 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.488 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -153.75 100.81 2.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.534 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.889 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.6 OUTLIER -123.93 100.24 6.65 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 0.0 109.474 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 m -141.13 142.84 34.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.335 -0.853 . . . . 0.0 109.555 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' NE2' ' O ' ' A' ' 10' ' ' ASN . 2.7 mt-30 -66.38 -167.66 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.355 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mp -111.17 171.63 7.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.193 -0.942 . . . . 0.0 109.541 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 9.3 tm0? -67.4 146.7 53.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.255 -0.903 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.25 68.62 1.6 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.427 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 1.7 m-85 -146.41 -165.73 2.3 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.301 -1.117 . . . . 0.0 109.499 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.464 ' O ' ' NE2' ' A' ' 5' ' ' GLN . 6.1 m-20 -89.57 141.31 28.7 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.677 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.47 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 19.5 t -143.42 158.08 43.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 0.0 109.391 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.47 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 10.0 p -99.23 145.24 10.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.848 HG22 ' O ' ' A' ' 37' ' ' THR . 29.3 m -120.36 -21.6 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 0.0 109.585 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -130.69 52.48 2.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.487 179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 14' ' ' ARG . 12.4 t -45.03 131.8 7.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.258 -0.902 . . . . 0.0 109.538 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -113.31 85.78 2.25 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.282 -0.886 . . . . 0.0 109.31 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 50.92 44.15 49.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.444 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -123.85 148.45 56.74 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.223 -1.163 . . . . 0.0 109.656 -179.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.5 Cg_endo -78.6 91.86 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.588 2.192 . . . . 0.0 110.012 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.3 t -134.12 161.44 34.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.86 . . . . 0.0 109.735 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.889 HG21 ' O ' ' A' ' 3' ' ' ARG . 23.7 mm -127.47 128.15 24.04 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 109.088 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.57 167.01 24.92 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.388 2.058 . . . . 0.0 110.626 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.489 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 89.4 m -60.62 146.88 43.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.361 -0.837 . . . . 0.0 109.498 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.2 m -60.73 165.09 4.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.188 -0.945 . . . . 0.0 109.498 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.8 ttm180 -46.01 151.29 0.49 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.921 . . . . 0.0 109.468 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.68 -6.23 79.92 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -125.36 124.81 42.34 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.082 -1.246 . . . . 0.0 109.506 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.4 147.58 26.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.161 -0.962 . . . . 0.0 109.38 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 63.2 m -103.51 133.35 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -121.68 159.16 27.12 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -113.98 153.91 28.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.28 -0.888 . . . . 0.0 109.42 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 34.3 m-85 -58.3 -72.65 0.09 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 109.436 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 168.74 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.182 -0.949 . . . . 0.0 109.531 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -77.74 110.8 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.448 2.099 . . . . 0.0 110.345 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 65.96 62.99 4.29 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 35' ' ' GLY . 6.0 p -43.36 120.18 1.82 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.289 -1.124 . . . . 0.0 109.568 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.848 ' O ' HG22 ' A' ' 13' ' ' VAL . 87.1 m -160.29 -81.48 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -0.881 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.61 122.24 45.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.362 -0.836 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.4 -145.67 5.93 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.9 OUTLIER -114.51 -173.27 2.27 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.153 -1.204 . . . . 0.0 109.502 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 4.2 t -138.2 127.04 23.83 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.321 -0.862 . . . . 0.0 109.425 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.638 ' O ' HD23 ' A' ' 27' ' ' LEU . 1.1 mm-40 -111.3 -178.3 3.42 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.235 -0.915 . . . . 0.0 109.483 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HA ' ' HG ' ' A' ' 27' ' ' LEU . 3.0 ttp180 -103.87 47.18 0.89 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.146 -0.972 . . . . 0.0 109.605 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.568 ' OXT' ' CD1' ' A' ' 44' ' ' TYR . 30.3 t80 . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.462 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.28 0.562 . . . . 0.0 109.491 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.9 t 54.2 76.14 0.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 109.534 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 3.2 mmm180 -85.98 84.56 7.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.949 . . . . 0.0 109.39 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.456 ' O ' ' O ' ' A' ' 5' ' ' GLN . 40.0 t -143.3 99.34 3.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.141 -0.975 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 4' ' ' CYS . 5.1 mt-30 -54.56 -169.25 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.365 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.02 -177.9 3.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.579 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.43 ' CD ' ' N ' ' A' ' 8' ' ' GLY . 18.2 tm0? -77.68 169.67 17.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.833 . . . . 0.0 109.444 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.43 ' N ' ' CD ' ' A' ' 7' ' ' GLN . . . 44.61 48.67 8.85 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -125.09 -164.19 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.252 -1.146 . . . . 0.0 109.372 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.39 122.94 45.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.947 . . . . 0.0 109.561 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.405 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 43.0 t -132.2 157.36 44.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.224 -0.922 . . . . 0.0 109.497 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.481 ' HB ' ' CE1' ' A' ' 38' ' ' TYR . 7.4 p -89.62 136.14 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 37' ' ' THR . 6.6 m -97.44 -22.2 5.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.317 -0.864 . . . . 0.0 109.26 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -91.09 67.15 5.89 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.359 -0.838 . . . . 0.0 109.314 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 50.2 m -94.15 27.35 2.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.271 -0.893 . . . . 0.0 109.62 -179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -87.68 109.62 19.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.195 -0.941 . . . . 0.0 109.401 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.68 -5.68 84.38 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 5.4 mp -125.31 112.56 26.02 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.084 -1.245 . . . . 0.0 109.466 179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.47 75.82 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.424 2.083 . . . . 0.0 110.361 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.06 -166.82 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.376 -0.827 . . . . 0.0 109.678 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.775 HD12 ' N ' ' A' ' 21' ' ' ILE . 4.0 mp -116.3 94.04 41.27 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.368 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.402 ' HA ' ' SG ' ' A' ' 11' ' ' CYS . 35.0 Cg_endo -77.65 -179.12 5.14 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.622 2.215 . . . . 0.0 110.464 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 55.8 m -71.59 154.04 41.71 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.447 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -49.21 161.1 0.18 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.218 -0.926 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.0 ttp180 -50.48 156.32 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.226 -0.921 . . . . 0.0 109.49 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.55 -49.2 1.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.602 HD23 ' HA ' ' A' ' 43' ' ' ARG . 10.1 mt -91.16 135.33 33.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.332 -1.099 . . . . 0.0 109.506 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.96 146.6 39.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.144 -0.972 . . . . 0.0 109.463 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.4 m -85.98 116.38 24.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.322 -0.861 . . . . 0.0 109.36 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.54 159.25 22.38 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 0.0 109.835 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.0 p -108.95 154.11 22.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.872 . . . . 0.0 109.35 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -107.81 1.07 22.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.639 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.572 ' CD2' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -127.2 158.25 69.81 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.052 -1.03 . . . . 0.0 109.629 179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD2' ' CD2' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -78.07 134.58 13.17 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.547 2.165 . . . . 0.0 110.525 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 53.53 47.11 64.27 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.7 -162.29 0.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -1.19 . . . . 0.0 109.438 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.54 ' O ' HG22 ' A' ' 13' ' ' VAL . 55.4 m -135.68 -58.58 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 0.0 109.591 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.481 ' CE1' ' HB ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -105.42 142.99 34.22 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.365 -0.834 . . . . 0.0 109.595 -179.9 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -142.09 -159.73 8.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 2.8 mtp180 -94.7 167.99 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -1.15 . . . . 0.0 109.436 179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 13.0 t -117.69 138.36 52.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 109.54 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -148.76 -175.48 4.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.602 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -85.98 50.2 1.93 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.242 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 87.9 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.97 -1.015 . . . . 0.0 109.477 -179.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 56.8 m -167.63 101.01 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.268 -0.895 . . . . 0.0 109.524 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.6 64.64 1.59 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.207 -0.933 . . . . 0.0 109.368 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -153.74 170.2 21.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.185 -0.947 . . . . 0.0 109.415 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -91.21 156.51 17.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.273 -0.892 . . . . 0.0 109.374 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.4 pp -85.98 154.97 21.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.544 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -71.15 115.18 9.99 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.511 -179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 111.41 41.4 1.15 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.43 ' O ' ' HG2' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -120.59 -149.17 0.43 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.233 -1.157 . . . . 0.0 109.688 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -118.6 109.44 16.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 0.0 109.497 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 53.5 t -102.31 153.16 20.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.179 -0.951 . . . . 0.0 109.482 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.49 HG12 ' H ' ' A' ' 13' ' ' VAL . 2.7 t -80.83 170.35 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.312 -0.868 . . . . 0.0 109.345 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.876 HG11 ' HB3' ' A' ' 31' ' ' SER . 3.2 m -122.54 -15.83 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.086 -1.009 . . . . 0.0 109.628 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.402 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -134.24 42.53 2.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.941 . . . . 0.0 109.674 -179.953 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.426 ' OG ' HG21 ' A' ' 20' ' ' THR . 0.5 OUTLIER -92.1 100.95 13.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' CG ' ' O ' ' A' ' 16' ' ' TYR . 6.2 p90 -150.83 122.29 7.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.237 -0.914 . . . . 0.0 109.618 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 98.57 -25.97 25.8 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.532 ' CG ' ' HD2' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -104.06 175.8 2.05 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.228 -1.16 . . . . 0.0 109.577 -179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 18' ' ' LEU . 34.6 Cg_endo -77.61 118.42 4.54 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.555 2.17 . . . . 0.0 110.397 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.426 HG21 ' OG ' ' A' ' 15' ' ' SER . 8.6 m -158.7 155.43 28.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.284 -0.885 . . . . 0.0 109.445 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -114.38 106.4 52.7 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.353 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.01 150.59 29.96 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.335 2.024 . . . . 0.0 110.422 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 90.1 m -51.32 163.53 0.25 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.227 -0.921 . . . . 0.0 109.472 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -178.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 109.584 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.452 ' HG3' ' N ' ' A' ' 26' ' ' GLY . 4.5 tpm_? -69.39 146.59 51.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.332 -0.855 . . . . 0.0 109.743 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.452 ' N ' ' HG3' ' A' ' 25' ' ' ARG . . . 91.24 -28.18 8.43 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.429 ' HG ' ' HG3' ' A' ' 43' ' ' ARG . 0.5 OUTLIER -83.28 140.97 32.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.114 -1.227 . . . . 0.0 109.686 -179.696 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -121.02 151.21 40.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.42 -0.8 . . . . 0.0 109.347 179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.6 m -98.65 121.58 40.77 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.265 -0.897 . . . . 0.0 109.566 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.404 ' O ' ' C ' ' A' ' 31' ' ' SER . 3.1 ttt180 -110.81 100.51 9.24 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.334 -0.854 . . . . 0.0 109.513 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.876 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -44.04 160.28 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.243 -0.911 . . . . 0.0 109.549 -179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 8.3 m-85 -59.51 -65.31 0.69 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.259 -0.901 . . . . 0.0 109.63 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.557 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 168.2 -53.78 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.069 -1.02 . . . . 0.0 109.847 -179.984 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.5 Cg_endo -78.86 66.99 8.64 Favored 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.584 2.189 . . . . 0.0 110.798 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.95 31.91 0.5 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.481 ' CB ' ' HB2' ' A' ' 32' ' ' TYR . 19.3 p -61.06 145.59 50.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.184 -1.186 . . . . 0.0 109.517 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 m -83.37 -27.75 29.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.245 -0.91 . . . . 0.0 109.488 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.57 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -122.77 117.33 25.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.482 -179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.444 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -106.35 -157.62 21.74 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -110.54 175.3 5.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.315 -1.109 . . . . 0.0 109.522 179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 9.0 t -128.69 137.83 51.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.301 -0.875 . . . . 0.0 109.556 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.99 173.62 11.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 109.329 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.429 ' HG3' ' HG ' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -90.85 58.13 3.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 109.352 -179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 14.8 t80 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.449 -179.9 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 176.52 56.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 0.0 109.601 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -145.33 93.49 2.38 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.088 -1.008 . . . . 0.0 109.568 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.453 ' O ' ' O ' ' A' ' 5' ' ' GLN . 26.4 p -152.39 156.66 39.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 0.0 109.483 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.453 ' O ' ' O ' ' A' ' 4' ' ' CYS . 4.3 mt-30 -46.45 172.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 -179.686 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.12 167.95 9.55 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.25 -0.907 . . . . 0.0 109.503 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 3.0 tt0 -73.84 149.77 41.4 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.324 -0.86 . . . . 0.0 109.33 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.497 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.06 65.75 3.18 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -149.69 -161.53 1.36 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.184 -1.186 . . . . 0.0 109.409 -179.913 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -82.75 161.92 21.9 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.027 -1.046 . . . . 0.0 109.539 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 41' ' ' CYS . 48.7 t -153.85 159.44 41.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.895 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG22 ' CZ ' ' A' ' 38' ' ' TYR . 35.4 t -118.38 96.21 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.261 -0.899 . . . . 0.0 109.325 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.47 HG11 ' HB3' ' A' ' 31' ' ' SER . 18.8 m -61.49 -26.74 40.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.45 ' O ' ' HB3' ' A' ' 15' ' ' SER . 0.2 OUTLIER -92.0 -84.56 0.27 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.486 ' OG ' ' HD2' ' A' ' 19' ' ' PRO . 0.5 OUTLIER 63.89 84.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -0.927 . . . . 0.0 109.378 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -78.14 107.6 10.84 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.157 -0.965 . . . . 0.0 109.695 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.4 17.19 67.07 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.444 ' HA ' ' OG ' ' A' ' 15' ' ' SER . 0.9 OUTLIER 55.22 66.52 3.82 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.288 -1.125 . . . . 0.0 109.521 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' OG ' ' A' ' 15' ' ' SER . 35.4 Cg_endo -78.04 -16.19 14.3 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.624 2.216 . . . . 0.0 110.551 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.426 HG22 ' N ' ' A' ' 21' ' ' ILE . 73.8 m -136.08 157.52 46.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.223 -0.923 . . . . 0.0 109.44 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' A' ' 22' ' ' PRO . 60.7 mt -63.84 139.44 97.64 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' A' ' 21' ' ' ILE . 36.2 Cg_endo -78.26 -174.09 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.533 2.155 . . . . 0.0 110.365 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.506 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -86.65 145.55 26.67 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.385 179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' O ' ' O ' ' A' ' 23' ' ' CYS . 0.0 OUTLIER -44.15 168.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.308 -0.87 . . . . 0.0 109.479 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.0 ttp180 -64.75 145.59 56.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.561 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.43 -15.13 55.87 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.871 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.4 OUTLIER -89.93 147.27 23.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -1.178 . . . . 0.0 109.538 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -121.92 156.45 33.34 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.238 -0.913 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.8 t -97.33 115.19 27.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.44 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.1 113.52 20.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.345 -0.847 . . . . 0.0 109.163 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.497 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.0 OUTLIER -92.9 179.13 5.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.28 -0.887 . . . . 0.0 109.56 -179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' ' HA2' ' A' ' 39' ' ' GLY . 4.9 p90 -129.45 12.32 5.93 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.203 -0.936 . . . . 0.0 109.658 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.453 ' HB3' ' HB2' ' A' ' 36' ' ' SER . 0.2 OUTLIER -127.55 162.52 48.41 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.222 -0.924 . . . . 0.0 109.493 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.31 73.27 5.89 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.512 2.141 . . . . 0.0 110.444 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 81.55 51.04 4.76 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.461 ' O ' ' CB ' ' A' ' 37' ' ' THR . 2.5 t -85.29 -8.86 58.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.329 -1.1 . . . . 0.0 109.561 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.461 ' CB ' ' O ' ' A' ' 36' ' ' SER . 1.3 m 72.5 3.05 4.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.501 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.48 ' CZ ' HG22 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -153.83 157.1 38.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.885 . . . . 0.0 109.188 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.525 ' HA2' ' CE1' ' A' ' 32' ' ' TYR . . . -173.61 -147.59 6.03 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -121.04 168.23 11.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.335 -1.097 . . . . 0.0 109.589 -179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.3 t -120.69 161.16 21.88 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.228 -0.92 . . . . 0.0 109.452 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.871 ' O ' HD23 ' A' ' 27' ' ' LEU . 10.3 pt20 -151.4 -178.2 6.52 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.374 -0.829 . . . . 0.0 109.306 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' O ' ' O ' ' A' ' 44' ' ' TYR . 12.9 ttt85 -105.77 46.39 0.92 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.243 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.509 ' OXT' ' CG ' ' A' ' 44' ' ' TYR . 79.6 t80 . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 117.943 -1.027 . . . . 0.0 109.485 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.412 ' C ' ' OG ' ' A' ' 2' ' ' SER . 2.2 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.294 0.568 . . . . 0.0 109.549 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.412 ' OG ' ' C ' ' A' ' 1' ' ' TYR . 0.0 OUTLIER -176.2 43.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.405 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.43 38.14 4.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.117 -0.99 . . . . 0.0 109.473 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.65 40.64 3.68 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.301 -0.875 . . . . 0.0 109.559 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 7.0 tp60 51.35 -160.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.445 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.38 -178.55 5.8 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.455 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.445 ' HG3' ' HB2' ' A' ' 43' ' ' ARG . 46.7 tt0 -82.0 153.25 26.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.331 -0.856 . . . . 0.0 109.653 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 7' ' ' GLN . . . 43.53 74.7 0.18 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 -163.92 1.9 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.288 -1.125 . . . . 0.0 109.374 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 -84.72 117.58 23.9 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.11 -0.994 . . . . 0.0 109.392 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 44.6 t -105.25 154.55 20.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.538 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.613 HG21 HG21 ' A' ' 20' ' ' THR . 10.6 p -102.04 149.18 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.253 -0.904 . . . . 0.0 109.419 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.9 m -130.01 -30.69 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.31 -0.868 . . . . 0.0 109.892 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.517 ' O ' HG23 ' A' ' 37' ' ' THR . 1.0 OUTLIER -154.01 63.86 0.71 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.933 . . . . 0.0 109.681 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.552 ' HB3' HG21 ' A' ' 20' ' ' THR . 35.7 t -109.59 66.72 0.63 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.687 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -78.32 149.48 33.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.643 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 88.83 -25.88 9.15 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -113.12 155.17 44.72 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.131 -1.217 . . . . 0.0 109.598 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -78.01 109.68 2.75 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.519 2.146 . . . . 0.0 110.063 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.613 HG21 HG21 ' A' ' 12' ' ' VAL . 9.1 t -135.97 129.88 32.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.296 -0.877 . . . . 0.0 109.618 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 6.4 mt -106.71 124.44 35.53 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.235 -0.916 . . . . 0.0 109.212 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.79 172.22 16.04 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.316 2.01 . . . . 0.0 110.366 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 47.6 m -65.5 -171.05 0.08 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.89 . . . . 0.0 109.574 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.94 -178.27 4.76 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.23 -0.919 . . . . 0.0 109.474 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.95 133.87 51.76 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.252 -0.905 . . . . 0.0 109.522 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.82 -20.04 27.35 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.834 -1.306 . . . . 0.0 109.834 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.599 HD23 ' C ' ' A' ' 42' ' ' GLN . 0.5 OUTLIER -100.57 126.97 47.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -1.155 . . . . 0.0 109.531 -179.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.98 160.1 17.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.556 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 8.7 t -114.6 127.6 55.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.364 -0.835 . . . . 0.0 109.377 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -129.69 111.15 12.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.146 -0.971 . . . . 0.0 109.619 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.491 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.8 t -63.33 145.06 56.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.625 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' CD2' ' HA2' ' A' ' 39' ' ' GLY . 34.7 m-85 -56.04 -72.55 0.07 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.321 -0.862 . . . . 0.0 109.342 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.469 ' CB ' ' HD2' ' A' ' 34' ' ' PRO . 0.8 OUTLIER -116.29 172.45 3.8 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.339 -0.851 . . . . 0.0 109.464 -179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 33' ' ' PHE . 35.2 Cg_endo -77.52 123.24 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.532 2.154 . . . . 0.0 110.254 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 100.22 18.59 21.35 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.3 t -106.58 178.88 4.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.378 -1.072 . . . . 0.0 109.545 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.517 HG23 ' O ' ' A' ' 14' ' ' ARG . 12.1 m -121.09 -10.17 9.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.445 -0.784 . . . . 0.0 109.526 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.77 170.47 14.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.216 -0.928 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' A' ' 32' ' ' TYR . . . -164.75 -138.89 2.51 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -126.99 166.22 17.96 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.344 -1.092 . . . . 0.0 109.602 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.28 129.17 53.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.118 -0.989 . . . . 0.0 109.562 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.599 ' C ' HD23 ' A' ' 27' ' ' LEU . 16.1 pt20 -124.38 146.38 48.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.417 -0.802 . . . . 0.0 109.388 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.445 ' HB2' ' HG3' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -88.45 42.93 1.1 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -0.873 . . . . 0.0 109.525 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.279 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.25 0.548 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 177.45 141.12 0.08 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.865 . . . . 0.0 109.416 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.94 77.19 1.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.142 -0.974 . . . . 0.0 109.535 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.498 ' CB ' ' HA ' ' A' ' 24' ' ' CYS . 1.4 p -127.45 173.71 9.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.203 -0.936 . . . . 0.0 109.501 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.16 -150.62 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.205 -0.935 . . . . 0.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 23.3 mt -127.21 162.15 26.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.283 -0.886 . . . . 0.0 109.492 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -73.48 137.67 44.63 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.214 -0.929 . . . . 0.0 109.519 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 73.76 54.28 6.68 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -140.51 -165.25 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.287 -1.125 . . . . 0.0 109.484 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -87.16 160.71 18.42 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.505 ' O ' ' CD2' ' A' ' 38' ' ' TYR . 0.1 OUTLIER -146.21 178.34 8.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.098 -1.001 . . . . 0.0 109.401 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 12' ' ' VAL . 2.4 p -121.71 95.65 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.2 -0.937 . . . . 0.0 109.27 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.96 HG22 ' O ' ' A' ' 37' ' ' THR . 3.2 m -67.95 -21.13 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.228 -0.92 . . . . 0.0 109.407 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.25 102.46 13.37 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.111 -0.993 . . . . 0.0 109.422 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 176.9 135.4 0.06 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.098 -1.001 . . . . 0.0 109.658 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 18.4 p90 -149.92 90.15 1.66 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.427 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.41 -6.12 83.51 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 18.4 mt -76.34 152.95 83.98 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.215 -1.168 . . . . 0.0 109.48 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 37.0 Cg_endo -80.88 54.05 5.06 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.895 2.397 . . . . 0.0 110.644 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 t -86.59 -179.73 6.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.052 -1.03 . . . . 0.0 109.452 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.7 mt -118.52 86.95 29.96 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.952 . . . . 0.0 109.612 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.88 -171.83 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.494 2.129 . . . . 0.0 110.45 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -63.47 171.09 2.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.46 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' HA ' ' CB ' ' A' ' 4' ' ' CYS . 0.1 OUTLIER -58.72 168.43 1.22 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 -179.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.34 132.23 45.34 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.357 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.28 -20.2 33.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 62.0 mt -95.27 167.42 11.36 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.304 -1.116 . . . . 0.0 109.356 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.43 149.76 51.07 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.27 -0.894 . . . . 0.0 109.341 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 15.3 m -121.87 138.89 54.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 0.0 109.65 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 ttt-85 -124.29 165.86 16.91 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.19 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.689 ' CA ' HG11 ' A' ' 13' ' ' VAL . 33.6 t -91.89 176.52 6.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.182 -0.949 . . . . 0.0 109.557 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.54 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 6.7 m-85 -75.29 -67.39 0.66 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.556 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.572 ' HB3' ' HD3' ' A' ' 34' ' ' PRO . 0.6 OUTLIER 163.3 -49.75 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.422 -0.799 . . . . 0.0 109.909 179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 33' ' ' PHE . 35.7 Cg_endo -78.23 70.34 7.2 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 C-N-CA 122.171 1.914 . . . . 0.0 110.908 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 41.28 43.29 3.54 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 110.047 -1.221 . . . . 0.0 110.047 179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 32' ' ' TYR . 0.5 OUTLIER -89.61 125.93 35.42 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -1.14 . . . . 0.0 109.42 179.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.96 ' O ' HG22 ' A' ' 13' ' ' VAL . 14.5 t -69.26 -23.66 63.88 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.263 -0.898 . . . . 0.0 109.557 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.606 ' HD1' HG23 ' A' ' 37' ' ' THR . 2.1 m-85 -113.58 160.85 18.1 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.302 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.58 -145.38 4.12 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtt180 -117.31 169.76 9.23 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -1.141 . . . . 0.0 109.53 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 47.8 t -126.4 141.62 51.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -0.818 . . . . 0.0 109.16 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.65 -177.31 5.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 0.0 109.686 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.14 41.44 1.05 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.273 -0.892 . . . . 0.0 109.509 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 10.0 t80 . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.486 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.7 t -121.99 52.93 1.24 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 0.0 109.573 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.5 mpt_? -121.6 39.33 3.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.278 -0.889 . . . . 0.0 109.407 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.425 ' O ' ' O ' ' A' ' 5' ' ' GLN . 51.3 t -157.95 129.58 6.79 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.202 -0.936 . . . . 0.0 109.507 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.425 ' O ' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -53.61 -173.73 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.307 -0.87 . . . . 0.0 109.53 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -110.04 164.88 12.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 0.0 109.685 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -78.36 139.09 38.82 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.365 -0.834 . . . . 0.0 109.649 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.91 56.41 3.3 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' ARG . 16.7 m-85 -143.02 -175.95 4.72 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.32 -1.106 . . . . 0.0 109.168 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 16.3 p-10 -81.9 152.57 26.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.271 -0.893 . . . . 0.0 109.718 -179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 48.8 t -154.96 156.57 36.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.439 -0.788 . . . . 0.0 109.337 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 43.1 t -81.7 136.58 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.143 -0.973 . . . . 0.0 109.549 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.713 HG11 ' CB ' ' A' ' 31' ' ' SER . 11.3 m -97.04 -25.55 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.271 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.464 ' NH1' ' OG1' ' A' ' 37' ' ' THR . 1.5 ttm180 -96.99 -65.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.368 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HB3' ' O ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 64.05 170.11 0.17 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.456 -0.777 . . . . 0.0 109.729 179.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.507 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 3.8 p90 -149.85 68.21 1.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.374 -0.829 . . . . 0.0 109.164 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.61 25.74 6.46 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.176 -1.57 . . . . 0.0 109.176 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.559 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 5.7 mt 51.66 59.06 15.68 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.446 -1.032 . . . . 0.0 109.886 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.7 Cg_endo -79.01 -68.28 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.583 2.188 . . . . 0.0 110.26 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.43 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 15.5 m -64.7 151.23 45.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 21.3 mt -65.46 113.7 12.68 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.25 -0.906 . . . . 0.0 109.64 -179.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.1 Cg_endo -77.83 169.37 20.79 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 122.344 2.03 . . . . 0.0 110.234 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 65.2 m -70.76 164.47 25.1 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.0 166.53 5.69 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.422 -0.799 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 -56.55 147.42 22.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.344 -0.847 . . . . 0.0 109.438 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.42 -26.41 17.87 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.86 136.04 38.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -1.129 . . . . 0.0 109.456 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.09 153.07 31.4 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.199 -0.938 . . . . 0.0 109.469 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 57.3 m -99.7 114.69 27.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.329 -0.857 . . . . 0.0 109.68 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.459 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 4.7 tpt180 -101.96 152.62 20.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.256 -0.903 . . . . 0.0 109.314 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.713 ' CB ' HG11 ' A' ' 13' ' ' VAL . 0.0 OUTLIER -96.92 168.64 10.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.065 -1.022 . . . . 0.0 109.468 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.461 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 13.2 m-85 -62.65 -65.01 0.75 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.134 -0.979 . . . . 0.0 109.532 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.552 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 166.8 -52.29 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 110.063 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -79.46 60.64 7.89 Favored 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.682 2.255 . . . . 0.0 111.166 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.448 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 40.14 42.73 2.44 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.8 p -75.88 -5.57 46.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.315 -1.109 . . . . 0.0 109.626 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.73 HG22 ' O ' ' A' ' 37' ' ' THR . 98.3 m 48.36 23.57 0.59 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.189 -0.944 . . . . 0.0 109.118 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 37' ' ' THR . 6.3 m-85 -160.26 138.32 9.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.421 -0.8 . . . . 0.0 108.983 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -155.62 -139.76 2.84 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 17.1 mtp180 -121.51 -169.74 1.91 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -1.136 . . . . 0.0 109.526 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' A' ' 9' ' ' PHE . 2.6 t -134.79 125.75 27.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.285 -0.884 . . . . 0.0 109.395 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -120.82 176.37 5.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.208 -0.932 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 30.1 ttt85 -100.44 62.78 1.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 117.923 -1.037 . . . . 0.0 109.489 180.0 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 92.1 p -157.95 64.38 0.46 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.574 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -118.46 164.46 15.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.352 -0.843 . . . . 0.0 109.362 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.9 t -155.53 138.98 15.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.266 -0.896 . . . . 0.0 109.402 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -75.12 152.87 38.48 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.294 -0.878 . . . . 0.0 109.391 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 18.1 mt -104.09 -178.38 3.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.274 -0.891 . . . . 0.0 109.588 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.48 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 14.9 tt0 -67.96 155.4 39.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 109.521 179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 67.28 29.65 74.55 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.9 OUTLIER -102.67 -164.53 1.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.344 -1.092 . . . . 0.0 109.351 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 26.4 m-20 -102.09 159.17 15.61 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.351 -0.843 . . . . 0.0 109.387 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -145.33 175.87 9.98 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.291 -0.881 . . . . 0.0 109.324 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 ' HB ' ' OG ' ' A' ' 15' ' ' SER . 1.0 OUTLIER -139.43 114.49 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 109.28 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 m -72.47 -11.17 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.919 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -107.68 23.45 14.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.373 -0.829 . . . . 0.0 109.25 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.454 ' OG ' ' HB ' ' A' ' 12' ' ' VAL . 1.0 OUTLIER -88.81 109.89 20.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.284 -0.885 . . . . 0.0 109.439 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CD2' ' O ' ' A' ' 16' ' ' TYR . 23.7 p90 -156.02 101.49 2.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.329 -0.857 . . . . 0.0 109.334 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.1 4.47 41.44 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.33 158.29 34.17 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.33 -1.1 . . . . 0.0 109.455 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.08 4.64 6.01 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.648 2.232 . . . . 0.0 110.73 -179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 45.7 m -52.34 108.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.063 -1.023 . . . . 0.0 109.18 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 26.9 mm -63.22 117.18 31.0 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.165 -0.959 . . . . 0.0 109.62 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.29 179.27 6.65 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.424 2.083 . . . . 0.0 110.16 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 11.1 m -65.06 169.36 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 0.0 109.434 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ARG . 14.1 m -69.19 151.79 45.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 26' ' ' GLY . 4.6 ttm180 -43.08 138.75 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.347 -0.846 . . . . 0.0 109.655 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 25' ' ' ARG . . . 96.25 5.86 59.12 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 42' ' ' GLN . 1.1 mt -125.5 128.05 47.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.248 -1.148 . . . . 0.0 109.7 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 29' ' ' CYS . 0.7 OUTLIER -108.92 -168.57 1.36 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 109.274 179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' H ' HG22 ' A' ' 28' ' ' THR . 88.2 m -142.06 158.77 43.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.113 -0.992 . . . . 0.0 109.539 179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.05 124.44 7.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.909 . . . . 0.0 109.436 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.3 t -49.98 150.87 2.1 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.217 -0.927 . . . . 0.0 109.612 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -50.17 -30.96 12.47 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.313 -0.867 . . . . 0.0 109.844 -179.834 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 171.43 -55.5 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.092 -1.005 . . . . 0.0 109.713 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.563 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 34.9 Cg_endo -77.24 -167.94 0.53 Allowed 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.43 2.086 . . . . 0.0 110.359 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -88.6 32.68 4.41 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -56.84 164.12 1.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -1.107 . . . . 0.0 109.406 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.919 HG23 ' HD3' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -93.11 -6.88 47.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.34 -0.85 . . . . 0.0 109.574 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 131.53 53.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.544 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -129.08 -166.16 11.88 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.65 135.29 53.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -1.191 . . . . 0.0 109.719 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 t -83.86 130.34 34.92 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 0.0 109.366 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.905 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.4 OUTLIER -140.76 -178.96 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 109.658 -179.813 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.77 50.59 1.59 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.352 -0.843 . . . . 0.0 109.453 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.507 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.09 71.19 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.514 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' C ' ' SG ' ' A' ' 4' ' ' CYS . 12.1 mmm-85 -100.27 60.23 1.03 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.294 -0.879 . . . . 0.0 109.536 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.413 ' SG ' ' C ' ' A' ' 3' ' ' ARG . 31.3 m -151.19 156.18 40.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.241 -0.912 . . . . 0.0 109.514 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -71.08 -157.9 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.276 -0.89 . . . . 0.0 109.324 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -107.2 159.44 16.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.298 -0.876 . . . . 0.0 109.535 -179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.1 tt0 -66.86 138.38 57.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.147 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 41' ' ' CYS . . . 78.36 40.14 20.4 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.1 OUTLIER -125.06 -160.57 0.96 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -1.195 . . . . 0.0 109.446 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -91.39 142.51 27.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 14.6 t -135.44 151.09 50.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.399 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.9 p -97.01 151.39 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -0.943 . . . . 0.0 109.156 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.505 HG23 ' N ' ' A' ' 14' ' ' ARG . 3.6 m -122.5 -41.2 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.164 -0.96 . . . . 0.0 109.719 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.505 ' N ' HG23 ' A' ' 13' ' ' VAL . 0.1 OUTLIER -118.01 86.31 2.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.887 . . . . 0.0 109.604 -179.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 1.6 p -78.71 167.75 20.75 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.266 -0.896 . . . . 0.0 109.344 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -156.54 64.85 0.54 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.209 -0.932 . . . . 0.0 109.435 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.27 42.57 6.18 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.694 HD22 HG23 ' A' ' 20' ' ' THR . 0.1 OUTLIER -136.53 149.32 67.05 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.262 -1.14 . . . . 0.0 109.478 -179.809 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.577 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.9 Cg_endo -78.09 4.85 5.83 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.669 2.246 . . . . 0.0 110.322 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.694 HG23 HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -42.39 111.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.506 -0.746 . . . . 0.0 109.567 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.9 mt -90.04 131.47 39.0 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.05 178.59 7.35 Favored 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 122.385 2.057 . . . . 0.0 110.453 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.424 ' HB3' HD13 ' A' ' 27' ' ' LEU . 72.4 m -68.18 156.67 37.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.289 -0.882 . . . . 0.0 109.368 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 166.45 5.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.053 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -56.22 150.32 14.55 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.446 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.65 -11.14 64.78 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.5 mt -115.03 147.67 39.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.235 -1.156 . . . . 0.0 109.518 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.53 157.61 24.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.332 -0.855 . . . . 0.0 109.355 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 83.4 m -116.18 124.93 51.53 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.099 -1.001 . . . . 0.0 109.551 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.72 110.3 20.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.36 -0.838 . . . . 0.0 109.631 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.06 150.46 46.58 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.209 -0.932 . . . . 0.0 109.443 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.563 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 23.2 m-85 -61.94 -72.62 0.12 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.208 -0.933 . . . . 0.0 109.656 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 32' ' ' TYR . 0.3 OUTLIER 169.73 -55.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.331 -0.856 . . . . 0.0 109.717 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.6 Cg_endo -77.42 114.41 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.386 2.058 . . . . 0.0 110.248 179.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 57.03 15.46 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.1 p -45.75 101.87 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.264 -1.139 . . . . 0.0 109.749 -179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.627 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.4 m -137.53 -47.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.111 -0.993 . . . . 0.0 109.251 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.627 ' CE1' HG22 ' A' ' 37' ' ' THR . 81.6 m-85 -143.87 133.52 23.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.415 -0.803 . . . . 0.0 109.195 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -130.9 -156.79 8.68 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -95.56 165.98 12.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -1.157 . . . . 0.0 109.561 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.453 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 17.0 t -125.07 132.44 53.17 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.271 -0.893 . . . . 0.0 109.484 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' C ' HD23 ' A' ' 27' ' ' LEU . 1.9 tt0 -133.88 159.92 39.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.233 -0.917 . . . . 0.0 109.455 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -89.6 50.23 1.87 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.149 -0.969 . . . . 0.0 109.468 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.892 -1.051 . . . . 0.0 109.483 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 t -158.15 81.78 0.85 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.914 . . . . 0.0 109.498 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.36 37.5 1.11 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.294 -0.879 . . . . 0.0 109.432 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.432 ' O ' ' O ' ' A' ' 5' ' ' GLN . 35.8 t -143.06 28.96 1.5 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.324 -0.86 . . . . 0.0 109.526 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER 55.16 169.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.392 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.0 mt -113.65 144.47 42.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.304 -0.872 . . . . 0.0 109.307 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -47.99 114.93 1.02 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.191 -0.943 . . . . 0.0 109.303 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 95.6 51.34 1.85 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.529 ' CB ' ' HG2' ' A' ' 5' ' ' GLN . 0.2 OUTLIER -123.62 -163.44 1.13 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -1.095 . . . . 0.0 109.401 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -99.26 124.86 44.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.223 -0.923 . . . . 0.0 109.432 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -108.22 156.28 19.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.518 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG12 ' N ' ' A' ' 15' ' ' SER . 43.0 t -97.09 121.56 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.414 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 31' ' ' SER . 27.2 m -97.55 -12.21 8.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -119.49 18.19 12.84 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.47 -179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.57 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -45.12 127.62 6.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 0.0 109.424 -179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -77.68 101.55 6.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.343 -0.848 . . . . 0.0 109.504 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 18' ' ' LEU . . . 71.6 7.24 64.42 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER 70.01 62.6 0.51 Allowed Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.105 -1.233 . . . . 0.0 109.554 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.523 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.55 -24.83 7.19 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.659 2.239 . . . . 0.0 110.342 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 t -97.53 -179.83 4.61 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.235 -0.915 . . . . 0.0 109.453 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.661 HG23 ' HD2' ' A' ' 22' ' ' PRO . 31.0 mm -86.81 140.16 33.15 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.34 -0.85 . . . . 0.0 109.208 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.661 ' HD2' HG23 ' A' ' 21' ' ' ILE . 35.6 Cg_endo -78.16 162.68 28.5 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.545 2.163 . . . . 0.0 110.49 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -67.33 169.73 8.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.356 -0.84 . . . . 0.0 109.462 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' LEU . 38.5 m -71.42 172.9 8.64 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.256 -0.902 . . . . 0.0 109.101 179.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -66.6 146.98 53.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.237 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.87 -12.33 59.95 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' O ' ' A' ' 42' ' ' GLN . 4.4 mm? -86.0 163.56 17.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.329 -1.101 . . . . 0.0 109.295 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -143.13 139.37 30.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.937 . . . . 0.0 109.583 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.6 m -100.22 108.05 20.04 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.303 -0.873 . . . . 0.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 -107.94 122.78 47.52 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.167 -0.958 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB3' HG11 ' A' ' 13' ' ' VAL . 3.5 p -77.16 132.58 38.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.439 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 22.9 m-85 -44.13 -65.96 0.44 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.272 -0.893 . . . . 0.0 109.399 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.553 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.79 -53.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.667 179.814 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.2 Cg_endo -78.04 114.65 3.63 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.362 2.041 . . . . 0.0 110.396 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' A' ' 36' ' ' SER . . . 61.86 60.6 7.82 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -44.95 110.66 0.25 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.135 -1.215 . . . . 0.0 109.525 179.99 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 m -163.16 -37.43 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.138 -0.977 . . . . 0.0 109.624 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.454 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -134.36 105.13 6.44 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.835 . . . . 0.0 109.552 -179.912 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -116.6 -160.89 12.21 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.472 ' HA ' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -113.06 172.97 6.62 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -1.18 . . . . 0.0 109.465 -179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.45 120.37 34.76 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.644 ' O ' HD13 ' A' ' 27' ' ' LEU . 3.3 mm-40 -114.11 168.98 9.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.347 -0.846 . . . . 0.0 109.555 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.471 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.89 54.97 2.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.258 -0.901 . . . . 0.0 109.551 179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.524 -179.919 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -166.97 135.3 2.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.58 ' O ' HG21 ' A' ' 21' ' ' ILE . 0.1 OUTLIER -143.55 42.68 1.49 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.059 -1.026 . . . . 0.0 109.796 -179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 p -86.0 147.39 26.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.34 -0.85 . . . . 0.0 109.283 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.9 mt-30 -49.35 153.98 0.95 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 0.0 109.863 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.454 HD23 ' HA ' ' A' ' 6' ' ' LEU . 7.8 mt -81.62 -173.81 4.62 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 0.0 109.412 179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -81.88 141.16 33.63 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.869 . . . . 0.0 109.494 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.11 75.43 0.46 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -154.24 -171.86 4.01 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.161 -1.199 . . . . 0.0 109.561 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -85.45 102.55 13.55 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.332 -0.855 . . . . 0.0 109.604 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 41.5 t -89.07 153.9 20.61 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.171 -0.956 . . . . 0.0 109.501 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.508 HG22 ' H ' ' A' ' 14' ' ' ARG . 9.9 p -96.39 142.63 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.491 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 37' ' ' THR . 28.0 m -123.37 7.43 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.286 -0.884 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.674 ' HD2' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -111.72 36.96 3.07 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.841 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 34.7 t -93.66 97.0 10.18 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.602 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.61 77.54 1.79 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.377 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 91.42 15.54 55.06 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.3 153.11 48.63 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.188 -1.184 . . . . 0.0 109.372 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.14 111.85 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.525 2.15 . . . . 0.0 110.349 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.488 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -148.36 162.31 39.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.204 -0.935 . . . . 0.0 109.509 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.58 HG21 ' O ' ' A' ' 3' ' ' ARG . 13.4 mm -110.32 96.57 27.21 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.374 -0.829 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 20' ' ' THR . 34.4 Cg_endo -76.98 -163.05 0.19 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.51 2.14 . . . . 0.0 110.239 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.509 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 0.6 OUTLIER -73.61 176.3 6.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.22 -0.925 . . . . 0.0 109.492 -179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 176.07 8.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.219 -0.925 . . . . 0.0 109.507 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -68.94 134.14 49.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.0 109.645 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.91 -7.82 49.43 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.509 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 16.9 mt -103.21 179.36 4.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -1.162 . . . . 0.0 109.538 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -137.47 132.07 32.79 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.6 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 49.5 t -98.99 141.62 31.52 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.272 -0.893 . . . . 0.0 109.257 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -147.0 144.71 29.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.086 -1.009 . . . . 0.0 109.773 -179.82 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.3 p -97.11 154.72 17.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.454 -0.779 . . . . 0.0 109.333 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.504 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 23.4 m-85 -62.05 -70.14 0.21 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.108 -0.995 . . . . 0.0 109.364 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.568 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.5 -53.48 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 0.0 109.362 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 35.4 Cg_endo -79.0 87.18 1.58 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.457 2.105 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.455 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 120.77 -36.58 3.3 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 11.5 p 47.36 49.37 15.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.32 -1.106 . . . . 0.0 109.601 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.674 HG23 ' HD2' ' A' ' 14' ' ' ARG . 52.5 m -120.99 -41.66 2.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.505 ' HD2' HG22 ' A' ' 37' ' ' THR . 2.1 m-85 -143.74 116.23 8.6 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.474 -0.766 . . . . 0.0 109.366 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.479 ' HA3' ' HA ' ' A' ' 31' ' ' SER . . . -114.13 -138.24 6.79 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.666 -1.373 . . . . 0.0 109.666 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.441 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 11.1 mtt180 -125.82 163.76 22.2 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.336 -1.097 . . . . 0.0 109.518 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -120.27 154.15 35.35 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.194 -0.941 . . . . 0.0 109.337 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -154.27 -174.82 5.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.169 -0.957 . . . . 0.0 109.519 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' CG ' ' CD2' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -128.05 75.85 1.64 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.365 -0.835 . . . . 0.0 109.39 -179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.9 p90 . . . . . 0 N--CA 1.487 1.406 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.65 -179.742 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.4 t -115.95 67.56 0.71 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.209 -0.932 . . . . 0.0 109.3 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.64 161.65 33.38 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.195 -0.941 . . . . 0.0 109.69 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -131.66 -151.74 0.47 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 0.0 109.239 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -139.13 158.82 43.5 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.479 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.46 134.78 34.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.607 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -54.85 152.09 7.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.365 -0.834 . . . . 0.0 109.255 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 79.83 21.28 66.34 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 3.0 m-85 -106.25 -167.85 1.35 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.279 -1.13 . . . . 0.0 109.444 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.434 ' HA ' ' HA ' ' A' ' 40' ' ' ARG . 0.5 OUTLIER -97.99 160.68 14.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.869 . . . . 0.0 109.263 179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 2.6 t -126.36 172.37 10.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 109.34 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 15' ' ' SER . 5.1 t -111.48 85.86 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 109.62 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.527 HG11 ' OG ' ' A' ' 31' ' ' SER . 2.6 m -52.25 -21.45 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 0.0 109.416 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.6 ttt180 -100.96 -80.63 0.49 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 109.371 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.565 ' N ' HG12 ' A' ' 12' ' ' VAL . 13.0 t 52.09 22.45 1.89 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.271 -0.893 . . . . 0.0 109.724 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 44.8 m-85 -97.86 110.39 22.97 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.315 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.19 -16.37 35.56 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 44.5 mt -134.0 143.95 49.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.339 -1.095 . . . . 0.0 109.419 -179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 35.8 Cg_endo -78.34 145.76 21.59 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.554 2.169 . . . . 0.0 110.385 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.432 HG21 HG21 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -154.64 -172.92 4.37 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.271 -0.893 . . . . 0.0 109.456 179.975 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mp -114.63 106.98 51.54 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.43 152.47 30.2 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.346 2.03 . . . . 0.0 110.461 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.498 ' HB3' ' CB ' ' A' ' 27' ' ' LEU . 79.8 m -59.31 -167.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -97.94 168.07 10.52 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 109.788 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -52.77 124.96 15.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.222 -0.924 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.67 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 103.22 12.18 32.01 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.67 HD22 ' C ' ' A' ' 26' ' ' GLY . 4.1 mm? -116.73 100.64 7.95 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.471 -1.017 . . . . 0.0 109.386 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.8 147.0 28.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.521 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 85.3 m -110.07 146.83 34.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.204 -0.935 . . . . 0.0 109.574 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -148.41 134.45 19.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.271 -0.893 . . . . 0.0 109.479 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.527 ' OG ' HG11 ' A' ' 13' ' ' VAL . 66.7 m -59.58 159.51 8.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.281 -0.887 . . . . 0.0 109.607 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.534 ' O ' ' CB ' ' A' ' 33' ' ' PHE . 26.9 m-85 -68.26 -29.07 67.79 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.256 -0.903 . . . . 0.0 109.436 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.58 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 23.7 t80 160.38 -47.28 0.0 OUTLIER Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.763 -0.586 . . . . 0.0 109.69 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 35.8 Cg_endo -77.89 -169.2 0.71 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 C-N-CA 121.959 1.772 . . . . 0.0 110.39 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -92.42 17.13 58.25 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -51.43 155.62 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.165 -1.197 . . . . 0.0 109.493 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.0 t -89.22 23.26 2.53 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 109.567 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -146.77 153.91 40.77 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.328 -0.858 . . . . 0.0 109.23 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 10' ' ' ASN . . . -155.02 -140.64 3.05 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 10' ' ' ASN . 2.7 ttt85 -118.32 176.0 5.44 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.331 -1.099 . . . . 0.0 109.508 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 25.0 t -142.84 124.22 14.73 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.26 -0.9 . . . . 0.0 109.098 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.534 ' C ' HD13 ' A' ' 27' ' ' LEU . 4.7 mt-30 -145.53 174.49 11.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -97.35 -8.76 28.83 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.352 -0.842 . . . . 0.0 109.473 179.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 43' ' ' ARG . 41.7 t80 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.532 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.424 ' O ' ' HB2' ' A' ' 2' ' ' SER . 97.0 m-85 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.226 0.536 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 1' ' ' TYR . 12.7 m 66.02 95.05 0.06 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.326 -0.859 . . . . 0.0 109.676 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.2 mpt_? -123.7 164.89 18.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.435 -0.791 . . . . 0.0 109.181 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.445 ' O ' ' O ' ' A' ' 5' ' ' GLN . 57.6 m -147.6 153.92 40.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.259 -0.901 . . . . 0.0 109.718 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' O ' ' O ' ' A' ' 4' ' ' CYS . 46.0 mt-30 -50.38 -96.54 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.278 -0.889 . . . . 0.0 109.315 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' HB3' ' CE1' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -160.45 168.97 23.98 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.074 -1.016 . . . . 0.0 109.582 -179.907 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -84.87 116.73 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.275 -0.891 . . . . 0.0 109.382 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' C ' ' CD1' ' A' ' 9' ' ' PHE . . . 105.24 48.54 1.05 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 6' ' ' LEU . 38.6 m-85 -141.59 -165.31 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.442 ' O ' ' OD1' ' A' ' 10' ' ' ASN . 17.5 p30 -79.62 138.14 37.33 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.088 -1.007 . . . . 0.0 109.489 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.424 ' SG ' ' SG ' ' A' ' 23' ' ' CYS . 42.5 t -121.57 154.0 37.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.232 -0.918 . . . . 0.0 109.434 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 12' ' ' VAL . 14.1 p -103.61 113.48 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.286 -0.884 . . . . 0.0 109.453 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 37' ' ' THR . 12.4 m -78.68 -20.12 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.64 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HB2' HG23 ' A' ' 37' ' ' THR . 6.6 tpp180 -99.28 57.7 1.07 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.442 ' HB3' HG21 ' A' ' 20' ' ' THR . 0.2 OUTLIER -103.78 5.27 35.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.138 -0.976 . . . . 0.0 109.493 -179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -95.52 107.03 19.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.206 -0.934 . . . . 0.0 109.23 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.76 -2.25 26.0 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.465 HD23 ' HD2' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -147.75 151.14 38.2 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.162 -1.199 . . . . 0.0 109.391 179.929 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.465 ' HD2' HD23 ' A' ' 18' ' ' LEU . 35.6 Cg_endo -78.22 123.57 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.572 2.181 . . . . 0.0 110.539 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.442 HG21 ' HB3' ' A' ' 15' ' ' SER . 11.4 t -162.85 178.87 8.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.259 -0.9 . . . . 0.0 109.317 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 93.5 mt -115.56 90.16 24.97 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.137 -0.977 . . . . 0.0 109.769 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 20' ' ' THR . 35.8 Cg_endo -78.06 -159.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.575 2.184 . . . . 0.0 110.128 179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 27' ' ' LEU . 89.4 m -86.69 164.83 16.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.263 -0.898 . . . . 0.0 109.702 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -71.83 -179.48 2.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.427 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 12.5 ttt85 -73.42 136.03 44.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.412 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 102.45 -24.19 31.75 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 23' ' ' CYS . 19.8 mt -85.64 142.79 28.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -1.134 . . . . 0.0 109.472 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -109.43 153.54 23.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 0.0 109.757 -179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 59.1 m -124.34 150.84 45.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -0.813 . . . . 0.0 109.131 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 ttt-85 -148.62 108.38 4.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -0.899 . . . . 0.0 109.61 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.451 ' HB2' ' HB2' ' A' ' 36' ' ' SER . 2.9 p -50.02 133.23 22.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.282 -0.886 . . . . 0.0 109.294 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.425 ' C ' ' O ' ' A' ' 31' ' ' SER . 27.9 m-85 -43.96 -53.12 6.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.396 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.601 ' CG ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER -106.33 172.27 4.06 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.253 -0.904 . . . . 0.0 109.28 179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 33' ' ' PHE . 35.1 Cg_endo -78.79 74.2 5.61 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.534 2.156 . . . . 0.0 110.275 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 36' ' ' SER . . . 146.5 -24.06 1.68 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 35' ' ' GLY . 4.6 m -50.49 -179.38 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.274 -1.133 . . . . 0.0 109.457 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.534 HG23 ' HB2' ' A' ' 14' ' ' ARG . 51.0 m -123.2 -12.29 7.89 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.652 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.32 118.86 23.96 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.324 -0.86 . . . . 0.0 109.637 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -124.41 -150.02 7.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.9 174.03 6.05 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.334 -1.098 . . . . 0.0 109.131 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -132.62 119.07 19.97 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.993 -1.067 . . . . 0.0 109.777 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -111.4 -173.18 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.37 -0.832 . . . . 0.0 109.257 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -112.7 68.05 0.67 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.111 -0.993 . . . . 0.0 109.459 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.919 -1.039 . . . . 0.0 109.448 179.841 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.488 0 CA-C-O 121.286 0.565 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.4 p -135.83 96.7 3.48 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -138.79 75.81 1.54 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.167 -0.958 . . . . 0.0 109.663 -179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' N ' ' A' ' 5' ' ' GLN . 28.6 t -117.23 156.83 27.07 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.124 -0.985 . . . . 0.0 109.394 179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.443 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER -85.36 172.32 11.16 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.333 -0.854 . . . . 0.0 109.46 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.597 ' HB2' ' CE2' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -115.71 -174.87 2.6 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.905 . . . . 0.0 109.372 179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -72.32 136.73 46.29 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.249 -0.907 . . . . 0.0 109.513 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.55 65.83 2.65 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.597 ' CE2' ' HB2' ' A' ' 6' ' ' LEU . 2.8 m-85 -140.35 -167.11 2.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -1.143 . . . . 0.0 109.373 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . 0.419 ' O ' ' OE1' ' A' ' 5' ' ' GLN . 4.7 m-20 -90.92 116.13 28.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.45 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HB3' ' HB2' ' A' ' 29' ' ' CYS . 35.8 t -109.01 152.61 24.74 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.155 -0.965 . . . . 0.0 109.406 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.545 HG23 ' HE1' ' A' ' 38' ' ' TYR . 8.3 p -106.39 131.44 56.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.651 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 37' ' ' THR . 19.1 m -102.1 -18.94 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -86.51 48.2 1.59 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.286 -0.884 . . . . 0.0 109.636 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 36.4 t -113.55 101.02 8.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.039 -1.038 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.538 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 5.3 p90 -144.54 70.68 1.29 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.223 -0.923 . . . . 0.0 109.304 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.42 -27.58 5.75 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.425 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 0.0 OUTLIER -96.96 143.45 26.14 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.305 -1.115 . . . . 0.0 109.388 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.2 Cg_endo -78.53 127.12 7.9 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.576 2.184 . . . . 0.0 110.43 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.468 HG22 ' H ' ' A' ' 21' ' ' ILE . 0.4 OUTLIER -141.62 -148.79 0.25 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.31 -0.869 . . . . 0.0 109.344 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.468 ' H ' HG22 ' A' ' 20' ' ' THR . 29.0 mm -124.99 84.15 59.36 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.143 -0.973 . . . . 0.0 109.385 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.92 156.14 30.61 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.651 2.234 . . . . 0.0 110.46 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.404 ' HB3' HD13 ' A' ' 27' ' ' LEU . 60.9 m -63.16 164.87 7.95 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.192 -0.942 . . . . 0.0 109.417 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 3.3 m -61.66 169.93 2.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.704 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -66.63 124.87 24.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.828 . . . . 0.0 109.568 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.19 -2.11 31.29 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.95 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.3 OUTLIER -101.76 152.26 21.07 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -1.142 . . . . 0.0 109.467 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.22 137.65 41.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.392 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.475 ' HB3' ' HA ' ' A' ' 41' ' ' CYS . 1.6 p -128.6 140.07 51.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.057 -1.027 . . . . 0.0 109.866 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.416 ' O ' ' C ' ' A' ' 31' ' ' SER . 1.1 ttp180 -127.72 142.26 51.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 0.0 109.317 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' OG ' ' N ' ' A' ' 36' ' ' SER . 0.3 OUTLIER -44.08 156.87 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.177 -0.952 . . . . 0.0 109.709 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 33' ' ' PHE . 18.1 m-85 -61.79 -39.16 90.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.454 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.584 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.0 OUTLIER 172.76 -54.16 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.171 -0.956 . . . . 0.0 109.827 179.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 37.5 Cg_endo -82.0 52.19 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.561 2.174 . . . . 0.0 110.577 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.37 32.08 1.11 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 31' ' ' SER . 6.5 t -52.0 146.4 8.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.355 -1.086 . . . . 0.0 109.793 -179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.489 ' O ' HG22 ' A' ' 13' ' ' VAL . 99.0 m -66.69 -33.18 75.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.307 -0.871 . . . . 0.0 109.189 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.545 ' HE1' HG23 ' A' ' 12' ' ' VAL . 0.3 OUTLIER -112.71 124.38 52.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.462 -0.774 . . . . 0.0 109.053 179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -113.05 -153.12 11.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 5.6 ttt180 -120.8 139.61 52.89 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.277 -1.131 . . . . 0.0 109.438 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 29' ' ' CYS . 0.5 OUTLIER -94.83 155.64 16.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.16 -0.962 . . . . 0.0 109.298 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.95 ' O ' HD23 ' A' ' 27' ' ' LEU . 31.9 mt-30 -148.69 172.2 14.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.235 -0.916 . . . . 0.0 109.522 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.85 35.64 0.9 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.302 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.1 t80 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.415 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -168.49 67.92 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.138 -0.976 . . . . 0.0 109.714 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.36 135.64 33.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.234 -0.916 . . . . 0.0 109.385 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 11.3 p -126.43 -174.03 3.01 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.252 -0.905 . . . . 0.0 109.571 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.448 ' O ' ' O ' ' A' ' 4' ' ' CYS . 7.5 mm-40 -53.41 -172.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.234 -0.916 . . . . 0.0 109.292 179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.19 121.57 31.62 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.61 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.414 ' HG2' ' N ' ' A' ' 8' ' ' GLY . 0.8 OUTLIER -60.57 149.0 36.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.42 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.414 ' N ' ' HG2' ' A' ' 7' ' ' GLN . . . 60.99 62.95 5.37 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -154.72 -151.81 0.37 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -1.152 . . . . 0.0 109.343 -179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -81.66 138.31 35.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.167 -0.958 . . . . 0.0 109.354 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 42.0 t -112.6 159.15 19.13 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.224 -0.922 . . . . 0.0 109.622 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 12' ' ' VAL . 11.6 p -118.42 127.83 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.287 -0.883 . . . . 0.0 109.484 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.749 HG22 ' O ' ' A' ' 37' ' ' THR . 4.0 m -117.12 -2.7 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -0.876 . . . . 0.0 109.461 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -89.66 54.41 2.87 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.922 . . . . 0.0 109.459 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.1 t -114.02 123.81 50.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.451 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.555 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 2.2 p90 -129.56 93.82 3.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.35 -0.844 . . . . 0.0 109.299 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.44 17.11 78.84 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.1 mp -105.8 164.16 15.59 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -1.125 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.97 -83.78 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.625 2.217 . . . . 0.0 110.459 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.445 HG21 HG11 ' A' ' 12' ' ' VAL . 10.8 m 48.18 69.98 0.49 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.251 -0.906 . . . . 0.0 109.458 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.42 HD13 ' HA ' ' A' ' 21' ' ' ILE . 16.4 mm -45.41 109.35 0.92 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.245 -0.909 . . . . 0.0 109.281 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.8 Cg_endo -77.63 -177.25 3.71 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.488 2.126 . . . . 0.0 110.571 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.596 ' HB3' HD13 ' A' ' 27' ' ' LEU . 77.7 m -48.05 176.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.371 -0.831 . . . . 0.0 109.609 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.507 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 54.9 m -74.21 174.69 8.39 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.477 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 ttm105 -67.92 137.29 55.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.486 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.96 -16.74 30.33 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.596 HD13 ' HB3' ' A' ' 23' ' ' CYS . 1.6 mp -93.88 167.82 11.38 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.242 -1.152 . . . . 0.0 109.456 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.88 167.81 20.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.456 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' SG ' HG12 ' A' ' 13' ' ' VAL . 18.6 t -123.67 128.95 50.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.477 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -124.24 110.86 15.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.509 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 13' ' ' VAL . 13.6 m -68.01 162.29 24.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.11 -0.994 . . . . 0.0 109.446 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.547 ' CE2' ' O ' ' A' ' 38' ' ' TYR . 27.9 m-85 -75.86 -71.34 0.38 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.188 -0.945 . . . . 0.0 109.541 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.558 ' N ' ' HD2' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 164.72 -52.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.414 -0.803 . . . . 0.0 109.474 -179.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 33' ' ' PHE . 36.0 Cg_endo -78.76 100.3 1.35 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.469 2.113 . . . . 0.0 110.403 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' OG ' ' A' ' 36' ' ' SER . . . 95.93 -33.58 5.47 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 35' ' ' GLY . 2.6 p 48.53 71.12 0.39 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -1.091 . . . . 0.0 109.532 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.749 ' O ' HG22 ' A' ' 13' ' ' VAL . 9.6 m -128.25 -74.69 0.57 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.49 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.547 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 3.2 m-85 -109.49 117.87 35.14 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.293 -0.88 . . . . 0.0 109.153 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.435 ' HA2' ' CE2' ' A' ' 32' ' ' TYR . . . -112.76 -128.3 4.93 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.7 ttt180 -133.25 144.37 49.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.378 -1.072 . . . . 0.0 109.479 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.5 t -106.64 120.86 43.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.259 -0.901 . . . . 0.0 109.218 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.509 ' O ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -114.94 175.21 5.6 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.187 -0.946 . . . . 0.0 109.748 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.45 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -117.91 67.87 0.76 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.364 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.407 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -148.18 77.77 1.41 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.34 -0.85 . . . . 0.0 109.41 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 5.5 ptm85 -163.29 36.25 0.09 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.924 . . . . 0.0 109.261 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 25.7 p -160.46 -177.24 6.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.259 -0.901 . . . . 0.0 109.447 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -104.25 179.69 4.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -0.869 . . . . 0.0 109.321 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD21 ' HE2' ' A' ' 9' ' ' PHE . 0.7 OUTLIER -82.44 173.11 12.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.154 -0.967 . . . . 0.0 109.412 -179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -81.65 138.4 35.3 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.302 -0.874 . . . . 0.0 109.561 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 96.77 74.26 1.19 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.422 ' HE2' HD21 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -156.15 -159.09 0.86 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.223 -1.163 . . . . 0.0 109.314 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -104.64 134.78 47.23 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.121 -0.987 . . . . 0.0 109.471 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 43.0 t -131.88 151.32 51.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.56 HG12 ' H ' ' A' ' 14' ' ' ARG . 7.2 t -95.1 145.92 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.189 -0.944 . . . . 0.0 109.47 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.533 HG11 ' HB3' ' A' ' 31' ' ' SER . 31.3 m -101.68 16.09 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.165 -0.96 . . . . 0.0 109.446 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.56 ' H ' HG12 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -140.74 17.55 2.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.353 -0.842 . . . . 0.0 109.367 -179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 17' ' ' GLY . 4.3 p -44.81 -29.68 0.83 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.395 -0.816 . . . . 0.0 109.561 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -48.35 98.2 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.243 -0.911 . . . . 0.0 109.244 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 15' ' ' SER . . . 140.35 -51.83 0.71 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.3 mp -102.12 150.82 37.83 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.343 -1.092 . . . . 0.0 109.094 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.2 113.82 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.399 2.066 . . . . 0.0 110.357 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.436 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -140.06 160.82 39.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.296 -0.878 . . . . 0.0 109.773 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.4 mp -98.17 109.82 53.56 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.343 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 23' ' ' CYS . 35.1 Cg_endo -77.48 160.15 32.09 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.348 2.032 . . . . 0.0 110.434 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.448 ' O ' ' O ' ' A' ' 22' ' ' PRO . 35.4 m -51.88 -175.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.181 -0.949 . . . . 0.0 109.653 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -84.24 168.75 15.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.335 -0.853 . . . . 0.0 109.476 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 11.1 ttp180 -59.69 135.28 57.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.273 -0.892 . . . . 0.0 109.36 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 104.84 -3.67 41.91 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.2 mp -114.53 170.56 8.22 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.246 -1.149 . . . . 0.0 109.313 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.48 163.67 39.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.955 . . . . 0.0 109.897 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.1 m -106.92 135.62 48.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.441 -0.787 . . . . 0.0 109.245 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.83 111.11 14.47 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.201 -0.937 . . . . 0.0 109.625 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.533 ' HB3' HG11 ' A' ' 13' ' ' VAL . 0.4 OUTLIER -66.19 140.41 58.18 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 179.808 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -57.58 -64.35 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.26 -0.9 . . . . 0.0 109.849 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 34' ' ' PRO . 97.8 m-85 -108.08 159.59 30.02 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.15 -0.969 . . . . 0.0 109.762 -179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 33' ' ' PHE . 35.5 Cg_endo -78.4 78.93 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.708 2.272 . . . . 0.0 110.457 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 152.44 -25.44 0.86 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -67.92 -178.66 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -1.166 . . . . 0.0 109.428 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.459 ' O ' HG22 ' A' ' 37' ' ' THR . 15.3 m -124.71 38.2 4.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.611 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.18 145.74 20.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 0.0 109.383 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.471 ' CA ' ' HA ' ' A' ' 31' ' ' SER . . . -146.63 -154.11 6.09 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 41' ' ' CYS . 5.8 ttm180 -139.88 142.77 36.5 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -1.142 . . . . 0.0 109.389 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.485 ' N ' ' HG2' ' A' ' 40' ' ' ARG . 47.7 t -83.47 141.14 31.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.218 -0.926 . . . . 0.0 109.5 -179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -148.68 -174.26 4.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.445 ' O ' ' OXT' ' A' ' 44' ' ' TYR . 3.5 ttp85 -93.12 49.3 1.4 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.386 -0.821 . . . . 0.0 109.511 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.569 ' O ' ' CD1' ' A' ' 44' ' ' TYR . 11.6 t80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.406 179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . . . . . . . . . 50.8 p90 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -151.16 -178.42 6.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 66.01 38.93 4.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.88 . . . . 0.0 109.459 -179.941 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -128.66 159.59 35.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.77 -173.61 2.39 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.892 . . . . 0.0 109.329 179.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.471 ' HB2' ' CD1' ' A' ' 9' ' ' PHE . 1.6 mt -96.25 170.77 9.02 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.391 -0.818 . . . . 0.0 109.521 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.22 133.43 40.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.219 -0.925 . . . . 0.0 109.365 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.79 68.59 1.53 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.471 ' CD1' ' HB2' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -143.79 -165.41 2.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -1.127 . . . . 0.0 109.529 -179.946 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -87.76 136.18 33.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.311 -0.868 . . . . 0.0 109.408 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 37.5 t -134.84 147.17 49.84 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.146 -0.971 . . . . 0.0 109.743 179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.44 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 2.2 p -89.37 150.2 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.32 -0.863 . . . . 0.0 109.325 179.891 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 37' ' ' THR . 0.5 OUTLIER -112.71 -22.04 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.663 -179.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.455 ' HB3' ' CE1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -113.36 -67.9 0.97 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 109.684 -179.767 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.42 ' CB ' ' O ' ' A' ' 14' ' ' ARG . 0.1 OUTLIER 70.53 85.59 0.13 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 0.0 109.131 -179.76 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -127.2 71.24 1.32 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.529 -179.702 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 164.49 -56.79 0.27 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.4 mp -132.71 149.09 72.03 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.305 -1.115 . . . . 0.0 109.494 179.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.18 96.89 1.11 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.702 2.268 . . . . 0.0 110.568 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.434 ' O ' ' C ' ' A' ' 21' ' ' ILE . 61.3 m -76.55 129.5 36.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.356 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.434 ' C ' ' O ' ' A' ' 20' ' ' THR . 52.8 mt -43.92 110.17 0.93 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.898 . . . . 0.0 109.217 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.96 167.62 24.84 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.355 2.037 . . . . 0.0 110.571 -179.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.9 m -71.3 -176.46 1.49 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.476 -179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -98.47 -161.67 0.89 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.878 . . . . 0.0 109.462 -179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.59 140.79 46.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.567 -179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.563 ' C ' HD22 ' A' ' 27' ' ' LEU . . . 88.84 -9.5 76.21 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.638 HD22 ' N ' ' A' ' 27' ' ' LEU . 3.7 mm? -99.73 96.61 7.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -1.104 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 28' ' ' THR . 0.6 OUTLIER -80.72 139.54 36.06 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.216 -0.928 . . . . 0.0 109.56 -179.955 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' O ' ' A' ' 12' ' ' VAL . 8.6 t -88.85 148.94 23.61 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.227 -0.921 . . . . 0.0 109.305 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 0.1 OUTLIER -154.67 140.66 18.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.374 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.14 179.05 7.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.843 . . . . 0.0 109.679 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' O ' ' CD2' ' A' ' 33' ' ' PHE . 25.4 m-85 -62.06 -47.13 86.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.334 -0.854 . . . . 0.0 109.547 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.565 ' CB ' ' HD3' ' A' ' 34' ' ' PRO . 0.2 OUTLIER 169.32 -53.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.286 -0.884 . . . . 0.0 109.714 -179.958 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 33' ' ' PHE . 36.7 Cg_endo -80.82 58.08 6.84 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.529 2.152 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 43.51 28.06 0.93 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -48.34 168.8 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -1.144 . . . . 0.0 109.385 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.439 HG21 ' OH ' ' A' ' 16' ' ' TYR . 17.5 m -92.4 -16.9 25.34 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.646 -179.807 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.408 ' O ' ' CE2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -135.38 141.84 45.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.323 -0.861 . . . . 0.0 109.644 -179.841 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -142.17 -128.86 2.35 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.862 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -143.77 176.26 9.38 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.213 -1.169 . . . . 0.0 109.37 179.971 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -123.62 120.42 32.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.291 -0.88 . . . . 0.0 109.357 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -111.16 176.05 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.015 . . . . 0.0 109.492 -179.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.44 18.33 14.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.0 109.553 -179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.165 -0.959 . . . . 0.0 109.462 179.862 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.431 ' H1 ' ' HD1' ' A' ' 1' ' ' TYR . 14.6 m-85 . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p 67.31 139.93 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.162 -0.962 . . . . 0.0 109.619 -179.935 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.5 112.47 0.71 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 0.0 109.562 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.471 ' HB3' ' O ' ' A' ' 22' ' ' PRO . 2.6 m -128.76 180.0 5.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.315 -0.866 . . . . 0.0 109.328 179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' OE1' ' O ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -53.64 164.76 0.49 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.23 -0.918 . . . . 0.0 109.305 179.863 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 137.65 32.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.881 . . . . 0.0 109.663 -179.644 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -52.86 103.03 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.265 -0.897 . . . . 0.0 109.398 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.23 44.18 0.8 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -128.6 -163.48 1.29 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.327 -1.101 . . . . 0.0 109.377 -179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -84.46 175.57 9.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.089 179.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.439 ' SG ' ' N ' ' A' ' 12' ' ' VAL . 26.5 t -155.2 156.73 36.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.035 -1.04 . . . . 0.0 109.768 -179.748 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.703 HG22 ' CE1' ' A' ' 38' ' ' TYR . 2.9 t -112.99 105.69 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.305 -0.872 . . . . 0.0 109.391 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 37' ' ' THR . 14.1 m -88.74 15.04 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.106 -0.996 . . . . 0.0 109.542 -179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.469 ' HD3' HG23 ' A' ' 37' ' ' THR . 0.0 OUTLIER -124.92 -5.04 7.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.327 -0.858 . . . . 0.0 109.665 -179.967 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.469 ' HB2' ' HG2' ' A' ' 19' ' ' PRO . 2.6 p -48.15 148.1 1.93 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.296 -0.877 . . . . 0.0 109.367 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.499 ' CD1' ' N ' ' A' ' 16' ' ' TYR . 9.3 p90 -127.36 106.25 9.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 109.42 179.952 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' O ' ' C ' ' A' ' 18' ' ' LEU . . . 97.22 30.42 7.4 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 -179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' N ' ' HD3' ' A' ' 19' ' ' PRO . 0.3 OUTLIER 42.21 59.17 10.22 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.543 -0.975 . . . . 0.0 109.724 -179.969 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' N ' ' A' ' 18' ' ' LEU . 36.4 Cg_endo -78.58 -60.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.53 2.154 . . . . 0.0 110.439 179.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.452 HG23 ' N ' ' A' ' 21' ' ' ILE . 5.5 t -63.26 -164.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.204 -0.935 . . . . 0.0 109.467 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.452 ' N ' HG23 ' A' ' 20' ' ' THR . 3.2 mt -123.62 98.18 40.84 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 0.0 109.388 -179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.471 ' O ' ' HB3' ' A' ' 4' ' ' CYS . 35.7 Cg_endo -77.19 158.11 33.66 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.492 2.128 . . . . 0.0 110.441 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.579 ' HB3' HD13 ' A' ' 27' ' ' LEU . 94.8 m -43.85 154.61 0.1 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.941 . . . . 0.0 109.68 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 56.2 m -55.62 166.6 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.546 179.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.54 145.53 22.86 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.467 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.82 -34.9 5.27 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.583 HD23 ' HA ' ' A' ' 43' ' ' ARG . 1.8 mt -86.35 167.75 14.48 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.398 -1.06 . . . . 0.0 109.294 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.37 135.88 41.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.097 -1.002 . . . . 0.0 109.841 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 13.7 t -90.53 146.43 24.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.382 -0.824 . . . . 0.0 109.076 179.762 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.3 ttt-85 -145.4 134.93 23.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.289 -0.882 . . . . 0.0 109.784 -179.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.444 ' HB2' HG11 ' A' ' 13' ' ' VAL . 0.9 OUTLIER -90.74 144.76 25.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.225 -0.922 . . . . 0.0 109.191 179.675 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' OH ' ' HG3' ' A' ' 40' ' ' ARG . 6.0 m-85 -47.16 -61.89 1.68 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.241 -0.912 . . . . 0.0 109.702 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -113.4 166.64 10.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 0.0 109.647 -179.74 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.02 93.19 1.09 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.751 2.301 . . . . 0.0 110.443 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 140.58 -33.49 2.05 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -46.46 163.26 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.381 -1.07 . . . . 0.0 109.443 -179.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.5 ' O ' HG22 ' A' ' 13' ' ' VAL . 20.6 m -103.93 -21.03 13.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.21 -0.931 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.703 ' CE1' HG22 ' A' ' 12' ' ' VAL . 0.0 OUTLIER -124.33 172.85 8.79 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.522 -179.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -175.54 -141.24 3.68 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.477 ' HG3' ' OH ' ' A' ' 32' ' ' TYR . 13.8 mtt180 -141.31 155.25 45.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -1.107 . . . . 0.0 109.371 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 52.4 t -103.57 128.39 50.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.186 -0.946 . . . . 0.0 109.437 -179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -149.82 179.36 8.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 0.0 109.432 179.984 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.583 ' HA ' HD23 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -85.76 47.38 1.43 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.854 . . . . 0.0 109.43 -179.838 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.489 ' OXT' ' CD2' ' A' ' 44' ' ' TYR . 82.3 t80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.506 179.887 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.497 ' O ' ' CB ' ' A' ' 2' ' ' SER . 1.8 t80 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 1' ' ' TYR . 1.2 m 75.75 122.17 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.259 -0.9 . . . . 0.0 109.409 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.3 mmm-85 -97.72 87.04 3.94 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.344 -0.847 . . . . 0.0 109.156 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 5.4 t -143.7 41.45 1.44 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 110.01 -179.906 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 55.12 -178.94 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.068 -1.02 . . . . 0.0 109.634 179.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -112.0 128.21 56.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.292 -0.88 . . . . 0.0 109.275 179.775 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -60.34 147.56 40.11 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 0.0 109.605 -179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.65 53.28 39.46 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.473 ' HB2' ' O ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -142.57 -161.21 1.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.165 -1.197 . . . . 0.0 109.486 179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 4.9 m120 -79.8 149.52 31.03 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.295 -0.878 . . . . 0.0 109.661 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 15.2 t -144.65 147.96 33.7 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.382 -0.824 . . . . 0.0 109.351 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.48 HG11 ' HB2' ' A' ' 15' ' ' SER . 58.4 t -96.16 149.47 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.179 -0.951 . . . . 0.0 109.171 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.9 m -108.73 -20.34 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.148 -0.97 . . . . 0.0 109.872 -179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.433 ' O ' ' O ' ' A' ' 15' ' ' SER . 0.0 OUTLIER -133.06 -49.77 0.87 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.237 -0.914 . . . . 0.0 109.616 -179.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.48 ' HB2' HG11 ' A' ' 12' ' ' VAL . 1.2 t 62.27 127.84 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 0.0 109.436 -179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 7.1 p90 -138.91 84.65 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.278 -0.889 . . . . 0.0 109.427 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.415 ' C ' ' HG ' ' A' ' 18' ' ' LEU . . . 159.83 -53.62 0.36 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.434 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 1.9 mt -137.29 157.99 73.19 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -1.165 . . . . 0.0 109.062 179.8 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 18' ' ' LEU . 34.8 Cg_endo -77.02 95.21 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.358 2.039 . . . . 0.0 110.45 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.419 HG21 ' HB ' ' A' ' 12' ' ' VAL . 14.1 t -69.07 153.49 43.67 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 21' ' ' ILE . 4.2 mp -86.26 126.35 65.1 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.151 -0.968 . . . . 0.0 109.419 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.71 169.5 19.58 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.436 2.09 . . . . 0.0 110.345 179.95 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 10.2 m -68.72 163.8 23.15 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 0.0 109.493 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -63.36 167.85 4.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 58.4 ttp85 -65.34 129.52 40.04 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.889 . . . . 0.0 109.43 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.42 -1.97 32.71 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.648 HD23 ' O ' ' A' ' 42' ' ' GLN . 0.2 OUTLIER -100.12 -167.82 1.51 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.35 179.952 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.423 ' O ' ' HA ' ' A' ' 41' ' ' CYS . 0.3 OUTLIER -153.8 136.87 15.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.319 -0.863 . . . . 0.0 109.626 -179.745 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 36.4 t -124.97 128.67 48.95 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.318 -0.864 . . . . 0.0 109.235 179.776 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' O ' ' HA3' ' A' ' 39' ' ' GLY . 2.0 ttp85 -144.88 153.85 42.01 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.082 -1.011 . . . . 0.0 109.819 -179.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.471 ' HA ' ' HA3' ' A' ' 39' ' ' GLY . 1.9 p -95.41 149.82 20.96 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.277 -0.89 . . . . 0.0 109.309 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -65.15 -65.5 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.109 -0.994 . . . . 0.0 109.497 -179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.07 157.08 37.11 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 109.674 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -77.89 81.86 2.58 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.558 2.172 . . . . 0.0 110.256 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 155.99 -35.97 0.61 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.331 -1.508 . . . . 0.0 109.331 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.3 m -61.17 146.0 49.14 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.43 -1.041 . . . . 0.0 109.36 179.905 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.21 27.79 3.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 109.594 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -145.98 159.01 43.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 30' ' ' ARG . . . -164.57 -135.31 1.8 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.4 ttt180 -148.87 155.12 40.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -1.143 . . . . 0.0 109.408 -179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 28' ' ' THR . 7.8 t -117.39 144.04 45.37 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.267 -0.895 . . . . 0.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.648 ' O ' HD23 ' A' ' 27' ' ' LEU . 90.1 mt-30 -142.6 178.33 7.69 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.168 -0.957 . . . . 0.0 109.665 -179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.0 OUTLIER -89.52 39.68 0.96 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -0.917 . . . . 0.0 109.505 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.145 -0.972 . . . . 0.0 109.467 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' TYR . . . . . 0.443 ' O ' ' O ' ' A' ' 2' ' ' SER . 9.1 m-85 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 1' ' ' TYR . 1.1 m 58.11 111.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.279 -0.888 . . . . 0.0 109.386 -179.935 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.63 154.03 2.41 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.127 -0.983 . . . . 0.0 109.424 179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.527 ' HB2' ' N ' ' A' ' 24' ' ' CYS . 11.4 p -105.91 62.5 0.66 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.586 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.458 ' HB2' ' O ' ' A' ' 4' ' ' CYS . 0.0 OUTLIER 60.88 -175.16 0.12 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.344 -0.847 . . . . 0.0 109.733 179.818 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -126.6 171.56 11.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.266 -0.896 . . . . 0.0 109.293 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -74.66 144.71 43.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 0.0 109.242 179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 55.37 77.62 0.15 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -154.37 -163.41 1.6 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -1.106 . . . . 0.0 109.497 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -95.2 141.49 28.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.209 -0.932 . . . . 0.0 109.78 -179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 38.4 t -143.17 148.1 35.99 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.351 -0.843 . . . . 0.0 109.299 179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG23 ' CE1' ' A' ' 38' ' ' TYR . 6.2 p -91.8 154.52 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.195 -0.941 . . . . 0.0 109.506 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.9 m -122.34 -27.87 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.485 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -36.36 3.61 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.204 -0.935 . . . . 0.0 109.591 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.416 ' HA ' HG21 ' A' ' 12' ' ' VAL . 0.5 OUTLIER 59.29 159.03 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.436 -0.79 . . . . 0.0 109.637 179.892 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 18' ' ' LEU . 5.9 p90 -153.0 79.44 1.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.352 -0.842 . . . . 0.0 109.509 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 61.03 56.02 26.38 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 16' ' ' TYR . 0.0 OUTLIER -150.57 143.88 16.84 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.29 -1.124 . . . . 0.0 109.413 179.855 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 36.3 Cg_endo -78.81 101.15 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.609 2.206 . . . . 0.0 110.429 179.989 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 m -135.18 116.8 14.88 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.302 -0.874 . . . . 0.0 109.436 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.408 HG21 HD13 ' A' ' 21' ' ' ILE . 23.0 mt -84.51 125.45 71.58 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 109.351 179.888 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.24 173.28 14.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 C-N-CA 122.381 2.054 . . . . 0.0 110.342 -179.876 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.659 ' HB3' HD12 ' A' ' 27' ' ' LEU . 7.3 m -67.53 153.27 44.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.893 . . . . 0.0 109.467 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.527 ' N ' ' HB2' ' A' ' 4' ' ' CYS . 7.9 p -87.35 -179.28 6.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.198 -0.939 . . . . 0.0 109.471 179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -50.71 143.71 9.25 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.247 -0.908 . . . . 0.0 109.332 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 109.8 -33.63 5.93 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.659 HD12 ' HB3' ' A' ' 23' ' ' CYS . 36.0 mt -105.24 -168.79 1.51 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.14 . . . . 0.0 109.432 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.06 119.41 2.81 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.244 -0.91 . . . . 0.0 109.522 179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.4 t -82.72 105.53 13.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.092 -1.005 . . . . 0.0 109.451 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.48 139.78 46.62 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.337 -0.852 . . . . 0.0 109.393 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 60.1 p -73.96 166.01 24.13 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.304 -0.873 . . . . 0.0 109.575 179.927 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.545 ' O ' ' CD1' ' A' ' 33' ' ' PHE . 54.3 m-85 -58.54 -56.22 24.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.166 -0.958 . . . . 0.0 109.524 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.56 ' N ' ' CD ' ' A' ' 34' ' ' PRO . 0.1 OUTLIER 163.97 -51.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.08 -1.012 . . . . 0.0 110.024 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.56 ' CD ' ' N ' ' A' ' 33' ' ' PHE . 37.0 Cg_endo -80.25 57.32 6.45 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.775 2.316 . . . . 0.0 111.177 -179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.42 ' C ' ' O ' ' A' ' 34' ' ' PRO . . . 42.41 47.73 5.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.5 144.73 39.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.329 -1.101 . . . . 0.0 109.571 179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.42 ' O ' HG22 ' A' ' 37' ' ' THR . 88.8 m -71.12 -10.31 59.55 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.222 -0.923 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . 0.424 ' CE1' HG23 ' A' ' 12' ' ' VAL . 1.4 m-85 -129.5 -175.47 3.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.174 -0.954 . . . . 0.0 109.37 179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -173.47 -151.79 8.39 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.413 ' HD2' ' CE1' ' A' ' 32' ' ' TYR . 1.5 mtp85 -134.51 161.32 35.4 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.294 -1.121 . . . . 0.0 109.391 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 11.9 t -109.93 128.48 55.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 109.489 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -122.7 175.36 6.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 0.0 109.41 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 3.6 mtm180 -92.82 40.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.893 . . . . 0.0 109.438 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.024 -0.988 . . . . 0.0 109.49 179.924 . . . . . . . . 1 1 . 1 stop_ save_